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Abstract 
The brocazines are a family of natural products bearing a disulfide diketopiperazine core that was 
isolated by Meng et al in 2014 and 2016 from an endophytic fungus derived from the marine 
mangrove plant Avicennia marina named Penicillium brocae MA-231. Seven different brocazines 
(A-G) and three different spirobrocazines were isolated, and of those brocazine F showed the 
strongest activity against prostate cancer cell line DU145 (IC50 of 1.7 M) and lung cancer cell 
line NCI-H460 (IC50 of 0.89 M). Brocazine G showed strong activity against ovarian carcinoma 
cell line A2780 (IC50 of 0.664 M), Ovarian endometrioid adenocarcinoma A2780 CisR cells 
(IC50 of 0.661 M) as well as possessing strong and selective activity against human pathogen 
Staphylococcus aureus (MIC of 0.25 μg/mL). Given the potent cytotoxicity of brocazine F and G 
and their intriguing polycyclic core structure, our laboratory devised a total synthesis route to 
access this family. By focusing on these compounds, we envision the construction of a screening 
library yielding a new series of small molecules; which can be accessed through the intermediates 
of the total synthesis route employed for the construction of brocazine F and G. Each intermediate 
will serve as the starting material for a unique set of small molecules, structurally different from 
the original natural product, but potentially having unique and potent biological activity. 
Therefore, the goal of this dissertation is to establish a reliable and reproducible route to access 
the brocazine family of diketopiperazine (DKP) natural products, from which the intermediates 
can be amendable for chemical derivatization for complex screening library construction.  
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Chapter 1 - Isolation of Brocazine Class Natural Products 
 
1.1 Natural Products and the Importance of Total Synthesis 
 
Natural products are mainly secondary metabolites produced by nature to perform specific 
functions such as self-defense, cell communication, and stress responses; though some natural 
products have interesting biological properties that can be used as therapeutics.1-3 Use of natural 
products for healthcare ranges from using a mixture of natural compounds, isolation of biologically 
important compounds from the original natural sources, total synthesis, and synthesizing of 
derivatives from the original natural products.4,5  54% of all the drugs that have been approved 
from 1981 to 2014 are either natural products (N), natural products derivatives (ND), or natural 
products mimics (NM) (Scheme 1.1.1).6 13% of the them were directly originated from natural 
products, 21% were the derivatives of natural products, and 20% were the mimics of the natural 
products. Only 46% of the drugs approved were discovered from synthetic and biological based 
sources. Therefore, it can be concluded that the natural products play a vital role in drug discovery 
research.   
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Scheme 1.1.1: All Approved Drugs from 1981-2014 
 
Total synthesis of natural products provides a reliable and sustainable way to access biologically 
active natural compounds for therapeutic applications. However, they can also be beneficial in 
opening new areas in drug discovery research.7-9 Previously, screening libraries were primarily 
filled with natural products and synthetic dyes. Later, synthetically derived and  target-based small 
molecules were added into screening libraries.10 With the use of high-throughput screening, it led 
to the need of more and more compounds for rapid assay screenings. Throughout these years, 
natural roducts remain to be a great souse to populate screening libraries due to their complex 
structures. Natural products can be considered as a great source to populate screening libraries, 
and to construct screening libraries by derivatization to access large number of small molecules, 
mainly due to their complex structures and the amenability for many chemical reactions (to be 
discussed later in this chapter).11 There are many methods that can be used for screening library 
construction, which include platform-based synthesis and derivatization the original natural 
product.  
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Most commercially available libraries, such as the ChemBridge library (largest chemical screening 
library), are synthesized via platform-based synthesis. In platform based synthesis, a large number 
(>10,000) of different molecules can be synthesized in a short period of time using automated 
methods.12 As such, these libraries are composed of mainly small molecules that are flat (as 
evaluated by the percentage/fraction of sp3-hybridized atoms in the compound) and lacking a large 
percentage of stereocenters. Multiple drugs have been discovered and approved by the FDA 
employing the ChemBridge library. A large percentage of these drugs act as kinase inhibitors, and 
also cause many off target side effects.13-15 Kinases are very common enzymes that play vital roles 
in cell growth and metabolism, though the overexpression of kinases can be observed in some 
disease conditions such as cancer. Therefore, the inhibition of kinases can cause various side 
effects due to their inhibition of undesired targets. Therefore, discovering bioactive molecules with 
higher degree of complexity is crucial in drug discovery research to have higher efficiency with 
lower side effects. Quantifying molecular complexity is no easy task and has been done in a variety 
of means.16-18 One such metric to assess molecular complexity can be performed by assessment of 
the percentage/fraction of sp3 hybridized carbons (Fsp3) and the number of stereo centers. 
Together, Fsp3 and the number of stereocenters can be an indicator of three-dimensional shape of 
molecules.19 In additional to molecular complexity, lipophilicity is also another major point of 
consideration for library design. Lipophilicity is commonly quantified by cLogP, which explains 
the absorption and the permeation of the molecule.20 The complexity and the lipophilicity of 
molecules directly affect the probability of finding drug candidates, which have higher potency 
and selectivity towards a particular protein target. Therefore, screening libraries with higher Fsp3 
/stereo centers and lower cLogP values have higher probability of finding drug like molecules. 
Small molecules in Chembridge library have the average Fsp3 of 0.23, whereas the average Fsp3 
4 
of FDA approved drugs is 0.47 (Scheme 1.1.2 A). The average number of  stereo centers in FDA 
approved drugs and the Chembridge library are 4.94 and 0.24, respectively (Scheme 1.1.2 B).18 
ChemBridge has been used to discover most of the compounds found in the FDA. However, Fsp3 
of the large percentage of molecules having antibacterial and anticancer activities is significantly 
higher than the Fsp3 of the molecules in ChemBridge library (Scheme 1.1.2 C). Moreover, the 
number of stereocenters of molecules having anticancer and antibacterial activities is significantly 
higher than that of ChemBridge library (Scheme 1.1.2 D). This means that there is a gap (shown 
in green boxes) in ChemBridge library that needs to be filled with molecules with higher degree 
of complexity. Therefore, it is beneficial to construct small molecule screening libraries with 
higher Fsp3and higher number of stereocenters to increase the probability of discovering molecules 
with drug like properties.  
 
Scheme 1.1.2: Fsp3 and Stereocenters of Small Molecules in ChemBridge Library 
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While ChemBridge is the most utilized, commercially available, small molecule screening library, 
multiple other academic research laboratories are developing new routes to construct their own 
libraries with targeted properties.21-24 One example is that of Prof. Paul Hergenrother at the 
University of Illinois who employs natural products as starting materials for the construction of 
screening libraries via ring distortions, termed complexity to diversity, in 2013.18 In this approach, 
the concept is to diversify a natural product into core scaffolds that differ from the parent natural 
product. These scaffolds are then further functionalized to provide new libraries for screening 
purposes that possess complexity imparted from the parent natural product. Accessing the core 
scaffolds was envisioned to arise from the diversification of the natural product through known 
synthetic transformations. Scheme 1.1.3 highlights the overview of the core scaffold construction. 
Starting from a polycyclic system, a natural product, it was envisioned that diversification of 1 
could arise from ring cleavage accessing 2. Furthermore, ring expansion upon 1 could access 3 
giving access to different chemical space found in both 1 and 2. Ring fusion upon 1 could also be 
performed to give access to 4, and similarly ring contraction of 1 to 5. Furthermore, these 
diversifications could be performed in parallel giving access to core scaffolds such as 6.  
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Scheme 1.1.3: General Concept of the Derivatization of Small Molecules 
 
In the complexity to diversity concept, the number of diversification steps could be endless. 
Therefore, Hergenrother decided to set forth a rule that all diversifications should be done in five 
synthetic steps or less.18, 25, 26 Numerous collection of libraries were constructed from various 
natural products, each possessing high Fsp3 character, high percentage of stereocenters, and 
synthetically amendable to allow for construction of targeted clogP properties. Unfortunately, 
screening of these collections of compounds (>500 compounds) revealed that all the biological 
activities were highly comparable to the parent natural product. While undesirable for the 
construction of variable chemical screening libraries, further thought on this matter led to the same 
conclusion. Each natural product employed in this route was synthesized and refined by nature to 
perform a particular function, and therefore, synthetic manipulations to the final natural product is 
less likely to produce molecules with different biological activities. Therefore, synthesis of 
libraries via a non-bio-inspired synthetic routes could give rise to small molecule libraries, which 
have a higher probability of finding molecules with different activities.  
1
2
34
5
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Our lab envisions on a noval   way of accessing new complex small molecule screening libraries 
by derivatizing the intermediates within total synthesis routes of natural products. This could allow 
the access of complex and diverse small molecule libraries that could potentially have diverse 
biological activities. We envision that this approach should prevent the activity biased by the 
natural product due to non-natural synthetic route that is being developed, as long as the route is 
not bio-inspired. For this endeavor, a natural product, which has a complex chemical structure and 
amendable for many chemical modifications will be selected as the first candidate for the 
derivatization. The natural product will be accessed from a commercially available material and 
many intermediates will be accessed in this synthetic route (Scheme 1.1.4). These intermediates 
will be derivatized to access screening libraries with scaffolds different to the original natural 
product, which could also potentially have activities different to the original natural product due 
to non-natural synthesis.  Therefore, the goal of this dissertation is to establish a reliable and 
reproducible route to access the brocazine family of diketopiperazine (DKP) natural products, from 
which the intermediates can be amendable for chemical derivatization for complex screening 
library construction. Furthermore, if the diversification of the intermediates within our brocazine 
fails to deliver new libraries with complex biological activities, the brocazine natural products 
accessed (each with wide biological activities) can be diversified via the complexity to diversity 
strategy for screening library construction.  
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Scheme 1.1.4: Screening Library Construction through Total Synthesis of Natural Products 
 
 
1.2 Diketopiperazines 
 
 
Many of the natural products that possess potent biological activities have 2,5-diketopiperazines 
(2,5-DKPs) core.27, 28 Structure of DKPs consists of a six membered cyclic ring with two amide 
bonds, and are the smallest possible cyclic peptides found in nature (Scheme 1.2.1).14 
 
Scheme 1.2.1  General Structure of 2,5-Diketopiperazine 
 
Some examples of naturally occurring bioactive DKPs currently used as therapeutics are 
Retosiban, Tadalafil, Plinabulin, and Aplaviroc (scheme 1.2.2). Retosiban is an oxytocin receptor 
antagonist developed by GlaxoSmithKline as a treatment for preterm labour.27, 29, 30 Plinabulin is 
a tubulin polymerization inhibitor that is in clinical trial for non-small cell lung cancer.27, 31 
Tadalafil is a phosphodiesterase inhibitor that is used to treat benign prostatic hyperplasia (BPH) 
and pulmonary arterial hypertension.27, 32 Aplaviroc is a CCR5 inhibitor developed by 
GlaxoSmithKline as a treatment for HIV infection.27, 33, 34 In addition, there are many bioactive 
DKP natural products that have been recently isolated from marine sources, which includes 
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epicoccins, brocazines, and spirobrocazines, which will be discussed later in this chapter and 
chapter 2.26, 35, 36 
 
Scheme 1.2.2: Examples of Biologically Active 2,5-Diketopiperazine Therapeutics  
(DKPs are highlighted in red) 
 
1.3 Isolation and Biological Activity of Brocazine F and G 
 
The brocazines are a new class of DKP natural products were isolated in 2014 by Wang group. 
These molecules were isolated from a bioassay guided approach to isolate bioactive natural 
products from marine sources. Brocazine family is a thiodiketopiperazines containing natural 
products that were isolated from fungal strain Penicillium brocae MA-231, which is an endophytic 
fungus derived from marine mangrove plant Avicennia marina.26 These compounds were isolated 
from the extracts of P. brocae MA-231 with multiple extractions with ethyl acetate and using a 
combination of column chromatography techniques such as silica gel, sephadex LH-20, and 
HPLC. Structurally, the brocazine family share a similar DKP carbon framework, highlighted in 
red, as shown in scheme 1.3.1. All brocazines have a thiodiketopiperazine central core, with one 
or more alcohol groups attached. Brocazine A and B possess ketone and enone systems, whereas 
brocazine C possesses a ketone in one side and an allylic diol system in the other side. Brocazine 
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D has two ketone systems and brocazine E has two allylic diol systems, whereas brocazine F 
possesses an enone system and an allylic diol system.  
 
Scheme 1.3.1: Structures of Brocazine A-F 
 
The brocazine cytotoxicity was determined by screening against different types of cancer cell lines: 
human prostate cancer (Dul45), human cervix carcinoma (HeLa), Human hepatoma cells (HepG2), 
human breast carcinoma (MCF-7), human large-cell lung carcinoma (NCI-H460), human gastric 
(SCG-7901), human pancreatic cancer (SWI-990), human colon carcinoma cancer (SW480), and 
human glioma cells (U251). Brocazine A, B, E, and F showed activity against many cancer cell 
lines tested.26 Most notably, it was found that brocazine F possessed an IC50 value of 0.89 μM 
against human large cell lung cancer cell line, NCI-H460. However, brocazine C and D did not 
show any activity toward none of the cell lines tested. These cytotoxic data suggest that the 
presence of either enone systems or the presence of more than one allylic diol systems are essential 
for the activity of brocazines.  
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Table 1.3.1: Cytotoxicity of Brocazine A-F Against Nine Tumor Cell Lines (IC50, μM) 
 
Human prostate cancer (Dul45), human cervix carcinoma (HeLa), Human hepatoma cells 
(HepG2), human breast carcinoma (MCF-7), human large-cell lung carcinoma (NCI-H460), 
human gastric (SCG-7901), human pancreatic cancer (SWI-990), human colon carcinoma cancer 
(SW480), human glioma cells (U251). --: no activity (>20 μM). N.t.: not tested. Paclitaxell, 
Cisplatinm, Cefitinibn, Doxorubicino, Gemcitabinep.) 
 DUL45 HELA HEPG2 MCF-7 NCI-
H460 
SGC-
7901 
SWI990 SW480 U251 
1 4.2 6.8 6.4 5.5 4.9 2.6 6.0 2.0 5.2 
2 3.6 5.3 5.5 6.1 4.0 2.4 6.4 1.2 3.5 
3 -- -- -- -- -- -- -- -- -- 
4 -- -- -- -- -- -- -- -- -- 
5 11.2 4.3 5.6 9.0 12.4 2.2 2.1 n.t 6.1 
6 1.7 6.9 2.9 3.0 0.89 8.0 5.9 n.t 5.3 
Positive 
control 
1.5l 5.0l 5.1m 1.8l 7.6n 2.9o 2.2p 11.3m 10.8n 
 
 
In 2016, Wang group isolated brocazine G and three different types of spirobrocazines (A-C) from 
fungal strain Penicillium brocae MA-231 (Scheme 1.3.2).35 Among these newly isolated 
brocazines, brocazine G showed strong activities towards A2780 (human ovarian cancer) and 
A2780 CisR (cisplatin resistance human ovarian cancer) cell lines with IC50 values of 0.664 μΜ 
and 0.661 μΜ respectively. In addition, brocazine G showed strong and selective activity against 
human pathogen Staphylococcus aureus with MIC value of 0.25 μg/mL. 
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Scheme 1.3.2: Structures of Spirobrocazine (A-C) and Brocazine 
 
Brocazine F/ G were selected for the total synthesis campaign due to their interesting biological 
activities, which have been discussed previously. Furthermore, brocazine F/G and the 
intermediates of the proposed synthetic route possess complex structures, which are amendable 
for many chemical modifications for screening library construction. Therefore, it was envisioned 
that the total synthesis campaign of brocazines and the screening library construction would open 
new areas of drug discovery research. Moreover, in the case of failed hypothesis of screening 
library construction from the intermediates of the route, it would be still possible to access the total 
synthesis of bioactive natural products, brocazine F and G. Moreover, the derivatization of the 
final natural products can be performed to access a small molecule screening library with higher 
degree of complexity.  
 
1.4 Synthetic Challenges of Brocazine’s & Similarity and Differences towards the Epicoccin’s  
 
 
To date, no synthesis of the brocazine family, or work towards this family has been reported. Upon 
selection of this family of natural products a closely related natural product family was found, the 
epicoccin’s. The epicoccin and brocazine families belong to the same thiodiketopiperazine family 
of natural products. Although both share a similar carbon framework, they do have some 
13 
differences, which have been highlighted (Scheme 1.4.1). Epicoccin G contains thiomethyl groups 
in the central DKP core, whereas, brocazine F and G have disulfide linkages in their central DKP 
cores. Moreover, epicoccin G has two cis 6:5 fused systems making the compound more puckered, 
whereas, brocazines have one or two trans 6:5 fused systems which makes their structure planer. 
Accessing trans 6:5 fused systems is challenging due to their planer conformation, which makes 
reaction conditions applicable to trans systems unavailable. This is mainly due to the difficult 
accessibility of the reagents to the reaction site producing the desired products. Moreover, the 
synthesis of trans 6:5 fused systems has not been reported as much compared to that of cis 6:5 
fused systems due to their synthetic challenges.  However, the synthesis of cis 6:5 fused system 
containing natural products such as epicoccin G and acetylaranotin has been reported by many 
research groups.37-39 In addition, the synthesis of asymmetrical DKPs are challenging as the 
functionalities need to be introduced to individual 6:5 fused systems before coupling them together 
to access DKP cores. However, in symmetrical DKPs, DKP core can be accessed first and the 
functionalities can be introduced directly to the DKP core (to be discussed in chapter 2). Therefore, 
some of the chemistry that has been used for symmetrical cis 6:5 systems such as epicoccin G and 
acetylaranotin cannot be directly used for the synthesis of brocazine F and G, and the development 
of new routes to access trans 6:5 system need to be explored.  
Individual 6:5 fused bicycle 
  
 
Scheme 1.4.1: Structural Differences of Epicoccin G and Brocazine F and G 
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1.5 Retrosynthetic Analysis of Brocazine F and G  
 
 
Proposed retrosynthetic analysis for the synthesis of brocazine F and G (Scheme 1.5.1). The final 
stages of accessing brocazine F and G are proposed to follow analogous disulfide incorporation 
upon the respective DKP cores, 7 and 8. DKP cores 7 and 8 can be accessed from the coupling of 
of 9/10 and 10/11, respectively. Diol 10 can be accessed from a palladium catalyzed deoxygenation 
of α-hydroxy ketone 12. Enone 9 can be directly accessed via an DMP oxidation of diol 10. The 
diene 11 can be accessed via a Zn-catalyzed elimination of the benzyl group of α-hydroxy ketone 
12, followed by the triflate enol ether formation and triflate elimination. The -hydroxy ketone 12 
can be stereo selectively accessed from the spiralization, ring rearrangement, benzoylation, and 
stereo selective Rubottom oxidation of the commercially available material Cbz-L-tyrosine.  
 
 
 
Scheme 1.5.1: Retrosynthetic Analysis of Brocazine F and G 
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Chapter 2 - Previous Synthetic Work  
 
 
2.1 Natural Products Similar to Brocazines 
 
 
Total synthesis of brocazine F and G has not yet been achieved. However, the total syntheses of 
DKP natural products similar to brocazines have been successfully achieved by several research 
groups. A literature review of the synthesis strategies that have been used in accessing brocazine 
like natural products will be discussed in this chapter. Epicoccin G, gliotoxin, and acetylaranotin 
are some natural products that are similar to brocazines. All of these natural products consist of at 
least one fused bicycle system, and these fused bicycles can be coupled together to access the DKP 
core of the natural product (Scheme 2.1.1). 
 
Scheme 2.1.1: Structures of Brocazine F & G and Natural Product Similar to Brocazines 
 
 
2.2 Accessing Trans Fused Bicycle System Utilizing the Chemistry Developed by Wipf Group 
 
 
The Wipf group has established a synthetic procedure that have been used by multiple groups for 
the synthesis of natural products with DKP cores.40 Wipf’s route to gain access to the 6:5 fused 
ring system commenced with the phenolic oxidation of Cbz-L-tyrosine with iodobenzene diacetate 
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to access the 6:5 spiral 13 in 35% yield. Subjecting 13 to basic methanol promoted lactone cleavage 
and subsequent amine addition via 1,4-Michael pathway to access 14 in 97% yield. Compound 14 
was benzoylated to obtain 15 in 56% yield, which was in turn transformed through a palladium-
catalyzed elimination to access trans-fused bicycle 16 in 90% yield. The final natural product 
tuberostermonine was obtained after 23 steps from compound 16 with the overall yield of 5.78% 
(Scheme 2.2.1).40 This chemistry, developed by Wipf group has laid foundation to multiple natural 
product total synthesis, which will be discussed later in this chapter.  
 
 
Scheme 2.2.1: Synthesis of trans 6:5 Fused Bicycle Compound 16 from Cbz-L-Tyrosine 
 
 
2.3 Total Synthesis of Epicoccin G by Nicolaou Group 
 
Epicoccin G, a symmetrical natural product, was isolated from the endophytic fungus Epicoccum 
nigrum by Dan Du and coworkers in 2010.36  This natural product has shown to exhibits anti-HIV 
activity in C8166 cells with the IC50 value of 13.5 μM. The enantioselective total synthesis of 
epicoccin G has been achieved by Nicolaou group in 2011.37 In this synthetic work, they have used 
some of the chemistry developed by Wipf group, as well as two-directional sulfenylation, 
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photooxygenation, and Kornblum - DeLaMare rearrangement to allow for enantioselective access 
the final natural product. 
 
Compound 17 was accessed via the route developed by Wipf group as discussed in subsection 2.2. 
Cis enone bicycle 18 was accessed via three step procedure, which includes acetylation of the 
tertiary alcohol of 17, followed by the zinc facilitated reduction, and base-induced isomerization 
with the overall yield of 51%. Luche reduction of enone 18 gave access to 19 in 92% yield and the 
saponification and Boc deprotection of 19 separately gave access to 20 in 99% and 21 in 99% 
yields, respectively. Coupling of compound 20 and 21 was performed with BOPCl, followed by 
Boc deprotection and aminolysis to yield DKP compound 22 with the overall yield of 66% over 3 
steps (Scheme 2.3.1).37  
 
 
Scheme 2.3.1: Synthesis of DKP Compound 22 from Compound 17 
 
Bistrifluoroacetate 23 was accessed from the trifluoroacetylation of compound 22 using 
trifluoroacetic anhydride in 69% yield. Treatment of 23 with Pd(PPh3), K2CO3 in dioxane 
promoted the elimination of the trifluoroacetate group to afford diene 24 in 90% yield. 
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Bismethylsulfonation was achieved with the formation of oligosulfide by using elemental sulfur 
and KHMDS, followed by the reduction of oligosulfide using NaBH4 with the subsequent 
quenching of the reaction using MeI to yield 25 in overall yield of 58% (Scheme 2.3.2).37 
 
Scheme 2.3.2: Synthesis of Bismethylsulfonated 25 from 22 
 
Accessing the oxidized carbon core was accomplished by a [4+2] addition of O2 (g) to diene 25 to 
afford 26, followed by the treatment of DBU to undergo regioselective Kornblum-DeLaMare 
rearrangement to give rise to 27 in 52% yield. DBU is a large non-nucleophilic bulky base and it 
can only access the hydrogen adjacent to the thiomethyl group resulting the desired product 27 due 
to sterics. In this procedure, alcohol enone systems can be stereo selectively introduced in one step 
procedure. However, this procedure uses O2 (g), TPP, and h, which can make the reaction 
dangerous and non-cost effective. Finally, the compound 27 was reduced by catalytic 
hydrogenation with Pd(OH)2/C to afford the natural product epicoccin G in 86% yield (Scheme 
2.3.3).37  
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Scheme 2.3.3: Synthesis of Epicoccin G from 25 via Regioselective Kornblum-DeLaMare 
Rearrangement 
 
2.4 Accessing Diene Bicycle System Utilizing the Chemistry Developed by Sundburg Group 
 
 
In 1996, Sundburg group developed a method to access the diene fragment of gliotoxin 32 using 
Rubottom oxidation and mercury amalgam facilitated elimination of a benzyl group.41 From 15, 
accessed by Wipf, TBS enol ether formation was performed using TBSOTf to afford the TBS enol 
ether 28 in 98% yield.40, 41 Compound 28 was then subjected to Rubottom oxidation conditions 
empoying DMDO as the oxidant to obtain 29 in 83% yield. Surprisingly, the crystal structure of 
compound 29 showed that the resultant alpha hydroxyl group (Shown in red) possessed S 
configuration compared to that of gliotoxin (R configuration) (Scheme 2.6). Compound 30 was 
accessed by the Luche reduction of enone 29 in 99% yield, and this material was acetylated to give 
31 in 94% yield. Mercury amalgam facilitated elimination of benzyl group of 31 resulted the 
opposite isomer of the diene system 32 of gliotoxin in 56% yield (Scheme 2.4.1).41 
20 
 
Scheme 2.4.1: Synthesis of Diene Alcohol Compound 32 from Compound 15 
  
2.5 Accessing Diene Bicycle System Utilizing the Chemistry Developed by Nicolaou Group 
 
 
In 2012, Nicolaou group developed a synthetic route to access gliotoxin utilizing the chemistry 
developed by Wipf and some of the chemistry that they have used for their total synthesis of 
epicoccin G.38 In this synthetic route, they have used diene formation, photooxidation, and Corey-
Winter Olefination to stereo-selectively access gliotoxin.  Luche reduction of enone 17 gave the 
selective reduction of the carbonyl group in enone system to obtain enol 33 in 99% yield. 
Stoichiometric control of acetylation of 33 only resulted the desired monoacetylated product 34 in 
91% yield. Palladium-catalyzed elimination of compound 34 accessed diene 35 in 86% yield, 
which was then subjected to photochemical addition of O2 (g) to access 36 in 73% yield. Treatment 
of compound 36 with thiourea resulted in the formation of the triol 37 in 84% yield. After the 
selective protection of lower alcohol group with TIPS group, thiocarbonyl group was introduced 
to 1, 2- diol system to yield compound 38 with the overall yield of 86%. Compound 38 was then 
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deoxygenated and deprotected to yield compound 39 in overall yield of 80%. Final natural product 
gliotoxin was obtained after 4 steps from diene 39 with the overall yield of 12.6% (Scheme 2.5.1).  
 
 
Scheme 2.5.1: Synthesis of Diene Alcohol compound 39 from Compound 17 
 
 
2.6 Accessing Enone Allylic Alcohol System Utilizing the Chemistry Developed by Tokuyama   
Group 
 
 
In 2012, Tokuyama group published the total synthesis of acetylaranotine, a thiodiketopiperazine 
natural product.39 In this paper, they have accessed the cis 6:5 fused allylic alcohol eneone system 
40 in their synthetic route to access acetylaranotin. Epoxidation 40 with H2O2 and NaOH afforded 
epoxy ketone 41 in 97% yield. Subjecting 41 to Wharton rearrangement conditions of N2H4•H2O, 
afforded enol 42 in 55% yield. The secondary alcohol of compound 42 was oxidized by DMP 
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oxidation to yield enone 43 in 97% yield. Introduction of alcohol group in the allylic position of 
enone was achieved via extended Rubottom oxidation to obtain the compound 44 with the overall 
yield of 56%. Surprisingly, the X-ray crystallographic structure showed that the resultant alcohol 
group possessed the undesired stereochemistry. However, the desired stereochemistry of this 
alcohol was accessed later via an oxidation-reduction procedure of the DKP core of acetylaranotin. 
The final natural product acetylaranotin was obtained after 11 steps from compound 44 with the 
overall yield of 0.59% (Scheme 2.6.1).  
 
 
Scheme 2.6.1: Synthesis of Acetylaranotin from Compound 40 
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Chapter 3 - Synthetic Efforts Towards Brocazine F and G and Discussion  
 
3.1 Spiral Ring formation 
 
 
Our synthetic endeavors towards the total synthesis of the brocazine family was commenced from 
Cbz-L-tyrosine/ Boc-L-Tyrosine and their transformation into the 6:5 spiral ring 13/48.40, 42 Cbz-
L-tyrosine and Boc-L-Tyrosine were converted to 6:5 spiral 13 and 48 using iodobenzene diacetate 
in 23% and 24% yields, respectively (Scheme 3.1.1). This reaction proceeds with the coordination 
of iodobenzene diacetate to the phenolic group of Cbz/Boc-L-tyrosine making the para position 
more electrophilic, which allows the oxygen of the carboxylic acid to attack the said position 
producing 6:5 spiral systems 13 and 48, respectively. Optimization of this reaction while not 
undertaken by Wipf, was undertaken to enhance access of 13 and 48. 
 
Scheme 3.1.1: Spiral Ring Formation Reaction 
 
The yield of this reaction was low due to the polymerization of Cbz-L-tyrosine after the 
coordination with iodobenzene diacetate, which was proved by analyzing the 1H NMR of the sticky 
brown substance that was collected after quenching the reaction. Therefore, it was decided to use 
a procedure found in literature which uses polymer supported hypervalent iodine source instead of 
iodobenzene diacetate to obtain a better yield for the spiralization reaction.43 The first attempt of 
the optimization of spiral ring formation reaction was done with polymer assisted material 47. 
Polymer 47 was synthesized by iodination of polystyrene 45 with I2, I2O5, and CCl4 to obtain 
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iodinated polystyrene 46, followed by the acetylation with H2O2 and Ac2O to yield polymer 47.43 
The advantage of this method is the ability to regenerate the polymer with H2O2 and Ac2O once it 
is used (Scheme 3.2). However, when the polymer 47 was used for the spiral ring formation 
reaction of Cbz-L-tyrosine, the spiral 13 was obtained in 25% yield (Scheme 3.1.2). Moreover, 
even after using different amounts of polymer (entry 1-4), time durations (entry 1, 5-7), and 
extraction methods (entry 9-11), it was unable to optimize the reaction yield higher than 25% 
(Table 3.1.1). The article that we referred for this procedure has reported 75-100% yields for the 
spiralization reactions of similar substrates. However, this procedure did not result a higher yield 
than 25% in the desired system, even after attempting the reaction with several people to test for 
the human error. Further optimization of the spiralization reaction with the polymer supported 
material is currently being undertaken.  
 
 
Scheme 3.1.2: Spiral Ring Formation Using Polymer Assisted Material 
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Table 3.1.1: Optimization of the Spiral Ring Formation Using Polymer Assisted Material 
Entry Scale Polymer mass Yield Note 
1 100 mg 250 mg 11 % 20 h 
2 100 mg 490 mg 20 % 20 h  
3 100 mg 1000 mg 19 % 20 h 
4 100 mg 80 mg 13 % 20 h 
5 100 mg 250 mg 13 % 6 h 
6 100 mg 250 mg 11 % 4 h 
7 100 mg 250 mg 4 % 1 h 
8 100 mg 250 mg 22 % 10 h 
9 100 mg 490 mg 20 % 6 h more solvent for polymer 
10 100 mg 490 mg 22 % 20 h extraction before filtering polymer 
11 100 mg 490 mg 5 % 1.5 h more solvent for tyrosine 
 
 
It was decided to further explore the initial methods to improve the yield of the spiralization 
reaction. Further attempts to optimize the spiral ring formation reaction was performed by using 
different solvents and temperatures (Table 3.1.2). First, it was decided to investigate the effect on 
temperature for the reaction yield using 0 °C, room temperature, and reflux conditions (entry 1-3, 
4-5)). However, it was observed that the temperature had no significant effect on the reaction yield 
in multiple solvents explored, resulting the yields around 25%. It was also observed that the 
reaction yield did not have a significant effect on the equivalents of the hypervalent iodine source 
used (entry 6). It was observed that the solvent had some effect on reaction yield, in which 
employing iPrOH:MeCN (1:4) and MeOH resulted in 45% and 18% yields, respectively (entry 
4,7). This increased yield could be due to the better solubility of the reactants and reagents when 
iPrOH:MeCN (1:4) was used. While further optimization is being undertaken, efforts towards the 
total synthesis of brocazone F and G was continued.   
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Table 3.1.2: Optimization of Wipf Spiral Ring Formation Reaction; Effect of Different Solvents 
and Temperatures 
 
 
Entry Solvent PhI(OAc)2 
(eq) 
Temperature % Yield  
1 Nitromethane (1 M) 1.0 RT 23% 
2 Nitromethane (1 M) 1.5 0 °C 8% 
3 Nitromethane (1 M) 1.5 Reflux 25% 
4 iPrOH: MeCN (4:1) (0.1 M) 1.5 RT 45% 
5 iPrOH: MeCN (4:1) (0.1 M) 1.5 0 °C 20% 
6 iPrOH: MeCN (4:1) (0.1 M) 2.0 reflux 44% 
7 MeOH (0.1 M) 1.5 RT 18% 
 
3.2 Accessing Benzylated 15 and 49  
 
Accessing 15 (Cbz) and 49 (Boc) were done following a procedure developed by Wipf group.40 
Treating 13 and 48 with 3M KOH at -20 C promoted the rearrangement to obtain 14 and 17 in 
90% and 80% yields, respectively. Treating the tertiary alcohol 14 and 17 with benzoic anhydride, 
DMAP, and pyridine at reflux conditions afforded the desired compounds 14 and 17 in 55% and 
56% yields, respectively (Scheme 3.2.1). Optimization of the benzoylation reaction was necessary 
as it was challenging to proceed forward with the total synthesis route with this lower yielding 
reaction in addition to the spiralization step.  
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Scheme 3.2.1: Accessing Benzylated Compounds 15 and 49 from Compound 13 and 48, 
Respectively 
 
DMAP forms an activated compound with benzoic anhydride making the esterification reaction 
with the alcohol more feasible. Therefore, the optimization of benzoylation reaction was attempted 
by using different equivalents of DMAP to test the effect of the equivalents of DMAP in reaction 
yield (Table 3.2.1, entry 1-2). However, the equivalence of DMAP did not have a significant effect 
on the yield of the reaction. Then, it was decided to use benzoyl chloride instead of benzoic 
anhydride. It was assumed that the benzoyl chloride would access the tertiary alcohol group more 
efficiently due to its smaller size. However, when benzoyl chloride was used instead of benzoic 
anhydride, the reaction yield dropped down to 18% (entry 3). This could be due to the lower 
stability of the benzoyl chloride, degrading before it reacts with the alcohol 14. Then it was thought 
that a smaller base such as Et3N would more efficiently access the tertiary alcohol group, 
increasing the reaction yield. However, the yield of the reaction did not have a significant effect 
when Et3N was used as the base (entry 4-5). Finally, it was decided to use benzoic anhydride (3 
eq), DMAP (0.1 eq), pyridine (5.12 eq), and Et3N (3 eq) under reflux conditions to test the 
combination effect of all the reactions in reaction yield. In this case, the yield was optimized to 
83% and the reproducible results were obtained in many trials tested (entry 6).  
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Table 3.2.1: Optimization of Benzoylation Reaction 
 
Entry Reagent (eq) DMAP (eq) Base (eq) % Yield 
1 Benzoic anhydride (2.00 eq) 0.05 Pyridine (5.12 eq) 56% 
2 Benzoic anhydride (2.00 eq) 0.10 Pyridine (5.12 eq) 55% 
3 Benzoyl chloride (2.00 eq) 0.05 Pyridine (5.12 eq) 18% 
4 Benzoic anhydride (2.00 eq) 0.10 Et
3
N (5.00 eq) 58% 
5 Benzoic anhydride (.00 eq) 0.10 Et
3
N (5.00 eq) 57% 
6 Benzoic anhydride (3.00 eq) 0.10 Pyridine (5.12 eq), Et
3
N (3.00 eq) 83% 
 
 
3.3 Objectives  
 
Accessing the carbon framework of the three main fragments of brocazine F and G was focused at 
the early stage of the project. The stereoselective access of the fragments would be focused once 
the main carbon frameworks of the fragments were accessed. The attempts that were undertaken 
to access the carbon framework of the fragments will be discussed in next sub sections. 
 
3.4 Efforts Towards Accessing Diene System 
 
Efforts towards accessing the carbon frameworks of diene system will be discussed in this section, 
structure shown in Scheme 3.3. Accessing these systems with the desired stereochemistry will be 
discussed in subsection 3.5.  
  
Scheme 3.4: Structure of Diene System 
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3.4.1 Na Catalyzed Reaction  
 
Accessing diene alcohol 32 was attempted using a synthetic route developed by Sundburg group.41  
TBS enol ether formation of 15 and 49 were accomplished with TBSOTf and Et3N to obtain 28 
and 50 in 98% yields for both Cbz and Boc protected compounds, which were subsequently treated 
with DMDO to perform a Rubottom oxidation to obtain -hydroxyl ketones 51 and 52 in 83% and 
70% yields, respectively. Moreover, the resultant - hydroxyl carbonyl ketones 51 had the 
opposite stereochemistry (S configuration) compared to the desired compound (R configuration). 
Stereochemistry was confirmed by the comparison with proton NMR of 51 with the published 
NMR of Sunburg group, where they also have accessed the S configuration. However, at this stage 
of the project, accessing the carbon framework of the diene alcohol system was considered, 
therefore, it was decided to continue with the envisioned route. The compounds 51 and 52 were 
TBS protected with TBSOTf and Et3N to obatin 29 and 53 in 98% and 85% yields, respectively. 
Up to this stage, both Cbz and Boc protected compounds were used in the route and both resulted 
the desired products with similar yields. However, chemo compatibility issues, concluding 
degradation with the TBS enol ether formation and Rubttom oxidation with the Boc protected 
nitrogen were observed. Therefore, it was decided to proceed forward with the Cbz protected 
compounds.  Luche reduction of 29 with NaBH4 and CeCl3 •7H2O selectively resulted allylic 
alcohol 30 in 99% yield, followed by the acetylation with Ac2O, DMAP, and Et3N to give 31 in 
94% yield (Scheme 3.3.1.1).  
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Scheme 3.4.1.1: Accessing Diene System 31 from Compound 15 
 
 
According to the Sunburg’s procedure, the elimination of the acetate and the benzoyl groups to 
access diene system has been achieved using sodium amalgam facilitated reaction. Sodium 
amalgam needs to be freshly prepared and handling mercury requires special safety precautions.  
Therefore, we attempted the reaction using Na (s) and Na-naphthalene instead of Na/Hg. However, 
the Na catalyzed elimination of the acetate and the benzoyl group using Na (s) and Na-naphthalene 
resulted the degradation of compound 31. (Scheme 3.3.1.2). These different results could be due 
to the different strengths of the Na present in Na/Hg, Na(s), and Na-naphthalene. In Na/Hg, Na 
has better handling properties and it allows Na to be relatively less active compared to that of pure 
Na(s) and Na-Naphthalene. This could result the degradation of 31 when Na(s) and Na-
naphthalene were used instead of Na/Hg. Therefore, milder conditions to introduce diene system 
needed to be investigated. 
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Scheme 3.4.1.2: Accessing Diene System 32 from Compound 31 
 
3.4.2 Lithium/Halogen Exchange Reaction 
 
With the failed Na-catalyzed reaction, it was envisioned to use a milder conditions of 
lithium/halogen exchange facilitated formation of diene to access 32 from 54. It was hypothesized 
that the compound 54 upon lithium/halogen exchange with nBuLi would afford 55, and would 
subsequently undergo the elimination of the acetate to result diene 32 in an internal E2’ like 
reaction (Scheme 3.3.2.1). 
 
Scheme 3.4.2.1: Lithium/ Halogen Exchange Reaction to Access the Diene System 
 
To investigate the synthetic feasibility of the route, it was decided to attempt the proposed 
lithium/halogen reaction facilitated diene formation with a simpler model system, lacking the 
OTBS group. Compound 56 was obtained by the acetylation of compound 14 in 92% yield, 
followed by the Luche reduction conditions to access allylic alcohol 57 in 99% yield.37 Then the 
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bromination of 57 was performed with Appel reaction conditions to access 58 in 78% yield.44 
Lithium/halogen exchange is usually performed with either n-BuLi or t-BuLi. Lithium/halogen 
exchange was attempted by treating compound 58 with nBuLi at -78 C. However, the reaction 
was unsuccessful with 85% of recovered starting material (Scheme 3.3.2.2). The could be mainly 
due to the unfavorable exchange of the halide with the n-Butyl group. Attempts with t-BuLi was 
not undertaken. 
  
Scheme 3.4.2.2: Accessing Diene System 59 from compound 14 
 
3.4.3  Comin’s Reagent 
 
Comin’s reagent can be used to convert carbonyl compounds into triflate enolates, and the triflate 
group can subsequently reductively be eliminated to access the corresponding alkene.24, 26 
Therefore, it was envisioned to use the Comin’s reagent on ketone 60 to access the triflate enolate 
61 and the subsequent reductive elimination of the triflate group to access the diene 32 (Scheme 
3.3.3.1).  
 
Scheme 3.4.3.1: Comin’s Reaction to Access the Diene System 
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Treating 56 with TBSOTf and Et3N afforded TBS enol ether 62 in 98% yield. Subsequent 
treatment with DMDO promoted a Rubottom oxidation to obtain compound 63 in 85% yield.41 
Protection of the free alcohol of 63 with TBSOTf and Et3N was performed to access 64 in 99% 
yield. Refluxing 64 under Zn-catalyzed conditions afforded acetate elimination and rearrangement 
to 60 in 71% yield. Subjecting 60 to Comins’ triflation conditions (PhNTf2) gave access to 61 in 
60% yield. Treating 61 with Pd(OAc)2 promoted the triflate removal with reductive elimination to 
access diene 32 in 42% yield. (Scheme 3.3.3.2).37, 39 Stereochemistry of the diene 32 was 
confirmed with the direct comparison of the NMRs of the same compound published by Sunburg 
group.41 With this route, the carbon framework of the diene system 32 has been successfully 
accessed.  
 
 
Scheme 3.4.3.2: Accessing Diene System 32 from Compound 56 Via Comin’s Reagent 
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3.5 Efforts Towards Accessing Diol System and Allylic Alcohol System  
 
Efforts towards accessing the carbon frameworks of diol and allylic alcohol systems will be 
discussed in this section, structures shown in Scheme 3.4. Accessing these systems with the 
desired stereochemistry will be discussed in subsection 3.5.  
  
Scheme 3.5: Structures of Diol System and Allylic Alcohol System 
 
3.5.1 Wharton Rearrangement and Allylic Oxidation  
 
It was envisioned that accessing allylic alcohol 66 could come from a synthetic route consists of 
Wharton rearrangement (16 to 65) and allylic oxidation reactions (65 to 66). In this route, trans-
fused bicycle 16 would be accessed first and the northern alcohol group, highlighted in red, would 
be accessed via Wharton rearrangement reaction. Then the southern alcohol group, highlighted in 
blue, was envisioned to be introduced via an allylic oxidation reaction, as shown in scheme 3.4.1.1.  
 
Scheme 3.5.1.1: Envisioned Route to Access the Diol 66 with Wharton Rearrangement and 
Allylic Oxidation 
 
Pd-catalyzed deoxygenation of 15 was performed with Pd(dba)3CHCl3, tribenzylphosphene, Et3N, 
and HCO2H to yield trans-fused 6:5 bicycle 16 in 90% yield.40 Epoxidation of 16 with H2O2 and 
NaOH afforded epoxy ketone 67 in 67% yield, whose stereochemistry was not determined. 
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Wharton rearrangement conditions gave access to 65 in 20% yield from 67. The highest yield 
reported for the Wharton rearrangement of the cis 6:5 bicycle was 56%.26 However, the Wharton 
rearrangement of trans 6:5 bicycle system resulted a lower yield of 20%. This could be due to the 
difference in the ring conformations of cis (puckered) and trans (flat) systems, making the reagents 
to access the reaction site of the molecule in different efficiencies. DMP oxidation upon the allylic 
alcohol in 65 afforded enone 70 in 92% yield.39 As typical Riley oxidation conditions with SeO2 
did not work for enone systems due to the electrophilic nature of enone double bond, literature 
reported similar allylic oxidation procedures were attempted. Guerra and coworkers have 
developed an allylic oxidation protocol of an enone with a Cu-Al-Ox catalyst, in which enone 71 
was oxidized to allylic alcohol 72 in 57%.45 Yoshioka  has developed an allylic oxidation of an 
enone using methanolic KOH with air as the termind odidant, in which enone 74 was oxidized to 
75 in 70% yield.46 However, none of these procedures resulted the desired product upon enone 70 
(Scheme 3.4.1.2). This could be mostly due to the nature of the trans fused ring system with many 
functionalities preventing the allylic oxidation of compound 70.  
 
36 
 
 
 
Scheme 3.5.1.2: Efforts Towards Accessing Compound 73 from compound 15 
 
 
3.5.2 Rubottom Oxidation and Wharton Rearrangement  
 
With the failed allylic oxidation, it was thought to reverse the alcohol installation; southern alcohol 
(blue) first, with a Rubottom oxidation of 16 to access 74. Then the northern alcohol; red would 
be introduced with Wharton rearrangement conditions to access diol 66 (Scheme 3.4.2.1).  
 
Scheme 3.5.2.1: Envisioned Route to Access the Diol 66 with Rubottom Oxidation and Wharton 
Rearrangement 
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Trans fused 6:5 bicycle 16 was converted to TBS enol ether 75 in 99% yield, followed by a 
Rubottom oxidation with mCPBA to give 74 in 40% yield.47 Stereochemistry of the α-hydroxy 
ketone was not investigated as the main objective of the project at this stage to access the carbon 
framework of the diol system. However, it was envisioned to investigate the stereochemistry of all 
the compounds once a reliable route to access the diol system was established. Epoxidation of 74 
with H2O2 and 6M NaOH afforded epoxy ketone 76 in 75% yield.39 Although, the Wharton 
rearrangement of 76 with N2H4 • H2O was attempted using different bases (KOH and t-BuOK) and 
different temperatures to obtain the desired product 66, it only resulted the hydrazone intermediate, 
as shown in scheme 3.13.48, 49 This could be due the interference of the sourthern alcohol group of 
76 with the formed epoxy hydrazone intermediate preventing the rearrangement reaction. 
Therefore, to prevent any possible interference with the hydrazine, it was decided to TBS protect 
the lower alcohol group before attempting the Wharton rearrangement (Scheme 3.4.2.2).  
 
Scheme 3.5.2.2: Accessing Diol System 66 Using Wharton Rearrangement 
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However, at this stage, another procedure to access α-hydroxy ketone 74 was needed to be 
investigated as the Rubottom oxidation procedure with mCPBA on compound 16 resulted in 
reproducibility issues. Therefore, the deoxygenation of Rubottom oxidized compound 29 was 
performed to access 77 in 90% yield.40  The epoxidation of 77 with H2O2, and NaOH resulted 
epoxy ketone 78 in 80% yield (Scheme 3.4.2.3), and the stereochemistry of the epoxide was not 
determined.39  
  
 
Scheme 3.5.2.3: Accessing Diol System 79 Using Wharton Rearrangement 
 
 
Optimization of Wharton rearrangement of 78 needed to be undertaken as it only resulted the 
hydrazone intermediate (Table 3.4.2.1). It was attempted to improve the yield by changing the 
equivalents of formic acid (CH3CO2H) added (entry 1-4). However, it only resulted the hydrazone 
intermediate at different temperatures screened. Then, it was decided to use a base instead of an 
acid for the rearrangement of the hydrazone. Although different bases such as t-BuOK and KOH 
were used in the reaction to facilitate the rearrangement, it only resulted the hydrazone 
intermediate at different temperatures tested (entry 5-6) After extensive efforts, product 79 was 
obtained in trace amounts when N2H4 • H2O (5 eq) and CH3CO2H (3 eq) were used at reflux 
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conditions (entry 7).39 However, another route to access diol system was needed as it was 
impossible perform multistep total synthesis with trace amount of material.  
 
Table 3.5.2.1: Optimization of Wharton Rearrangement 
 
Entry Reagents  Acid/Base Solvent Temp. %Yield 
1 N2H4 • H2O (2 eq)  CH3CO2H (1 eq) DCM Zero-RT-reflux Hydrazone 
2 N2H4 • H2O (2 eq)  CH3CO2H (2 eq) DCM Zero-RT-reflux Hydrazone 
3 N2H4 • H2O (2 eq)  CH3CO2H (2 eq) MeOH Zero-RT-reflux Hydrazone 
4 N2H4 • H2O (4 eq)  CH3CO2H (3 eq) DCM Zero-RT-reflux Hydrazone 
5 N2H4 • H2O (4 eq)  t-BuOK (1.5 eq) DCM Zero-RT-reflux Hydrazone 
6 N2H4 • H2O (2 eq)  KOH (4 eq) MeOH Zero-RT-reflux Hydrazone 
7 N2H4 • H2O (5 eq)  CH3CO2H (3 eq) DCM Zero-RT-reflux Trace 
amount of 
product 
 
3.5.3 Mislow-Evans Reaction 
 
A Mislow-Evans reaction can be used to access allylic alcohols from allylic sulfoxides in [2,3] 
sigmatropic rearrangement.50 It was envisioned that addition of 80 would access 81, which would 
then primed to undergo the Mislow-Evans rearrangement to 82 (Scheme 3.4.3.1). 
 
Scheme 3.5.3.1: Mislow-Evans Reaction to Access the Diol 82 
 
 Luche reduction of enone 77 was accomplished to obtain allylic alcohol 83 in 98% yield, followed 
by the mesylation to access 84 in 71% yield.  Accessing the thiophenol 80 from 84 with thiophenol, 
N
H
H
CO2Me
CbzOTBS
OH
82
N
H
H
CO2Me
CbzOTBS
80
PhS N
H
H
CO2Me
CbzOTBS
S
O
81
40 
Cs2CO3, and TBAI, was unsuccessful, even under reflux conditions (Scheme 3.4.3.2).50 Therefore, 
accessing the thiophenol 86 from compound 83 via a brominated intermediate was envisioned. 
However, the bromination of compound 83 using Appel reaction was unsuccessful with the 98% 
recovery of the starting material. This could be due to the ring conformation of 6:5 trans-fused 
system or the steric interference of the adjacent OTBS group making the reaction not feasible. 
 
 
Scheme 3.5.3.2: Efforts Towards Accessing Diol System 82 with Mislaw-Evans Reaction 
 
3.5.4  Using SN2’ Reaction 
 
Saunders and coworkers have discussed the use of LiOAc and HMPT for an SN2’ type acetate 
rearrangement to convert mesylate 87 to 88 (SN2) and 89 (SN2’) (Scheme 3.4.4.1).51 Therefore, it 
was envisioned to attempt this SN2’ reaction conditions on the compound 84 to access 91. 
However, this procedure was unsuccessful upon system 84 to access 91 and even 90, and gave full 
recovery of the starting material. This could be due to the ring conformation of 84 and the 
functionalities around making the reaction sterically not feasible.   
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Scheme 3.5.4.1: Efforts Towards Accessing Compound 91 Using SN2’ Reaction 
 
3.5.5  Grieco Conditions 
 
Grieco reaction is very similar to Mislow-Evans reaction as they both undergo [2,3] sigmatropic 
rearrangement to perform allylic alcohol rearrangements. Therefore, it was envisioned to use 
Grieco conditions to access selenide 92 and subsequent rearrangement via the oxidized 
intermediate 93 to access the diol 94 (Scheme 3.4.5.1).  
 
Scheme 3.5.5.1: Grieco Conditions to Access the Diol System 94 
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74% yield.  Since the reaction worked successfully with the model system, it was decided to 
attempt the reaction in the actual system 83. Grieco condition of compound 83 resulted allylic 
selenide 98 in 71% yield, followed by the mCPBA oxidation facilitated sigmatropic rearrangement 
of selenide group was performed to obtain compound 99 in 78% yield. DMP oxidation of diol 99 
gave access to enone 100 in 92% yield (Scheme 3.4.5.2).52 With this route, the main carbon 
frameworks of diol system 99 and the enone system 100 have been successfully accessed. 
 
 
Scheme 3.5.5.2: Accessing Diol System 99 Using Grieco Conditions 
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3.6 Accessing the Main Fragments with Desired Stereochemistry  
 
The carbon frameworks of all three fragments of brocazine F and G have been successfully 
accessed. However, in order to synthesize brocazine F and G, these three groups needed to be 
accessed with desired stereocenters. The desired stereochemistry of the southern alcohol group; 
blue, needs to be accessed first, and the northern alcohol group; red, needs to be accessed next 
(Scheme 3.5.1.1).  
 
Scheme 3.6.1: The fragments that have been Accessed and Envisioned to be Accessed 
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Treatment of 28 with DMDO and mCPBA provided two different compounds. DMDO has been 
shown to afford 51, and we propose mCPBA gives access to the epimer about this alcohol, 12, 
accessed in 75% yield. Stereochemistry of the newly introduced alcohol was confirmed by 
comparing the proton NMRs of DMDO oxidation product 51 with the mCPBA oxidation product 
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constant of the Hx and Hy in 51 is 12 Hz. This indicates that the Hx and Hy are facing the opposite 
direction (trans) in 12, whereas Hx and Hy are facing the same direction (cis) in 51 (Scheme 
3.5.1.2). These data supported that the obtained -hydroxy ketone with mCPBA reaction possessed 
the desired stereochemistry (R configuration). 
 
  
  
Scheme 3.6.1.1: Rubottom Oxidation to Access -Hyroxy Ketone and NMR Characterization to 
Determine the Stereochemistry 
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Free alcohol group of 7 was TBS protected with TBSOTf and Et3N to obtain 104 in 99% yield, 
subsequent Pd-catalyzed deoxygenation afforded trans-fused bicycle 105 in 82% yield.40, 41 Luche 
reduction of enone 105 at room temperature  produced the allylic alcohol 106 in 99% yield, the 
mixture of two stereoisomers were carried forward. Treatment of Grieco conditions upon 106 
resulted in allylic selenides 107 and 108 in 90% yield (dr- 9:4). The mCPBA oxidation facilitated 
sigmatropic rearrangement of selenide group to diols 101 and 109, 85% yield for both compounds. 
Oxidation of diol 109 resulted in enone 102 in 92% yield (Scheme 3.5.1.3).52  
 
 
Scheme 3.6.1.2: Accessing the Diol 101 and enone 102 with Desired Stereochemistry 
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The stereochemistry of the diols 101 and 109 were determined via the comparison of the coupling 
constants between the Hu and Hz. Analysis of the coupling constants between Hu and Hz in 101 
and 109 revealed J= 24 Hz and 12 Hz, respectively (Scheme 3.5.1.4). From this, it can be 
concluded that 101 is the R configuration and 109 is S configuration with respect to the northern 
alcohol group. With this route, the diol 101 and the enone 102 have been successfully accessed 
with the desired stereocenters.  
 
 
Scheme 3.6.1.3: NMR Characterization to Determined the Stereochemistry of Diols 101 and 109 
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3.6.2  Diene System 
 
The desired stereoisomer of the diene 103 was accessed following a route consisting of Comins’s 
reagent. Zn-catalyzed elimination of the benzoyl group of compound 104 under reflux conditions 
was performed to access compound 110 in 74% yield.37 Comins’ reaction of compound 110 
converted the carbonyl group of 110 to a triflate enol ether 111 in 62% yield.  The reductive 
elimination of the triflate group of 111 with a Pd(OAc)2 catalyzed reaction at 65 C resulted the 
diene 103 in 61% yield (Scheme 3.5.2.1).39 with this route, the diene system 103 has been accessed 
with the desired stereochemistry. 
  
 
Scheme 3.6.2.1: Accessing Diene System 103 with Desired Stereochemistry 
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fragments to access the DKP cores of brocazine F and G. For this, Cbz deprotection to access the 
free amine and the saponification to access the free carboxylic acid needs to be performed. 
Saponification is a simple and straightforward reaction, and it was assumed that it would work 
well in our systems as they do not have any functionalities intolerable to basic conditions. 
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However, Cbz deprotection in the presence of enone/ allylic alcohol is challenging, as the double 
bond can also be reduced concurrent to Cbz deprotection. Therefore, Cbz deprotection conditions 
suitable for systems containing enone/ allylic alcohol were investigated using model systems.  
 
Typical conditions of Cbz deprotection with H2(g) under high pressure cannot be used for the 
systems containing double bonds as they can also get reduced along with the Cbz deprotection. 
Therefore, a literature precedent Cbz deprotection using in situ generation of H2 (g) was attempted 
with compound 15 and 16 using Pd(OAc)2, Et3N, and Et3SiH.39, 40  However, the desired products 
were not isolated and the fully reduced products 113 and 115 were obtained, respectively. It was 
hypothesized that the enone system could be making the double bond more electrophilic, resulting 
these undesired products. Therefore, compound 15 was reduced using Luche reduction conditions 
to obtain compound 116 in 97% yield, and Cbz deprotection was attempted. However, the reaction 
was unsuccessful with the fully recovered starting material 116. At this point, it was hypothesized 
that the free alcohol group could be chelating the Pd-catalyst. Therefore, TBS protection of 
compound 118 was performed to obtain 119 in 98% yield, and the Cbz deprotection was performed 
to successfully obtain amine 120 in 70% yield (Scheme 3.6.1).  
49 
 
 
Scheme 3.7.1: Investigations into Cbz Deprotection 
 
 
3.8 Investigations into Analog Synthesis 
 
It was envisioned to use compound 99 for analog synthesis as it can be used to test the feasibility 
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family. First, TBS protection of compound 99 was performed to access 121 in 98% yield.39 
Saponification and Cbz deprotection of compound 121 separately gave carboxylic acid 122 and 
amine 123 in 98% and 52% yields, respectively. Coupling of 122 and 123 with BOPCl gave 
compound 124 in 69% yield (Scheme 3.7.1).39 Although the aminolysis of 124 was attempted, 
purification was challenging as the scale of the reaction was very low. Therefore, it was decided 
to mainly focus on the actual system with desired stereochemistry to access the brocazine natural 
products and revisit the DKP analog synthesis later in the project.  
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Scheme 3.8.1: Investigations into Analog Synthesis 
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and S8 resulted the oligosulfide 127 in 62% yield.37 Subjecting oligosulfide 127 to conditions of 
NaBH4 and KI3 did not result the desired product 128. Therefore, it was needed to further confirm 
the formation of the compound 127 by checking the activity of KHMDS on compound 126. It was 
decided to use D2O and MeI instead of S8 and incorporate deuterium and methyl groups to the 
compound 126, respectively. If the reaction was successful, the desired products formation should 
be clearly visible in 1H NMR due to the disappearance of the deuterated atoms (with D2O) and the 
appearance of the methyl peaks (with MeI) in the NMRs. With this, it can also be confirmed the 
feasibility of the formation of 127 when S8 was used due to the similarities of the reactions. 
Compound 126 was treated with KHMDS, followed by the subsequent addition of D2O to access 
compound 129 in 68% yield. Compound 126 was treated with KHMDS, followed by the 
subsequent addition of MeI to access compound 130 in 69% yield. These results showed that the 
treatment of 126 with S8 and KHMDS should also have resulted the desired oligosulfide 127. Then, 
it was needed to confirm the reduction of the 127 with NaBH4. To explore this, compound 127 
was reduced with NaBH4, followed by MeI to access thiomethylate 131 in 64% yield.54 With this 
results, further confirmation of 127 was achieved. Then the disulfide linkage formation with KI3 
was attempted again, and it was still not successful. Therefore, it was decided to use O2 (g) instead 
of KI3 for the disulfide incorporation reaction.37 However, the reaction was still not successful 
resulting the dimerized DKP product. Therefore, it was envisioned to use very dilute conditions 
(0.001M) when introducing O2 (g) to the reaction to prevent the dimerization reaction. Then the 
reaction was successful and the desired product 128 was accessed in 43% yield (Scheme 3.8.1).39 
With this, a reliable and reproducible procedure to introduce disulfide linkage into DKP cores, 
which can be used in brocazine DKP cores has been successfully optimized.   
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Scheme 3.9.1: Investigations into Disulfide Linkage Incorporation 
 
 
3.10 Accessing the DKP Core of Brocazine F  
 
Investigations into accessing the DKP core of brocazine F will be discussed in this section. 
According to the previous studies (section 3.6) the free alcohol group of 101 needed be protected 
as it can interfere with the Cbz deprotection reaction. Moreover, the enone 102 cannot be directly 
used for the Cbz deprotection as it can reduce the enone double bond concurrent to Cbz 
deprotection. Therefore, it was decided to TBS and acetyl protect the alcohol 101 separately to 
access 133 and 135, respectively, and couple them together to access the DKP core 137. Then the 
acetyl group can be selectively deprotected to access 139, and the free alcohol can be oxidized to 
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access the desired enone system 140. Brocazine F can then be accessed after the deprotection of 
all the protecting groups (Scheme 3.9.1). 
 
Scheme 3.10.1: Envisioned route to Access Brocazine F 
 
Treatment of 101 with TBSOTf gave access to 132 in 92% yield, followed by the saponification 
with 2M KOH at 45 C to access the carboxylic acid 133 in 87%.39 Acetylation of 101 was 
performed with Ac2O, DMAP, and Et3N to obtain compound 134 in 88% yield, followed by the 
Cbz deprotection with Pd(OAc)2, Et3N, and Et3SiH to access amine 135 in 56% yield.38 Coupling 
of the acid 133 and the amine 135 gave access to 136 in 23% yield (Scheme 3.9.2). The lower 
yield of the coupling reaction could be due to the steric effects caused by the functionalities and 
the ring conformation of the reactants. The investigations into the optimization of the reaction 
yield are currently underway. Aminolysis of 136 was performed in very low scale (9 mg), to access 
the DKP 137. However, further purification of 137 is needed for full characterization.  
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Scheme 3.10.2: Accessing the DKP core of Brocazine F 
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Chapter 4 - Future Work and Conclusion 
 
Brocazine F and G are natural products bearing a disulfide diketopiperazine core that was isolated 
by Meng et al in 2014 and 2016 from an endophytic fungus derived from the marine mangrove 
plant Avicennia marina named Penicillium brocae MA-231. Due to their potent biological 
activities and the intriguing polycyclic core structure, our laboratory devised a total synthesis route 
to access this family. We also envisioned on a new way of accessing small molecule screening 
libraries by derivatizing the intermediates of the total synthesis routes of these natural products. 
This could allow the access of complex and diverse small molecule libraries which could 
potentially have diverse biological activities due to non-natural synthetic route that is being 
developed. Therefore, in this dissertation a reliable and reproducible route to access the brocazine 
family of diketopiperazine (DKP) natural products, from which the intermediates can be 
amendable for chemical derivatization for complex screening library construction was discussed. 
 
Efforts towards the total synthesis of the brocazine family started from Cbz-L-tyrosine/ Boc-L-
tyrosine and its transformation into the 6:5 spiral ring 13/48 in 23% and 24% yields, respectively. 
After the extensive efforts to optimize the yield of the reaction using polymer assisted reaction 
conditions and using various temperature/solvent conditions, the reaction yield was optimized to 
45%. Treating 13 and 48 with 3M KOH at -20 C promoted the rearrangement to obtain 14 and 17 
in 90% and 80% yields, respectively. Accessing 15 (Cbz) and 49 (Boc) were done by treating the 
tertiary alcohol 14 and 17 with benzoic anhydride, DMAP, and pyridine at reflux conditions to 
afford the desired products in 55% and 56% yields, respectively. The optimization of the 
benzoylation reaction was attempted by using different reagents (benzoic chloride/ benzoic 
anhydride), different bases, and different equivalences of bases/DMAP/ reagents. The reaction 
56 
yield was optimized to 83% when benzoic anhydride (3 eq), DMAP (0.1 eq), pyridine (5.12 eq), 
and Et3N (3 eq) were used under reflux conditions (Scheme 4.1).  
 
 
Scheme 4.1: Accessing Benzylated Compounds 15 and 49  
 
TBS enol ether formation of 15 and 49 were performed with TBSOTf and Et3N to obtain 28 and 
50 in 98% yields in both Cbz and Boc protected compounds, which were subsequently treated with 
DMDO to perform a Rubottom oxidation to obtain -hydroxyl ketones 51 and 52 in 83% and 70% 
yields, respectively. Moreover, the resultant - hydroxyl carbonyl ketones 51 had the opposite 
stereochemistry (S configuration) compared to the desired compound (R configuration) (Scheme 
4.2). At this stage, the Boc protected compound resulted degradation issues with TBS enol ether 
formation and Rubottom oxidation reactions. Therefore, it was decided to proceed forward only 
with the Cbz protected compounds.  
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Scheme 4.2: Accessing -hydroxyl ketones 29 and 53  
 
Extensive efforts towards accessing the diene 32 from the TBS protected -hydroxyl ketone 29 
was taken by using Na-catalyzed reaction and lithium-halogen exchange reaction. However, none 
of these efforts were successful, resulting either the degraded product or the starting material 29. 
Finally, it was decided to attempt the Comin’s reagent facilitated triflate enolate formation and the 
subsequent triflate removal to access the diene 32. Comins’ reaction conditions on 60 gave access 
to triflate 61 in 60% yield, followed by the elimination of the triflate group by Pd-catalyzed 
reaction with Pd(OAc)2, PPh3, and n-Bu3N to access diene 32 in 42% yield. With this approach, 
we were able to successfully access the carbon framework of the diene 32 (Scheme 4.3). 
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Scheme 4.3: Accessing the Carbon Framework of Diene 32  
  
Accessing the main carbon framework of the diol system was first attempted with route consists 
of Wharton rearrangement and allylic oxidation reactions. Wharton rearrangement conditions of 
67 gave access to 65 in 20% yield, followed by the DMP oxidation to afford enone 70 in 92% 
yield. However, the attempts for the allylic oxidation of enone 70 by following literature reported 
procedures such as using methanolic KOH and Cu-Al-Ox catalyst were unsuccessful resulting 
degraded product and the starting material, respectively. With the failed allylic oxidation, it was 
envisioned to reverse the alcohol installation by using Rubottom oxidation followed by Wharton 
rearrangement. The deoxygenation of Rubottom oxidized compound 29 was performed to access 
77 in 90% yield, followed by the epoxidation resulted epoxy ketone 78 in 80% yield. However, 
the Wharton rearrangement of 78 mainly returned the hydrazone intermediate with trace amount 
of product even after the extensive efforts to optimize the yield. Therefore, the investigations into 
another approaches to introduce the diol system were attempted. It was envisioned to attempt 
Mislow-Evans reaction to access the diol 82. Accessing the thiophenol 80 from 84 with thiophenol, 
Cs2CO3, and TBAI, was unsuccessful even under reflux conditions. Therefore, accessing the 
NO
CO2Me
Cbz
OAc
H
NTBSO
CO2Me
Cbz
OAc
H
NO
CO2Me
Cbz
OAc
H
OH
TBSOTf, Et3N
DCM
98%
DMDO
Acetone, 0 oC
85%
NO
CO2Me
Cbz
OAc
H
OTBS
NO
CO2Me
CbzHOTBS
Activated Zn, Glacial Acetic acid
MeOH, Reflux
71%
TBSOTf, Et3N
DCM
99%
NTfO
CO2Me
CbzHOTBS
PhNTf2, KHMDS
THF, -78 oC
60%
N
CO2Me
CbzHOTBS
Pd(OAc)2, PPh3,
n-Bu3N, HCO2H
DMF, 65 oC
42%
56 62
63 64
60 61 32
59 
thiophenol 86 from compound 83 via a brominated intermediate was attempted. However, the 
bromination of compound 83 using an Appel reaction was unsuccessful with the 98% recovery of 
the starting material. With the unsuccessful Mislow-Evans reaction, it was envisioned to attempt 
a SN2’ reaction with LiOAc and HMPT on the mesylate 84 to access diol 91. However, this 
procedure was unsuccessful with the full recovery of the starting material. 
 
Finally, it was envisioned to attempt Grieco conditions and subsequent rearrangement facilitated 
access of the diol 94. Grieco condition of allylic alcohol 83 resulted allylic selenide 98 in 71% 
yield, followed by the mCPBA oxidation facilitated sigmatropic rearrangement of selenide group 
was performed to obtain compound 99 in 78% yield. DMP oxidation of diol 99 gave access to 
enone 100 in 92% yield. With this, we have successfully accessed the main carbon frameworks of 
diol 99 and the enone 100 (Scheme 4.4).  
 
Scheme 4.4: Accessing the Carbon Framework of Diol 99 and Enone 100  
 
We have successfully accessed the carbon framework of all fragments of brocazine F and G. 
However, these fragments needed to be accessed with desired sterocenters. The desired 
stereochemistry of the sorthern alcohol was obtained when mCPBA was used rather than DMDO 
as the oxidant for the Rubottom oxidation reaction. Deoxygenation of TBS protected Rubottom 
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oxidation product 104 was performed to access trans-fused bicycle 105 in 82% yield, followed by 
the Luche reduction to access the allylic alcohol 106 in 99% yield. The Grieco conditions of the 
mixture of two distereomers 106 resulted allylic selenides 107 and 108 with the overall yield of 
90% (dr- 9:4). The mCPBA oxidation facilitated sigmatropic rearrangement of selenide group gave 
access to the diols 101 and 109 in the highest yield of 85% for both compounds. The oxidation of 
diol 109 resulted enone 102 in 92% yield. The desired stereoisomer of the diene 103 was accessed 
following a route consists of Comins’s reagent. Comins’ reaction of compound 110 resulted triflate 
enol ether 111 in 62% yield, followed by the elimination of the triflate group of 111 with a 
Pd(OAc)2 catalyzed reaction at 65 C resulted the diene 103 in 61% yield. At this stage, we have 
successfully accessed all the fragments of brocazine F and G with desired stereochemistry. In the 
next stage, coupling of the fragments was needed to be performed to access the desired DKP cores 
of brocazine F and G (Scheme 4.5).  
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Scheme 4.5: Accessing the Fragments of Brocazine F and G with Desired Stereochemistry  
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Investigations into the Cbz deprotection showed that the presence of enone or free alcohol groups 
interfere with the Cbz deprotection reaction conditions. Therefore, all the free alcohol groups 
needed to be protected before performing the Cbz deprotection. It was decided to TBS and acetyl 
protect the alcohol 101 separately to access 133 and 135, respectively, and coupled them together 
with BOPCl to access 136 in 23% yield. The investigations into the optimization of the reaction 
yield is currently underway. Aminolysis of 136 was attempted in 9 mg scale and the desired DKP 
137 was obtained. However, further purification of the compound is needed in order to fully 
confirm the presence of the desired DKP 137 (Scheme 4.6). 
 
Scheme 4.6: Accessing the DKP core of Brocazine F 
 
In future work, disulfide incorporation to the DKP core of 137 needs to be performed to access the 
thiodiketopiperazine 141. The acetate group of the DKP 137 needs be deprotected to access 139 
and the free alcohol group can be selectively oxidized to access the desired enone system 140. 
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Finally, brocazine F can then be accessed after the deprotection of all the protecting groups 
(Scheme 4.7).  
 
Scheme 4.7: Proposed Route to Access Brocazine F 
 
 
Coupling of carboxylic acid 133 with amine 141 to obtain 142, followed by the aminolysis will be 
performed to access the DKP core of brocazine G. Disulfide incorporation to the DKP core of 143 
will be performed to access the thiodiketopiperazine 144. Finally, brocazine F can then be accessed 
after the deprotection of all the protecting groups (Scheme 4.8).  
 
 
 
Scheme 4.8: Proposed Route to Access Brocazine G 
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Chapter 6 -  Experimental and NMRs 
General Methods 
 
All reactions were carried out under an argon atmosphere with dry solvents under anhydrous 
conditions, unless otherwise noted. Reactions were monitored by thin-layer chromatography 
(TLC) carried out on 0.25 mm E. Merck silica gel plates (60F-254) and the visualization was done 
using UV light and KMnO4/heat. Sorbtech silica gel (60, particle size 40-63 m) was used for 
silica gel chromatography. Nuclear magnetic resonance (NMR) spectra were recorded on a Varian 
Unity plus and Bruker spectrometer for 1H (400 MHz or 600 MHz) and 13C (101 MHz or 151 
MHz) in deuterated chloroform (CDCl3), unless otherwise indicated. Signal patterns are indicated 
as br, broad peak; s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet. The rotamer peaks were 
shown in (). All the non-aqueous reactions were performed under an inert atmosphere of aargon 
in flame-dried glassware, containing a stir bar, unless otherwise noted.  Anhydrous diethyl ether 
(Et2O), toluene (PhMe), N,N-dimethylsulforamide (DMF), tetrahydrofuran (THF), 
dichloromethane (DCM), and acetonitrile (MeCN) were obtained via a dual column solvent 
purification system (J.C Mayer of Glass Contour). All other solvents and reagents were obtained 
from commercial sources without further purification unless noted. Organic extracts were dried 
with NaSO4 (unless otherwise noted) before filtration and concentration under reduced pressure.  
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Tert-butyl (S)-(2,8-dioxo-1-oxaspiro[4.5]deca-6,9-dien-3-yl)carbamate (48) 
 
    Boc-L-Tyrosine             48 
 
To a stirred solution of iodobenzene diacetate (4.3 g, 13.3 mmol, 1.5 eq) in iPrOH: MeCN (1:4, 
0.20 M, 66.5 mL) was added a stirred solution of Boc-L- tyrosine (2.5 g, 8.9 mmol, 1 eq) in 
iPrOH: MeCN (1:4, 0.23 M, 39 mL) dropwise over 30 minutes, and then was stirred at room 
temperature. After 3 h, the reaction was quenched with saturated aqueous NaHCO3 and the organic 
layer was extracted with EtOAc (× 3). The combined organic layers were washed with saturated 
aqueous NaHCO3 (× 2), dried with anhydrous Na2SO4, and concentrated in vacuo. The crude 
residue was purified by flash column chromatography (silica gel, EtOAc: hexanes, 1:1) to give 
compound 48 as a yellow foam (1.1 g, 43% yield). Rf = 0.58 (silica, EtOAc:hexanes, 1:1); 1H 
NMR (400 MHz, Chloroform-d) δ 6.90 – 6.80 (m, 2H), 6.34 – 6.25 (m, 2H), 5.17 (s, 1H), 4.59 – 
4.45 (brs, 1H), 2.75 (t, J = 11.2 Hz, 1H), 2.45 (t, J = 12.4 Hz, 1H), 1.46 (s, 9H). 13C NMR (151 
MHz, Chloroform-d) δ 184.08, 173.61, 155.22, 144.22, 143.93, 129.73, 129.14, 81.23, 76.14, 
50.19, 38.67, 28.24. Known compound; all the spectral data matches the data reported in reference 
52.  
 
Notebook Entries: 
Procedure    – cwh2-015 
1H                – cwh1-094 
13C               – cwh2-015 
O
O
OBocHN
OH
NHBoc
CO2H
Iodobenzene diacetate
iPrOH: MeCN (1:4)
43%
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1-(tert-butyl) 2-methyl (2S,3aR,7aR)-3a-hydroxy-6-oxo-2,3,3a,6,7,7a-hexahydro-1H-indole-
1,2-dicarboxylate (17) 
 
       48               17 
 
To a stirred solution of 3M KOH (120 mL, 0.10 M) and MeOH (120 mL, 0.10 M) at -20 C was 
added compound 48 (3.0 g, 10.7 mmol, 1 eq) dissolved in MeOH (100 mL, 0.14 M), and then was 
stirred at -20 C. After 30 minutes, the reaction was quenched with 5M HCl until a pH of 2 and 
was extracted with EtOAc (× 3). The combined organic layers were washed with brine, dried with 
anhydrous Na2SO4, and concentrated in vacuo. The crude residue was purified by flash column 
chromatography (silica gel, EtOAc:hexanes, 1:1) to give compound 17 as a yellow foam (3 g, 82% 
yield). Rf = 0.24 (silica, EtOAc:hexanes, 1:1); Rotamers were shown in ( ).  1H NMR (400 MHz, 
Chloroform-d) δ 6.83 – 6.74 (m, 1H), 6.03 – 5.94 (m, 1H), 4.49 – 4.29 (m, 2H), 3.82 + 3.75 (s + 
s’, 3H), 3.10 (m, 1H), 2.49 (m, 1H), 2.29 – 2.12 (m, 2H), 1.41 (s, 9H). 13C NMR (101 MHz, 
Chloroform-d) δ (196.33, 196.31), (175.52, 175.50), (153.65, 153.63) (148.57, 148.19), (129.28, 
129.15), (81.75, 81.42), (76.76, 75.74), (65.86, 65.53), (58.82, 58.67), (53.41, 53.05), (42.90, 
42.18), (40.71, 39.73), (28.51, 28.38). Known compound; all the spectral data matches the data 
reported in reference 38. The procedure was taken from reference 40. 
 
 
Notebook Entries: 
Procedure    – cwh1-297 
1H                – cwh1-297-pure 
13C               – cwh1-297-pure 
O
O
OBocHN
NO
CO2Me
Boc
OH
H
3M KOH
MeOH
82%
76 
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1-(tert-butyl) 2-methyl (2S,3aR,7aR)-3a-(benzoyloxy)-6-oxo-2,3,3a,6,7,7a-hexahydro-1H-
indole-1,2-dicarboxylate (49) 
 
                             17                                                       49 
To a stirred solution of compound 17 (920 mg, 2.96 mmol, 1 eq) in DCM (30 mL, 0.10 M) was 
added benzoic anhydride (2.0 g, 8.87 mmol, 3.0 eq), DMAP (37 mg, 0.30 mmol, 0.1 eq), pyridine 
(1.25 mL, 15.39 mmol, 5.12 eq), and Et3N (1.7 mL, 11.84 mmol, 4.0 eq), and then brought to 
reflux. After 48 h, the reaction was quenched with 1M HCl and the organic layer was extracted 
with DCM (× 3). The combined organic layers were washed with brine, dried with anhydrous 
Na2SO4, and concentrated in vacuo. The crude residue was purified by flash column 
chromatography (silica gel, EtOAc:hexanes, 1:5 and 2:1) to give compound 49 as a light-yellow 
foam (1.0 g, 82% yield). Rf = 0.54 (silica, EtOAc:hexanes, 1:1); Rotamers were shown in ( ). 1H 
NMR (400 MHz, Chloroform-d) δ 7.96 – 7.89 (m, 2H), 7.58 (dt, J = 10.7, 5.7 Hz, 1H), 7.50 –7.39 
(m, 2H), 7.04 (dd, J = 30.1, 10.4 Hz, 1H), 6.13 (dd, J = 10.4, 4.5 Hz, 1H), 4.92 (ddd, J = 21.9, 9.7, 
6.8 Hz, 1H), 4.61 (ddd, J = 58.4, 9.5, 2.0 Hz, 1H), 3.56 (s+ s’, 3H), 3.41 – 3.26 (m, 1H), 3.07 – 
2.96 (m, 1H), 2.67 (ddd, J = 26.0, 14.2, 9.5 Hz, 1H), 2.55 – 2.41 (m, 1H), 1.48 (s, 9H). 13C NMR 
(151 MHz, Chloroform-d) δ (195.32, 195.26), (171.75, 171.11), (165.40, 165.23), (153.39, 
152.97), (145.23, 144.23), (133.75, 133.66), (130.06, 129.83), (129.81, 129.54), (129.39, 
129.30),(128.53, 128.47), (83.92, 82.69), (81.49, 80.92), (61.42, 60.97), (58.44, 58.09), (52.46, 
52.24), (42.80, 41.43), (39.56, 38.90), (28.26, 28.24). . Known compound; all the spectral data 
matches the data reported in reference 40. 
Notebook Entries: 
Procedure    – cwh4-073 
1H                – cwh1-370-pure         13C        – cwh2-103-A 
NO
CO2Me
Boc
OH
H
NO
CO2Me
Boc
OBz
H
Benzoic anhydride, DMAP,
Pyridine, Et3N
DCM
82%
78 
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1-(tert-butyl) 2-methyl (2S,3aR,7aR)-3a-(benzoyloxy)-6-((tert-butyldimethylsilyl)oxy)-
2,3,3a,7a-tetrahydro-1H-indole-1,2-dicarboxylate (50) 
 
         15          50 
 
To a stirred solution of compound 15 (110 mg, 0.26 mmol, 1 eq) in DCM (1.7 mL, 0.156 M) was 
added Et3N (0.07 mL, 0.53 mmol, 2.04 eq) and TBSOTf (0.065 mL, 0.286 mmol, 1.1 eq), and then 
was stirred at room temperature. After 1 h, the reaction was quenched with saturated aqueous 
NaHCO3 and organic layers were extracted with DCM (× 3). The combined organic layers were 
washed with brine, dried with anhydrous Na2SO4, and concentrated in vacuo. The crude residue 
was purified by flash column chromatography (silica gel, EtOAc:hexanes, 1:3) to give compound    
50 as a white foam (129 mg, 98% yield). Rf = 0.47 (silica, EtOAc:hexanes, 1:3); Rotamers were 
shown in ( ). 1H NMR (400 MHz, Chloroform-d) δ 7.91 (m, 2H), 7.62 – 7.50 (m, 1H), 7.47 – 7.38 
(m, 2H), 6.11 – 5.72 (m, 2H), 5.45 – 5.17 (m, 2H), 4.56 – 4.30 (m, 1H), 3.57 (s + s’, 3H), 2.90 (m, 
1H), 2.50 – 2.38 (m, 1H), 1.50 + 1.40 (s+ s’, 9H), 0.93 (s+ s’, 9H), 0.22 + 0.13 (s+ s’, 6H). 13C 
NMR (101 MHz, Chloroform-d) δ (172.91, 172.17), (165.60, 165.26) (146.96, 146.57), (133.53, 
133.41), (130.27, 130.19), (129.89, 129.88), (129.60, 128.95), (128.58, 128.51), (125.87, 125.35), 
(103.65, 103.59), (97.90, 97.77), (86.32, 85.00), (80.81, 80.40), (63.52, 63.09), (55.55, 54.99), 
(52.47, 52.27), (42.46, 41.65), (28.71, 28.51), (25.85, 25.83), (18.30, 18.26), (-4.24, -4.30). New 
compound; Procedure was taken from reference 41. 
Notebook Entries: 
Procedure    – cwh3-084 
1H                – cwh3-084 
13C               – cwh3-084 
 
NO
CO2Me
Boc
OBz
H
NTBSO
CO2Me
Boc
OBz
H
TBSOTf, Et3N
DCM
98%
80 
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1-(tert-butyl) 2-methyl (2S,3aR,7S,7aR)-3a-(benzoyloxy)-7-((tert-butyldimethylsilyl)oxy)-6-
oxo-2,3,3a,6,7,7a-hexahydro-1H-indole-1,2-dicarboxylate (52) 
 
    50           52 
 
To a stirred solution of compound 50 (60 mg, 0.11 mmol, 1 eq) in acetone (1.3 mL, 0.0875 M) 
was added freshly prepared DMDO (2.3 mL, 0.15 mmol, 1.34 eq) at 0 C, and then was stirred at 
0 C. After 1 h, the reaction mixture was concentrated in vacuo. The crude residue was purified 
by flash column chromatography (silica gel, EtOAc: hexanes, 1:6) to give compound 52 as a white 
foam (431 mg, 79% yield). Rf = 0.13 (silica, EtOAc:hexanes, 1:6); Rotamers were shown in ( ). 
1H NMR (400 MHz, Chloroform-d) δ 7.91 (m, 2H), 7.58 – 7.52 (m, 1H), 7.45 – 7.40 (m, 2H), 6.96 
(ddd, J = 34.8, 10.5, 2.0 Hz, 1H), 6.14 – 5.97 (m, 1H), 5.82 – 5.46 (m, 1H), 5.19 – 4.93 (m, 1H), 
4.58 – 4.39 (m, 1H), 3.51 (s+ s’, 3H), 2.92 – 2.87 (m, 1H), 2.53 – 2.34 (m, 1H), 1.42 (m, 9H), 0.93 
– 0.87 (m, 9H), 0.20 – 0.10 (m, 6H). New compound; Procedure was taken from reference 41. 
(Compound was degraded and 13C was not obtained) 
DMDO Preparation 
Solution of 24 g of NaHCO3 was stirred in a 1 L RBF containing 20 mL of H2O and 30 mL 
acetone at 0 ºC. After 20 min, 25 g of oxone was added, the flask is loosely covered and the mixture 
was vigorously stirred at 0 ºC. After 15 min, the mixture was rotovaped carefully and the rotavaped 
light yellow solution (DMDO) was collected. Then the DMDO solution was dried with Na2SO4 
and used for the reaction immediately. 
Notebook Entries: 
Procedure    – cwh3-089 
1H                – cwh3-089 
NTBSO
CO2Me
Boc
OBz
H
NO
CO2Me
Boc
OBz
H
OTBS
DMDO
Acetone
79%
82 
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Benzyl (2,8-dioxo-1-oxaspiro [4.5] deca-6,9-dien-3-yl) carbamate (13)             
 
              Cbz-L-tyrosine    13 
  
To a stirred solution of iodobenzene diacetate (7.7 g, 23.78 mmol, 1.5 eq) in iPrOH: MeCN (1:4, 
0.20 M, 80 mL) was added a stirred solution of Cbz-L- tyrosine (5g, 15.85 mmol, 1 eq) in iPrOH: 
MeCN (1:4, 0.23 M, 70 mL) dropwise over 30 minutes, and then was stirred at room temperature. 
After 3 h, the reaction was quenched with saturated aqueous NaHCO3 and the organic layers were 
extracted with EtOAc (× 3). The combined organic layers were washed with saturated aqueous 
NaHCO3 (× 2), dried with anhydrous Na2SO4, and concentrated in vacuo. The crude residue was 
purified by flash column chromatography (silica gel, EtOAc: hexanes, 1:1) to give compound 13 
as a yellow foam (2.23 g, 45% yield). Rf = 0.59 (silica, EtOAc:hexanes, 1:1); 1H NMR (400 MHz, 
Chloroform-d) δ 7.45 – 7.30 (m, 5H), 6.86 (s, 2H), 6.28 (t, J = 9.1 Hz, 2H), 5.65 (d, J = 6.3 Hz, 
1H), 5.13 (d, J = 2.2 Hz, 1H), 4.61 (s, 1H), 2.70 (d, J = 10.1 Hz, 1H), 2.48 (t, J = 12.1 Hz, 1H). 13C 
NMR (101 MHz, Chloroform-d) δ 184.17, 173.47, 156.12, 146.19, 144.22, 135.82, 130.06, 
129.45, 128.68, 76.43, 67.92, 50.75, 38.73. Known compound; all the spectral data matches the 
data reported in reference 40. 
 
Notebook Entries: 
Procedure     –  cwh4-001 
1H                –   cwh1-256-pure 
13C               –   cwh2-256-pure-c13 
O
O
OCbzHN
OH
NHCbz
CO2H
Iodobenzene diacetate
iPrOH: MeCN (1:4)
45%
84 
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1-benzyl 2-methyl (2S,3aR,7aR)-3a-hydroxy-6-oxo-2,3,3a,6,7,7a-hexahydro-1H-indole-1,2-
dicarboxylate (14) 
 
         13                                                          14 
To a stirred solution of 3M KOH (64 mL, 0.10 M) and MeOH (64 mL, 0.10 M) at -20 C was 
added compound 13 (2.0 g, 6.38 mmol, 1 eq) dissolved in MeOH (46 mL, 0.14 M), and then was 
stirred at -20 C. After 30 minutes, the reaction was quenched with 5M HCl until a pH of 2 and 
was extracted with EtOAc (× 3). The combined organic layers were washed with brine, dried with 
anhydrous Na2SO4, and concentrated in vacuo. The crude residue was purified by flash column 
chromatography (silica gel, EtOAc:hexanes, 1:1) to give compound 14 as a yellow foam (2 g, 92% 
yield). Rf = 0.25 (silica, EtOAc:hexanes, 1:1); Rotamers were shown in ( ). 1H NMR (400 MHz, 
Chloroform-d) δ 7.36 – 7.27 (m, 5H), 6.84 – 6.78 (m, 1H), 6.10 – 5.96 (m, 1H), 5.24 – 4.98 (m, 
2H), 4.56 – 4.44 (m, 3H), 3.83+ 3.56 (s + s’, 3H), 3.10 – 3.00 (m, 1H), 2.60 – 2.48 (m, 1H), 2.36 
– 2.17 (m, 2H). 13C NMR (101 MHz, Chloroform-d) δ (196.09, 196.01), (175.20, 175.22), (154.57, 
153.87), (148.30, 147.98), (135.95, 135.40), (129.39, 129.25), (128.90, 128.73), (128.64, 128.53), 
(128.36, 128.32), (76.82, 75.82), (68.16, 67.92), (66.18, 65.91), (59.11, 58.73), (53.55, 53.11), 
(42.92, 42.12), (40.76, 39.76). Known compound; all the spectral data matches the data reported 
in reference 40. 
 
Notebook Entries: 
Procedure    – cwh4-003 
1H                – cwh1-318-pure 
13C               – cwh1-318-pure-c13 
O
O
OCbzHN
NO
CO2Me
Cbz
OH
H
3M KOH
MeOH
92%
86 
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1-benzyl 2-methyl (2S,3aR,7aR)-3a-(benzoyloxy)-6-oxo-2,3,3a,6,7,7a-hexahydro-1H-indole-
1,2-dicarboxylate (15) 
 
         14                     15 
To a stirred solution of compound 14  (2.0 g, 5.79 mmol, 1 eq) in DCM (58 mL, 0.10 M) was 
added benzoic anhydride (3.9 g, 17.38 mmol, 3 eq), DMAP (71 mg, 0.579 mmol, 0.1 eq), pyridine 
(2.4 mL, 30.10 mmol, 5,12 eq), and Et3N (3.2 mL, 23.16 mmol, 4.0 eq) and the reaction mixture 
was refluxed. After 48 h, the reaction was quenched with 1M HCl and the organic layers were 
extracted with DCM (× 3). The combined organic layers were washed with brine, dried with 
anhydrous Na2SO4, and concentrated in vacuo. The crude residue was purified by flash column 
chromatography (silica gel, EtOAc:hexanes, 1:5 and 2:1) to give compound 15 as a light-yellow 
foam (1.97 g, 82% yield). Rf = 0.54 (silica, EtOAc:hexanes, 1:1); Rotamers were shown in ( ). 1H 
NMR (400 MHz, Chloroform-d) δ 7.85 – 7.78 (m, 2H), 7.52 – 7.45 (m, 1H), 7.34 (m, 2H), 7.30 – 
7.17 (m, 5H),, 7.03 – 6.93 (m, 1H), 6.04 (dd, J = 10.4, 7.8 Hz, 1H), 5.17 – 4.90 (m, 3H), 4.60 (ddd, 
J = 40.4, 9.6, 1.8 Hz, 1H), 3.49 – 3.26 (s+ s’, 3H), 3.40 – 3.23 (m, 1H), 3.06 – 2.96 (m, 1H), 2.68 
– 2.54 (m, 1H), 2.43 – 2.27 (m, 1H). 13C NMR (101 MHz, Chloroform-d) δ (195.09, 195.06), 
(171.48, 170.91), (145.06, 144.22), (133.97, 133.95), (130.36, 130.3l5), (130.05, 130.01), (129.84, 
129.80), (129.64, 129.62), (129.50, 129.47), (128.88, 128.86), (128.72, 128.70), (128.61, 128.59), 
(128.53, 128.52), (128.44, 128.43), (84.09, 82.93), (68.13, 67.66), (62.15, 61.47), (58.67, 58.51), 
(52.74, 52.53), (42.99, 41.71), (39.73, 38.91). Known compound; all the spectral data matches the 
data reported in reference 40. 
Notebook Entries: Procedure  – cwh4-022     1H   – cwh3-285-pure-1     13C    – cwh3-285-c13-1 
NO
CO2Me
Cbz
OH
H
NO
CO2Me
Cbz
OBz
H
Benzoic anhydride, DMAP,
Pyridine, Et3N
DCM
80%
88 
 
 
89 
1-benzyl 2-methyl (2S,3aR,7aR)-3a-(benzoyloxy)-6-((tert-butyldimethylsilyl)oxy)-2,3,3a,7a-
tetrahydro-1H-indole-1,2-dicarboxylate (28) 
 
                               15        28 
 
To a stirred solution of compound 15 (191 mg, 0.42 mmol, 1 eq) in DCM (2.7 mL, 0.156 M) was 
added Et3N (0.12 mL, 0.87 mmol, 2.04 eq) and TBSOTf (0.14 mL, 0.63 mmol, 1.50 eq), and then 
was stirred at room temperature. After 1 h, the reaction was quenched with saturated aqueous 
NaHCO3 and organic layer was extracted with DCM (× 3). The combined organic layers were 
washed with brine, dried with anhydrous Na2SO4, and concentrated in vacuo. The crude residue 
was purified by flash column chromatography (silica gel, EtOAc:hexanes, 1:3) to give compound 
28 as a white foam (232 mg, 98% yield). Rf = 0.48 (silica, EtOAc:hexanes, 1:3); Rotamers were 
shown in ( ). 1H NMR (400 MHz, Chloroform-d) δ 7.86 (m, 2H), 7.58 – 7.47 (m, 1H), 7.46 – 7.19 
(m, 7H)), 6.03 (dd, J = 19.4, 10.2 Hz, 1H), 5.72 (ddd, J = 18.1, 10.2, 2.1 Hz, 1H), 5.42 – 4.98 (m, 
4H), 4.42 (dd, J = 30.9, 9.4 Hz, 1H), 3.44 (s +s’, 3H), 3.04 – 2.84 (m, 1H), 2.42 (ddd, J = 14.0, 9.6, 
6.6 Hz, 1H), 0.96 – 0.79 (m, 9H), 0.15 (m, 6H). 13C (101 MHz, Chloroform-d) δ (172.91, 172.16), 
(165.60, 165.59), (153.88, 153.82), (146.96, 146.57), (133.53, 133.41), (130.27, 130.19), (130.04, 
129.91), (129.89, 129.88), (129.61, 129.60), (129.32, 129.30), (128.96, 128.95), (128.58, 128.51), 
(125.87, 125.35), (103.65, 103.59), (86.32, 85.00), (80.81, 80.40), (63.52, 63.09), (55.55, 54.99), 
(52.47, 52.27), (42.45, 41.65), (28.71, 28.51), (25.85, 25.83), (18.26, 18.25), (-4.24, -4.30). Known 
compound; all the spectral data matches the data reported in reference 41. 
Notebook Entries: 
Procedure    – cwh3-064                                                                                                                                                                              
1H                – cwh3-064                    13C               – cwh3-084-c13 
NO
CO2Me
Cbz
OBz
H
NTBSO
CO2Me
Cbz
OBz
H
TBSOTf, Et3N
DCM
98%
90 
 
 
91 
1-benzyl 2-methyl (2S,3aR,7S,7aR)-3a-(benzoyloxy)-7-hydroxy-6-oxo-2,3,3a,6,7,7a-
hexahydro-1H-indole-1,2-dicarboxylate (51) 
 
              28                      51 
 
 To a stirred solution of compound 28 (700 mg, 1.32 mmol, 1 eq) in acetone (16 mL, 0.0875 M) 
was added freshly prepared DMDO (30 mL, 1.77 mmol, 1.34 eq) at 0 C, and then was stirred at 
0 C. After 1 h, the reaction mixture was concentrated in vacuo and the crude residue was purified 
by flash column chromatography (silica gel, EtOAc:hexanes, 1:1) to give compound 51 as a white 
foam (472 mg, 83% yield). Rf = 0.43 (silica, EtOAc:hexanes, 1:1); 1H NMR (400 MHz, 
Chloroform-d) δ 7.94 (dd, J = 19.6, 7.7 Hz, 2H), 7.59 (t, J = 7.3 Hz, 1H), 7.45 (t, J = 7.8 Hz, 2H), 
7.38 – 7.25 (m, 5H), 7.11 (d, J = 10.4 Hz, 1H), 6.15 (d, J = 10.3 Hz, 1H), 5.39 (s, 1H), 5.21 (d, J = 
12.0 Hz, 1H), 4.99 (s, 1H), 4.93 – 4.86 (m, 1H), 4.46 (dd, J = 9.0, 6.4 Hz, 1H), 3.66 – 3.58 (m, 
1H), 3.41 (s, 3H), 3.18 (dd, J = 13.6, 9.1 Hz, 1H), 2.53 (dd, J = 13.6, 6.4 Hz, 1H). 13C NMR (101 
MHz, Chloroform-d) δ 196.22, 171.90, 165.29, 154.98, 142.54, 135.68, 134.05, 130.06, 129.58, 
129.27, 128.80, 128.73, 128.58, 128.44, 82.76, 70.98, 68.35, 67.26, 59.52, 52.58, 39.77. Known 
compound; all the spectral data matches the data reported in reference 41. 
 
Notebook Entries: 
Procedure    – cwh3-118 
1H                – cwh3-118-c-pure 
13C               – cwh3-192-c13 
 
NTBSO
CO2Me
Cbz
OBz
H
NO
CO2Me
Cbz
OBz
H
OH
DMDO
Acetone
83%
92 
 
 
93 
1-benzyl 2-methyl (2S,3aR,7S,7aR)-3a-(benzoyloxy)-7-((tert-butyldimethylsilyl)oxy)-6-oxo-
2,3,3a,6,7,7a-hexahydro-1H-indole-1,2-dicarboxylate (29) 
 
         51       29 
 
To a stirred solution of compound 51 (240 mg, 0.51 mmol, 1 eq) in DCM (9.0 mL, 0.056 M) was 
added Et3N (0.20 mL, 1.70 mmol, 3.3 eq) and TBSOTf (0.13 mL, 0.56 mmol, 1.1 eq), and then 
was stirred at room temperature. After 4 h, the reaction was quenched with saturated aqueous 
NaHCO3 and organic layer was extracted with DCM (× 3). The combined organic layers were 
washed with brine, dried with anhydrous Na2SO4, and concentrated in vacuo. The crude residue 
was purified by flash column chromatography (silica gel, EtOAc:hexanes, 1:6) to give compound 
29 as a white foam (292 mg, 99% yield). Rf = 0.22 (silica, EtOAc:hexanes, 1:6); Rotamers were 
shown in ( ). 1H NMR (400 MHz, Chloroform-d) δ 7.85 (m, 2H), 7.56 – 7.49 (m, 1H), 7.42 – 7.25 
(m, 7H), 7.00 – 6.90 (m, 1H), 6.21 – 6.02 (m, 1H), 5.22 – 4.95 (m, 3H), 4.71 – 4.58 (m, 2H), 3.43 
(s+ s’, 3H), 2.97 – 2.80 (m, 2H), 0.77 (m, 9H), -0.14 (m, 6H). 13C NMR (101 MHz, Chloroform-
d) δ (195.14,195.12), (171.90, 170.89), (153.73, 153.70), (143.94, 143.28,) (136.18, 133.79), 
(133.75, 130.02), (129.95, 129.75), (129.55, 129.53), (128.99, 128.89), (128.70, 128.66), (128.63, 
128.61), (128.41, 128.39), (128.36, 127.93), (84.44, 83.49), (72.66, 71.13), (68.04, 67.64), (66.47, 
65.73), (60.02, 59.68), (52.59, 52.42), (40.39, 39.73), (25.77, 25.76), (18.08,14.35), (-5.13, -5.26). 
Known compound; all the spectral data matches the data reported in reference 41. 
Notebook Entries: 
Procedure    – cwh3-146 
1H                – cwh3-146 
13C               – cwh3-146-c13 
 
NO
CO2Me
Cbz
OBz
H
OH
NO
CO2Me
Cbz
OBz
H
TBSOTf, Et3N
DCM
99% OTBS
94 
 
 
95 
1-benzyl 2-methyl (2S,3aR,7S,7aS)-7-((tert-butyldimethylsilyl)oxy)-6-oxo-2,3,3a,6,7,7a-
hexahydro-1H-indole-1,2-dicarboxylate (77)   
 
                29                  77 
To a stirred solution of compound 29 (150 mg, 0.26 mmol, 1 eq) in THF (1.0 mL, 0.22 M) was 
added Pd(dba)3CHCl3 (5 mg, 0.005 mmol, 0.02 eq) and tribenzylphosphene (6 mg, 0.02 mmol, 
0.08 eq). After stirring for 1-minute Et3N (0.13 mL, 0.90 mmol, 3.47 eq) was added immediately 
followed by the addition of 95% HCO2H (0.04 mL, 0.90 mmol, 3.47 eq) and the reaction mixture 
was refluxed. After 12 h, the reaction was quenched with saturated aqueous NaHCO3 and the 
organic layer was extracted with EtOAc (× 3). The combined organic layers were washed with 
brine, dried with anhydrous Na2SO4, and concentrated in vacuo. The crude residue was purified 
by flash column chromatography (silica gel, EtOAc: hexanes, 1:3) to give compound 77 as a light-
yellow foam (107 mg, 90% yield). Rf = 0.43 (silica, EtOAc:hexanes, 1:3); Rotamers were shown 
in ( ). 1H NMR (600 MHz, Chloroform-d) δ 7.41 – 7.21 (m, 5H), 6.86 – 6.68 (m, 1H), 6.09 – 5.89 
(m, 1H), 5.23 – 4.90 (m, 2H), 4.51 – 4.30 (m, 2H), 3.64 (s+ s’, 3H), 3.22 – 3.02 (m, 1H), 2.59 – 
2.42 (m, 1H), 2.09 (m, 1H), 1.26 – 1.19 (m, 1H), 0.84 – 0.69 (m, 9H), 0.02 – -0.21 (m, 6H). 13C 
NMR (151 MHz, Chloroform-d) δ (173.85, 173.73), (166.08, 166.07), (155.09, 154.58), (136.14, 
133.21), (133.17, 130.62), (129.91, 129.75), (128.61, 128.47), (128.42, 128.25), (128.15, 128.01), 
(123.36, 123.11), (77.77, 77.75), (69.32, 68.86), (67.60, 67.42), (60.67, 59.86), (56.92,56.91), 
(52.98, 52.61), (39.42, 38.23), (32.52, 31.68). New compound; Procedure was taken from 
reference 40. 
Notebook Entries: 
Procedure    – cwh3-150          1H  – cwh3-128     13C  – cwh3-128 
NO
CO2Me
Cbz
OBz
H
NO
CO2Me
Cbz
H
H
Pd(dba)3CHCl3, Tribenzylphosphene
Et3N, HCO2H
THF
90%OTBS
OTBS
96 
 
 
97 
1-benzyl 2-methyl (2S,3aR,6R,7S,7aS)-7-((tert-butyldimethylsilyl)oxy)-6-hydroxy-
2,3,3a,6,7,7a-hexahydro-1H-indole-1,2-dicarboxylate (83) 
 
   77             83 
 
To a stirred solution of compound 77 (30 mg, 0.065 mmol, 1 eq) in THF:MeOH 1:1 (0.75 mL, 
0.0875M) was added CeCl3 •7H2O (24 mg, 0.065 mmol, 1 eq) and stirred for 5 mins. Then NaBH4 
(2.5 mg, 0.065 mmol, 1 eq) was added portion wise, and then was stirred at 0 C. After 5 mins, the 
reaction was quenched with saturated aqueous NaHCO3 and organic layer was extracted with 
EtOAc (× 3). The combined organic layers were washed with brine, dried with anhydrous Na2SO4, 
and concentrated in vacuo. The crude residue was purified by flash column chromatography (silica 
gel, EtOAc:hexanes, 1:3) to give compound 83 as a white foam (29 mg, 99% yield). Rf = 0.39 
(silica, EtOAc:hexanes, 1:3); Rotamers were shown in ( ). 1H NMR (400 MHz, Chloroform-d) δ 
7.49 – 7.13 (m, 5H), 5.67 – 5.52 (m, 1H), 5.50 – 5.38 (m, 1H), 5.24 – 4.90 (m, 2H), 4.39 – 4.11 
(m, 4H), 3.59 (s+ s’, 3H), 2.35 – 2.18 (m, 1H), 1.85 (m, 2H), 0.80 (m, 9H), -0.11 (m, 6H). 13C 
NMR (101 MHz, Chloroform-d) δ (173.51, 173.44), (154.85, 154.32), (136.45, 136.37), (129.48, 
129.10,) (129.06, 128.87), (128.85, 128.62), (128.58, 128.35), (128.33, 128.29), (126.73, 126.45), 
(69.94, 69.02), (68.90, 68.86), (67.68, 67.35), (60.74, 60.48), (59.80, 59.16), (52.53, 52.34), 
(37.02, 36.02), (35.23, 34.24), (26.21, 26.17), (18.25, 18.24), (-4.26, -4.92). New compound; 
Procedure was taken from reference 41. 
Notebook Entries: 
Procedure    – cwh3-327     1H     – cwh3-327-pure        13C               – cwh3-327-c13 
NO
CO2Me
Cbz
H
H
OTBS
NHO
CO2Me
Cbz
H
H
OTBS
CeCl3. 7H2O, NaBH4
THF/MeOH
0 ºC
99%
98 
 
 
99 
1-benzyl 2-methyl (2S,3aR,6S,7S,7aS)-7-((tert-butyldimethylsilyl)oxy)-6-((2-
nitrophenyl)selanyl)-2,3,3a,6,7,7a-hexahydro-1H-indole-1,2-dicarboxylate (98) 
 
   83        98 
To a stirred solution of compound 83 (60 mg, 0.130 mmol, 1 eq) in THF (1.3 mL, 0.1 M) was 
added o-NO2-C6H4SeCN (59 mg, 0.260 mmol, 2 eq). Then Bu3P (0.07 mL, 0.286 mmol, 2.2 eq) 
was added drop wise and the reaction mixture was refluxed. After 16 h, the reaction was quenched 
with saturated aqueous NaHCO3 and organic layer was extracted with EtOAc (× 3). The combined 
organic layers were washed with brine, dried with anhydrous Na2SO4, and concentrated in vacuo. 
The crude residue was purified by flash column chromatography (silica gel, EtOAc:hexanes, 1:6) 
to give compound 98 as a white foam (58 mg, 71% yield). Rf = 0.57 (silica, EtOAc:hexanes, 1:6); 
Rotamers were shown in ( ). 1H NMR (600 MHz, Chloroform-d) δ 8.37 – 7.27 (m, 10H), 5.97 (m, 
2H), 5.31 – 4.91 (m, 2H), 4.66 (m, 1H), 4.34 – 4.09 (m, 2H), 3.60 (s+ s’, 3H), 2.96 – 2.74 (m, 1H), 
2.48 (ddd, J = 22.3, 12.5, 9.5 Hz, 1H), 2.23 – 2.03 (m, 1H), 0.97 – 0.76 (m, 9H), -0.01 (m, 6H). 13C 
NMR (151 MHz, Chloroform-d) δ (173.30, 173.16), (154.35, 153.92), (149.33, 147.11), (136.33, 
135.29), (133.84, 133.73), (133.65, 132.97), (130.68, 130.29), (129.33, 129.07), (128.68, 128.58), 
(128.42, 128.25), (128.05, 127.98), (127.90, 126.84), (126.07, 125.51), (67.44, 67.00), (62.88, 
62.20), (59.51, 59.24), (58.01, 56.90), (52.33, 52.10), (39.70, 38.82), (37.99, 37.67), (35.98, 
34.65), (25.75, 25.76), (17.76, 17.75) (-4.67, -4.66). New compound; Procedure was taken from 
reference 52. 
Notebook Entries: 
Procedure    – cwh3-427            1H    – cwh3-427-C      13C        – cwh3-427-C 
NHO
CO2Me
Cbz
H
H
OTBS
NSe
CO2Me
Cbz
H
H
OTBSO2N
o-NO2-C6H4SeCN, Bu3P
THF
71%
100 
 
 
101 
1-benzyl 2-methyl (2S,3aS,4R,7R,7aS)-7-((tert-butyldimethylsilyl)oxy)-4-hydroxy-
2,3,3a,4,7,7a-hexahydro-1H-indole-1,2-dicarboxylate (99) 
 
                            98    99 
 
To a stirred solution of compound 98 (20 mg, 0.031 mmol, 1 eq) in DCM (1.2 mL, 0.025 M) was 
added mCPBA (8.3 mg, 0.037 mmol, 1.2 eq) in DCM (0.4 mL, 0.10 M) at -78 C, and then was 
stirred at 0 C. After 5 h, the reaction was quenched with saturated aqueous NaHCO3 and organic 
layer was extracted with DCM (× 3). The combined organic layers were washed with brine, dried 
with anhydrous Na2SO4, and concentrated in vacuo. The crude residue was purified by flash 
column chromatography (silica gel, EtOAc:hexanes, 1:3) to give compound 99 as a white foam 
(11.1 mg, 78% yield). Rf = 0.45 (silica, EtOAc:hexanes, 1:3); Rotamers were shown in ( ). 1H 
NMR (600 MHz, Chloroform-d) δ 7.47 – 7.26 (m, 5H), 6.01 – 5.81 (m, 2H), 5.28 – 4.96 (m, 2H), 
4.47 – 4.22 (m, 3H), 3.65 (s +s’, 3H), 2.97 – 2.82 (m, 1H), 2.32 (m, 1H), 2.01 (m, 1H), 1.70-1.63 
(m, 1H), 0.87 – 0.72 (m, 9H), 0.07 – -0.20 (m, 6H).  13C NMR (151 MHz, Chloroform-d) δ (173.62, 
173.56), (154.54, 153.79), (136.48, 136.44), (131.23, 130.83), (128.52, 128.39), (128.26, 128.09), 
(128.03, 127.99), (125.08, 124.93), (69.44, 69.28), (68.34, 67.91), (67.75, 67.13), (60.03, 59.73), 
(56.60, 55.98), (52.30, 52.11), (36.63, 35.89), (34.35, 29.73), (25.65, 25.62), (17.65, 17.64). New 
compound; Procedure was taken from reference 52. 
Notebook Entries: 
Procedure    – cwh3-432 
1H                – cwh3-432-B 
13C               – cwh3-432-B 
 
NSe
CO2Me
Cbz
H
H
OTBSO2N
N
CO2Me
Cbz
H
H
OTBS
OH
mCPBA
DCM
0 ºC
78%
102 
 
 
 
103 
1-benzyl 2-methyl (2S,3aS,7R,7aS)-4,7-bis((tert-butyldimethylsilyl)oxy)-2,3,3a,4,7,7a-
hexahydro-1H-indole-1,2-dicarboxylate (121) 
 
                        99    121 
 
To a stirred solution of compound 99 (22 mg, 0.0476 mmol, 1 eq) in DCM (0.5 mL, 0.10 M) was 
added Et3N (0.013 mL, 0.0952 mmol, 2 eq) and TBSOTf (0.013 mL, 0.0571 mmol, 1.2 eq), and 
then was stirred at room temperature. After 2 h, the reaction was quenched with saturated aqueous 
NaHCO3 and organic layer was extracted with DCM (× 3). The combined organic layers were 
washed with brine, dried with anhydrous Na2SO4, and concentrated in vacuo. The crude residue 
was purified by flash column chromatography (silica gel, EtOAc:hexanes, 1:6) to give compound 
121 as a white foam (26.7 mg, 98% yield). Rf = 0.44 (silica, EtOAc:hexanes, 1:6); Rotamers were 
shown in ( ). 1H NMR (400 MHz, Chloroform-d) δ 7.40 – 7.27 (m, 5H), 5.94 – 5.70 (m, 2H), 5.27 
– 4.95 (m, 2H), 4.72 – 4.29 (m, 3H), 4.11 – 3.87 (m, 1H), 3.75 + 3.56 (s +s’, 3H), 2.58 – 1.94 (m, 
3H), 0.90 – 0.79 (m, 18H), 0.12 – -0.13 (m, 12H).l 13C NMR (151 MHz, Chloroform-d) δ (173.64, 
173.50), (154.77, 154.21), (136.67, 136.53), (136.37, 135.93), (129.55, 128.64), (128.53, 128.39), 
(128.26, 128.11), (127.94, 127.75), (70.98, 70.33), (68.02, 67.38), (67.22, 66.86), (63.92, 63.12), 
(59.73, 58.43), (52.27, 52.10), (43.77, 42.83), (36.40, 35.13), (25.85, 25.70, 25.64), (18.12, 17.74), 
(8.69, 8.68), (-4.55, -4.58). New compound; Procedure was taken from reference 39. 
 
Notebook Entries: 
Procedure    – cwh4-004 
1H                – cwh4-090 
13C               – cwh4-004 
N
CO2Me
Cbz
H
H
OTBS
OH
N
CO2Me
Cbz
H
H
OTBS
OTBS
TBSOTf, Et3N
DCM
98%
104 
 
 
 
105 
(2S,3aS,7R,7aS)-1-((benzyloxy)carbonyl)-4,7-bis((tert-butyldimethylsilyl)oxy)-2,3,3a,4,7,7a-
hexahydro-1H-indole-2-carboxylic acid (122) 
 
 
                         121                                                                                  122 
 
To a stirred solution of compound 121 (27 mg, 0.0467 mmol, 1 eq) in THF:MeOH 1:1 (1.0 mL, 
0.05 M) was added 2M KOH (0.5 mL, 0.10 M), and then was stirred at room temperature. After 1 
h, the reaction was acidified to pH 2 with 1M HCl and organic layers were extracted with EtOAc 
(× 3). The combined organic layers were dried with anhydrous Na2SO4 and concentrated in vacuo 
to give compound 122 as a white foam (25.5 mg, 98% yield). Rf = 0.12 (silica, EtOAc:hexanes, 
6:1); [Rotamers were shown in ( )]. 1H NMR (600 MHz, Chloroform-d) δ 7.38 – 7.27 (m, 5H), 
6.01 – 5.78 (m, 2H), 5.29 – 5.04 (m, 2H), 4.48 – 4.30 (m, 2H), 3.98 (ddd, J = 16.8, 9.2, 3.6 Hz, 
1H), 2.47 – 2.13 (m, 2H), 0.92 – 0.79 (m, 18H), 0.12 – -0.12 (m, 12H). Directly used in the next 
reaction without further purification. New compound; Procedure was taken from reference 39. 
 
Notebook Entries: 
Procedure    – cwh4-008 
1H                – cwh4-008 
N
CO2Me
Cbz
H
H
OTBS
OTBS
N
CO2H
Cbz
H
H
OTBS
OTBS
2M KOH
THF/MeOH
98%
106 
 
 
 
 
 
 
 
 
 
 
 
107 
Methyl (2S,3aS,4R,7R,7aS)-4,7-bis((tert-butyldimethylsilyl)oxy)-2,3,3a,4,7,7a-hexahydro-
1H-indole-2-carboxylate (123) 
 
                       121       123 
 
To a stirred solution of compound 121 (31 mg, 0.054 mmol, 1 eq) in DCM (0.54 mL, 0.10 M) was 
added Pd(OAc)2 (29 mg, 0.130 mmol, 2.4 eq) and Et3N (0.04 mL, 0.260 mmol, 4.8 eq), was and 
stirred for 5 mins at 45 C. Then Et3SiH (0.18 mL, 1.08 mmol, 20 eq) was added drop wise, and 
then was stirred at 45 C. After 20 h, the reaction was filtered through celite pad and concentrated 
in vacuo. The crude residue was purified by flash column chromatography (silica gel, 
EtOAc:hexanes, 1:1) to give compound 123 as an oily residue (12 mg, 52% yield). Rf = 0.35 
(silica, EtOAc:hexanes, 1:1); Rotamers were shown in ( ). 1H NMR (400 MHz, Chloroform-d) δ 
5.80 – 5.69 (m, 2H), 4.52 (m, 1H), 4.21 – 4.15 (m, 1H), 3.96 (m, 1H), 3.76 (s, 3H), 3.67 – 3.59 (m, 
1H), 2.50 (m, 1H), 2.35 – 2.31 (m, 1H), 2.20 – 2.16 (m, 1H), 2.08 – 2.04 (m, 1H), 0.92 (m, 18H), 
0.19 – 0.05 (m, 12H). New compound; Procedure was taken from reference 39. 
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109 
Benzyl (2S,3aS,4R,7R,7aS)-2-((2S,3aS,4R,7R,7aS)-4,7-bis((tert-butyldimethylsilyl)oxy)-2-
(methoxycarbonyl)-2,3,3a,4,7,7a-hexahydro-1H-indole-1-carbonyl)-4,7-bis((tert-
butyldimethylsilyl)oxy)-2,3,3a,4,7,7a-hexahydro-1H-indole-1-carboxylate (124) 
 
     122                                    123                                                                          124 
 
To a stirred solution of carboxylic acid 122 (11 mg, 0.02 mmol, 1 eq) and amine 123 (9 mg, 0.02 
mmol, 1 eq) in DCM (0.20 mL, 0.10 M) was cooled to 0 ºC. Then Et3N (0.008 mL, 0.06 mmol, 
3.0 eq) was added and stirred. After 5 mins, BOPCl (5 mg, 0.02 mmol, 1 eq) was added portion 
wise, and then was stirred at room temperature. After 20 h, the reaction was concentrated in vacuo 
and the crude residue was purified by flash column chromatography (silica gel, EtOAc:hexanes, 
3:1) to give compound 124 as a white foam (13.5 mg, 69% yield). Rf = 0.62 (silica, 
EtOAc:hexanes, 3:1); Rotamers were shown in ( ). 1H NMR (400 MHz, Chloroform-d) δ 7.35 (m, 
5H), 5.90 (m, 4H), 5.23 – 5.02 (m, 2H), 4.56 – 3.93 (m, 7H), 3.81 – 3.58 (s+ s’, 3H), 2.72 – 1.75 
(m, 7H), 0.92 – 0.81 (m, 36H), 0.11 – -0.08 (m, 24H). New compound; Procedure was taken from 
reference 39. 
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111 
1-benzyl 2-methyl (2S,3aS,7S,7aS)-7-((tert-butyldimethylsilyl)oxy)-4-oxo-2,3,3a,4,7,7a-
hexahydro-1H-indole-1,2-dicarboxylate (100) 
 
                        99         100 
 
 To a stirred solution of compound 99 (10 mg, 0.022 mmol, 1 eq) in DCM (0.23 mL, 0.10 M) was 
added DMP (14 mg, 0.033 mmol, 1.5 eq) and K2CO3 (7.7 mg, 0.056 mmol, 2.6 eq), and then was 
stirred at room temperature. After 4 h, the reaction was diluted with H2O and organic layer was 
extracted with DCM (5 mL × 3). The combined organic layers were washed with brine, dried with 
anhydrous Na2SO4, and concentrated in vacuo. The crude residue was purified by flash column 
chromatography (silica gel, EtOAc:hexanes, 1:1) to give compound 100 as a white foam (9.2 mg, 
92% yield). Rf = 0.52 (silica, EtOAc:hexanes, 1:1); Rotamers were shown in ( ). 1H NMR (600 
MHz, Chloroform-d) δ 7.46 – 7.20 (m, 5H), 7.03 – 6.88 (m, 1H), 6.11 (m, 1H), 5.29 – 4.69 (m, 
3H), 4.57 – 4.35 (m, 2H), 3.82 + 3.56 (s+ s’, 3H), 3.27 – 3.13 (m, 1H), 2.62 – 2.50 (m, 1H), 2.38 
– 2.24 (m, 1H), 0.81 (m, 9H), 0.08 – -0.19 (m, 6H). 13C NMR (151 MHz, Chloroform-d) δ (198.13, 
198.12), (172.82, 172.81), (153.79, 153.78), (146.90, 146.68), (136.11, 135.98), (130.72, 130.70), 
(128.66, 128.58), (128.45, 128.13), (128.03, 127.98), (67.66, 67.26), (62.84, 61.93), (59.63, 
58.97), (52.49, 52.30), (45.79, 44.87), (33.72, 32.81), (29.97, 29.73), (25.56, 22.74), (17.66, 
14.17), (-4.62, -4.61). New compound; Procedure was taken from reference 39. 
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113 
1-benzyl 2-methyl (2S,3aR,7aR)-3a-acetoxy-6-oxo-2,3,3a,6,7,7a-hexahydro-1H-indole-1,2-
dicarboxylate (56) 
 
                             14      56 
 
To a stirred solution of compound 14 (800 mg, 2.55 mmol, 1 eq) in DCM (26 mL, 0.10 M) was 
added acetic anhydride (0.48 mL, 5.10 mmol, 2 eq), DMAP (62 mg, 0.51 mmol, 0.2 eq), and Et3N 
(1.1 mL, 7.66 mmol, 3.0 eq), and then was stirred at room temperature. After 15 h, the reaction 
was quenched with saturated aqueous NaHCO3 and the organic layer was extracted with DCM (× 
3). The combined organic layers were washed with brine, dried with anhydrous Na2SO4, and 
concentrated in vacuo. The crude residue was purified by flash column chromatography (silica gel, 
EtOAc:hexanes 1:1) to give compound 56 as a light-yellow foam (908 mg, 92% yield). Rf = 0.30 
(silica, EtOAc:hexanes, 1:1); Rotamers were shown in ( ). 1H NMR (400 MHz, Chloroform-d) δ 
7.40 – 7.29 (m, 5H), 6.91 (m, 1H), 6.12 – 6.03 (m, 1H), 5.25 – 5.02 (m, 2H), 4.84 – 4.55 (m, 2H), 
3.76 + 3.54 (s+ s’, 3H), 3.38 – 3.18 (m, 1H), 2.91 – 2.79 (m, 1H), 2.60 – 2.28 (m, 2H), 2.00 (s+ s’, 
3H). 13C NMR (101 MHz, Chloroform-d) δ (194.89, 194.81), (171.20, 170.59), (170.04, 169.83), 
(154.06, 153.67), (144.75, 144.11), (135.97, 135.76), (129.93, 129.55), (128.67, 128.49), (128.41, 
128.32), (128.22, 128.14), (83.15, 81.89), (67.91, 67.47), (61.68, 60.99), (58.29, 58.10), (52.50, 
52.33), (42.68, 41.31), (39.34, 38.35), (21.55, 21.47). New compound; Procedure was taken from 
reference 38. 
Notebook Entries: 
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115 
1-benzyl 2-methyl (2S,3aR,7aR)-3a-acetoxy-6-((tert-butyldimethylsilyl)oxy)-2,3,3a,7a-
tetrahydro-1H-indole-1,2-dicarboxylate (62) 
 
                            56      62 
 
To a stirred solution of compound 56 (700 mg, 1.81 mmol, 1 eq) in DCM (18 mL, 0.10 M) was 
added Et3N (0.51 mL, 3.69 mmol, 2.04 eq) and TBSOTf (0.46 mL, 1.99 mmol, 1.1 eq), and then 
was stirred at room temperature. After 1 h, the reaction was quenched with saturated aqueous 
NaHCO3 and organic layer was extracted with DCM (× 3). The combined organic layers were 
washed with brine, dried with anhydrous Na2SO4, and concentrated in vacuo. The crude residue 
was purified by flash column chromatography (silica gel, EtOAc:hexanes, 1:3) to give compound 
62 as a white foam (888.86 mg, 98% yield). Rf = 0.43 (silica, EtOAc:hexanes, 1:3); Rotamers 
were shown in ( ). 1H NMR (600 MHz, Chloroform-d) δ 7.44 – 7.30 (m, 5H), 5.94 (m, 1H), 5.69 
(m, 1H), 5.39 – 5.02 (m, 3H), 4.43 – 4.30 (m, 1H), 3.66 (s+ s’, 3H), 3.24 – 3.11 (m, 1H), 2.72 (m, 
1H), 2.33 (m, 1H), 2.02 + 1.92 (s+ s’, 3H), 0.92 – 0.87 (m, 9H), 0.11 (m, 6H). 13C NMR (151 
MHz, Chloroform-d) δ (172.10, 171.52), (169.99, 169.68), (154.74, 154.36), (146.79, 146.59), 
(136.44, 136.16), (129.18, 128.84), (128.61, 128.44), (128.29, 128.22), (128.03, 127.97), (125.48, 
125.24), (103.32, 103.00), (85.23, 83.97), (67.46, 67.07), (63.78, 62.98), (55.14, 54.93), (52.32, 
52.16), (46.66, 40.67), (25.71, 25.68), (25.60, 25.54), (21.67, 21.57), (17.99, 8.80), (-2.92, -3.56). 
New compound; Procedure was taken from reference 41. 
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117 
1-benzyl 2-methyl (2S,3aR,7S,7aR)-3a-acetoxy-7-hydroxy-6-oxo-2,3,3a,6,7,7a-hexahydro-
1H-indole-1,2-dicarboxylate (63) 
 
                                   62         63 
 
To a stirred solution of compound 62 (900 mg, 1.79 mmol, 1 eq) in acetone (21 mL, 0.0875 M) 
was added freshly prepared DMDO (40 mL, 2.40 mmol, 1.34 eq, 0.06M) at 0 C, and then was 
stirred at 0 C. After 1 h, the reaction mixture was concentrated in vacuo and the crude residue to 
give compound 63 as a white foam (472 mg, 85% yield). Rf = 0.40 (silica, EtOAc:hexanes, 1:1); 
Crude material was used for the next reaction without further purification.  
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118 
1-benzyl 2-methyl (2S,3aR,7S,7aR)-3a-acetoxy-7-((tert-butyldimethylsilyl)oxy)-6-oxo-
2,3,3a,6,7,7a-hexahydro-1H-indole-1,2-dicarboxylate (64) 
 
                                63          64 
 
To a stirred solution of compound 63 (720 mg, 1.78 mmol, 1 eq) in DCM (18 mL, 0.10 M) was 
added Et3N (0.50 mL, 3.57 mmol, 2 eq) and TBSOTf (0.45 mL, 1.96 mmol, 1.1 eq), and then was 
stirred at room temperature. After 10 h, the reaction was quenched with saturated aqueous 
NaHCO3 and organic layer was extracted with DCM (× 3). The combined organic layers were 
washed with brine, dried with anhydrous Na2SO4, and concentrated in vacuo. The crude residue 
was purified by flash column chromatography (silica gel, EtOAc:hexanes, 1:3) to give compound 
64 as a white foam (911.79 mg, 99% yield). Rf = 0.42 (silica, EtOAc:hexanes, 1:3); Rotamers 
were shown in ( ). 1H NMR (600 MHz, Chloroform-d) δ 7.38 – 7.20 (m, 5H), 6.82 (m, 1H), 6.01 
(m, 1H), 5.24 – 4.93 (m, 2H), 4.77 (dd, J = 34.0, 3.9 Hz, 1H), 4.61 – 4.52 (m, 1H), 4.25 (d, J = 4.1 
Hz, 1H), 3.74 + 3.53 (s+ s’, 3H), 2.69 (m, 2H), 1.92 (s+ s’, 3H), 0.73 (m, 9H), 0.06 – -0.22 (m, 
6H). 13C NMR (151 MHz, Chloroform-d) δ (195.13, 194.82), (171.59, 171.02), (170.20, 169.89), 
(153.61, 153.41), (143.66, 143.27), (135.97, 135.69), (128.83, 128.69), (128.51, 128.45), (128.18, 
128.15), (127.86, 127.57), (83.53, 82.50), (72.27, 70.82), (67.82, 67.43), (65.96, 65.26), (59.58, 
59.24), (52.35, 52.24), (39.96, 39.04), (25.54, 25.52), (21.72, 21.61), (17.83, 17.80). New 
compound; Procedure was taken from reference 41. 
Notebook Entries: 
Procedure    – cwh4-041 
1H                – cwh3-440 
13C               – cwh3-440 
 
NO
CO2Me
Cbz
OAc
H
OH
NO
CO2Me
Cbz
OAc
H
OTBS
TBSOTf, Et3N
DCM
99%
119 
 
 
120 
1-benzyl 2-methyl (2S,7S,7aS)-7-((tert-butyldimethylsilyl)oxy)-6-oxo-2,3,5,6,7,7a-
hexahydro-1H-indole-1,2-dicarboxylate (60) 
 
   64        60 
 
To a stirred solution of compound 64 (300 mg, 0.58 mmol, 1 eq) in MeOH (3 mL, 0.0223 M) was 
added activated Zn (303, 4.64 mmol, 8 eq) and glacial acetic acid (0.07 mL, 1.16 mmol, 2 eq). The 
reaction mixture was refluxed for 0.5 h and was filtered through celite pad. The organic layer was 
concentrated in vacuo and the crude residue was purified by flash column chromatography (silica 
gel, EtOAc:hexanes, 1:3) to give compound 60 as a white foam (188.86 mg, 71% yield). Rf = 0.44 
(silica, EtOAc:hexanes, 1:3) ; Rotamers were shown in ( ); 1H NMR (600 MHz, Chloroform-d) δ 
7.41 – 7.29 (m, 5H), 5.73 (m, 1H), 5.32 – 4.65 (m, 3H), 4.55 – 4.26 (m, 2H), 3.81 + 3.30 (s+ s’, 
3H), 3.16 – 2.59 (m, 4H), 0.79 (m, 9H), 0.06 (m, 6H). 13C NMR (151 MHz, Chloroform-d) δ 
(207.62, 207.61), (172.66, 172.65) (154.21, 153.41), (135.83, 135.82), (134.25, 134.24), (133.28, 
133.30), (128.63, 128.44), (128.35, 128.23), (116.82, 116.81), (73.42, 72.01), (67.65, 67.34), 
(62.87, 62.28), (60.84, 60.39), (52.47, 52.09), (36.74, 36.73), (35.11, 34.81), (25.50, 25.49), 
(17.89. 17.88). New compound; Procedure was taken from reference 39. 
Notebook Entries: 
Procedure    – cwh4-042 
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122 
1-benzyl 2-methyl (2S,7S,7aS)-7-((tert-butyldimethylsilyl)oxy)-6-
(((trifluoromethyl)sulfonyl)oxy)-2,3,7,7a-tetrahydro-1H-indole-1,2-dicarboxylate (61) 
 
        60                  61 
 
To a stirred solution of compound 60 (140 mg, 0.30 mmol, 1 eq) in THF (3 mL, 0.10 M) was 
cooled to – 78 C. Then PhNTf2 (120 mg, 0.335 mmol, 1.1 eq) was added followed by KHMDS 
(0.72 mL, 0.36 mmol, 1.2 eq), and then reaction mixture was stirred at – 78 C. After 0.5 h, the 
reaction was quenched with H2O and organic layer was extracted with EtOAc (50 mL × 3). The 
combined organic layers were washed with brine, dried with anhydrous Na2SO4, and concentrated 
in vacuo. The crude residue was purified by flash column chromatography (silica gel, 
EtOAc:hexanes, 1:6) to give compound 61 as a white foam (106 mg, 60% yield). Rf = 0.33 (silica, 
EtOAc:hexanes, 1:6); Rotamers were shown in ( ). 1H NMR (400 MHz, Chloroform-d) δ 7.38 – 
7.26 (m, 5H), 6.10 (dd, J = 11.3, 5.8 Hz, 1H), 5.90 – 5.77 (m, 1H), 5.22 – 4.47 (m, 5H), 3.60 (s+ 
s’, 3H), 3.01 – 2.76 (m, 2H), 0.78 (m, 9H), 0.10 – -0.17 (m, 6H). 13C NMR (101 MHz, Chloroform-
d) δ (172.57, 172.56), (154.16, 154.14), (150.74, 150.73), (140.12, 138.62), (135.74, 133.43), 
(129.66, 128.66), (128.48, 128.43), (127.50, 123.62), (118.07, 117.32), (112.84, 112.83), (68.08, 
67.48), (67.33, 66.33), (65.06, 64.41), (62.05, 61.42), (52.55, 52.21), (33.63, 33.28), (25.52, 
25.44), (18.03, 18.02), (-5.10, -5.49). New compound; Procedure was taken from reference 39. 
Notebook Entries: 
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124 
1-benzyl 2-methyl (2S,7R,7aS)-7-((tert-butyldimethylsilyl)oxy)-2,3,7,7a-tetrahydro-1H-
indole-1,2-dicarboxylate (32) 
 
       61             32 
 
To a stirred solution of compound 61 (31 mg, 0.052 mmol, 1 eq) in DMF (0.5 mL, 0.10 M) was 
added Pd(OAc)2 (2.4 mg, 0.01 mmol, 0.2 eq) and PPh3 (5.5 mg, 0.02 mmol, 0.4 eq). Then n-Bu3N 
(0.062 mL, 0.260 mmol, 5 eq) and HCO2H (0.006 mL, 0.152 mmol, 3 eq) were added, and then 
was stirred at 65 C. After 0.5 h, the reaction was quenched with 1M HCl and organic layer was 
extracted with EtOAc (× 3). The combined organic layers were washed with brine, dried with 
anhydrous Na2SO4, and concentrated in vacuo. The crude residue was purified by flash column 
chromatography (silica gel, EtOAc: hexanes, 1:3) to give compound 32 as a white foam (23 mg, 
59% yield). Rf = 0.41 (silica, EtOAc:hexanes, 1:3); Rotamers were shown in ( ).   1H NMR (400 
MHz, Chloroform-d) δ 7.38 – 7.31 (m, 5H), 6.10 – 5.74 (m, 3H), 5.26 – 4.92 (m, 2H), 4.70 – 4.34 
(m, 3H), 3.77 + 3.38 (s+ s’, 3H), 3.00 – 2.69 (m, 2H), 0.83 – 0.76 (m, 9H), 0.04 – -0.13 (m, 6H). 13C 
NMR (101 MHz, Chloroform-d) δ (173.10, 172.85), (154.10, 154.09), (136.93, 136.14), (128.53, 
128.41), (128.33, 128.17), (128.14, 128.08), (126.68, 126.34), (125.72, 125.43), (116.01, 115.89), 
(67.45, 67.14), (63.46, 62.84), (62.54, 61.68), (61.43, 61.09), (52.36, 51.98), (34.37, 33.94), 
(29.72, 25.69), (25.66, 25.63), (17.91, 17.90), (-3.94, -4.03). Known compound; all the spectral 
data matches the data reported in 33. Procedure was taken from reference 39. 
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126 
1-benzyl 2-methyl (2S,3aR,7R,7aR)-3a-(benzoyloxy)-7-hydroxy-6-oxo-2,3,3a,6,7,7a-
hexahydro-1H-indole-1,2-dicarboxylate (12) 
 
    28           12 
 
To a stirred solution of compound 28 (1.4 g, 3.01 mmol, 1 eq) in DCM (30 mL, 0.10 M) was added 
77% mCPBA (743 mg, 3.32 mmol, 1.1 eq) at 0 C, and then was stirred at 0 C. After 0.5 h, the 
reaction mixture was quenched with 1M HCl and extracted the organic layer with DCM (× 3).  The 
combined organic layers were washed with NaHCO3, dried with anhydrous Na2SO4, and 
concentrated in vacuo. The crude residue was purified by flash column chromatography (silica gel, 
EtOAc:hexanes, 1:1) to give compound 12 as a white foam (1.05 g, 75% yield). Rf = 0.52 (silica, 
EtOAc:hexanes, 1:1); 1H NMR (400 MHz, Chloroform-d) δ 7.94 (m, 2H), 7.60 (m, 1H), 7.46 (m, 
2H), 7.37 – 7.28 (m, 5H), 7.12 (d, J = 10.3 Hz, 1H), 6.16 (d, J = 10.3 Hz, 1H), 5.22 – 4.86 (m, 4H), 
4.50 – 4.38 (m, 1H), 3.67 – 3.58 (m, 1H), 3.41 (s, 3H), 3.24 – 3.15 (m, 1H), 2.52 (dd, J = 13.6, 6.7 
Hz, 1H). 13C NMR (101 MHz, Chloroform-d) δ 195.94, 171.63, 165.03, 154.93, 141.82, 135.32, 
133.90, 130.17, 129.86, 128.95, 128.61, 128.54, 128.40, 128.31, 82.39, 71.11, 68.30, 67.34, 59.25, 
52.39, 39.40, 29.72. New compound; Procedure was taken from reference 41. 
 
Notebook Entries: 
Procedure    – cwh4-220 
1H                – cwh4-154 
13C               – cwh4-154 
 
NTBSO
CO2Me
Cbz
OBz
H
NO
CO2Me
Cbz
OBz
H
OH
mCPBA
DCM
75%
127 
 
 
128 
1-benzyl 2-methyl (2S,3aR,7R,7aR)-3a-(benzoyloxy)-7-((tert-butyldimethylsilyl)oxy)-6-oxo-
2,3,3a,6,7,7a-hexahydro-1H-indole-1,2-dicarboxylate (104) 
 
           12       104 
To a stirred solution of compound 12 (450 mg, 0.967 mmol, 1 eq) in DCM (9.7 mL, 0.10 M) was 
added Et3N (0.27 mL, 1.934 mmol, 2 eq) and TBSOTf (0.27 mL, 1.064 mmol, 1.1 eq) and then 
was stirred at room temperature. After 4 h, the reaction was quenched with saturated aqueous 
NaHCO3 and organic layer was extracted with DCM (× 3). The combined organic layers were 
washed with brine, dried with anhydrous Na2SO4, and concentrated in vacuo. The crude residue 
was purified by flash column chromatography (silica gel, EtOAc:hexanes, 1:1) to give compound 
104 as a white foam (511 mg, 97% yield). Rf = 0.82 (silica, EtOAc:hexanes, 1:1); Rotamers were 
shown in ( ). 1H NMR (400 MHz, Chloroform-d) δ 7.90 (td, J = 8.4, 1.3 Hz, 2H), 7.57 (td, J = 7.4, 
5.5 Hz, 1H), 7.45 – 7.27 (m, 7H), 6.99 (dd, J = 25.5, 10.5 Hz, 1H), 6.22 – 6.03 (m, 1H), 5.28 – 
4.97 (m, 2H), 4.74 – 4.57 (m, 2H), 4.45 – 4.29 (m, 1H), 3.47 (s+ s’, 3H), 3.01 – 2.80 (m, 2H), 0.80 
(m, 9H), -0.10 (m, 6H). 13C NMR (101 MHz, Chloroform-d) δ (195.23, 194.94), (171.70, 171.15), 
(165.46, 165.19), (153.62, 153.52), (143.74, 143.08), (135.95, 135.93), (133.58, 133.55), (129.81, 
129.74), (128.78, 128.68), (128.49, 128.45), (128.42, 128.40), (128.20, 128.18), (128.14, 127.71), 
(84.22, 83.27), (72.44, 70.91), (67.84, 67.43), (66.25, 65.51), (59.80, 59.47), (52.39, 52.23), 
(40.18, 39.52), (25.56, 25.56), (17.87, 17.84), (-5.47, -5.49). New compound; Procedure was taken 
from reference 41. 
Notebook Entries: 
Procedure    – cwh4- 158 
1H                – cwh4-158 
13C               – cwh4-158 
NO
CO2Me
Cbz
OBz
H
OH
NO
CO2Me
Cbz
OBz
H
TBSOTf, Et3N
DCM
97% OTBS
129 
 
 
130 
1-benzyl 2-methyl (2S,3aR,7R,7aS)-7-((tert-butyldimethylsilyl)oxy)-6-oxo-2,3,3a,6,7,7a-
hexahydro-1H-indole-1,2-dicarboxylate (105) 
 
   104            105 
 
To a stirred solution of compound 104 (400 mg, 0.733 mmol, 1 eq) in THF (3.3 mL, 0.22 M) was 
added Pd(dba)3CHCl3 (15 mg, 0.0147 mmol, 0.02 eq) and tribenzylphosphene (17.8 mg, 0.0586 
mmol, 0.08 eq). After stirring for 1 minute, Et3N (0.35 mL, 2.544 mmol, 3.47 eq) was added 
immediately followed by the addition of 95% HCO2H (0.10 mL, 2.544 mmol, 3.47 eq), and then 
was refluxed. After 12 h, the reaction was quenched with saturated aqueous NaHCO3 and the 
organic layer was extracted with EtOAc (× 3). The combined organic layers were washed with 
brine, dried with anhydrous Na2SO4, and concentrated in vacuo. The crude residue was purified 
by flash column chromatography (silica gel, EtOAc: hexanes, 1:1) to give compound 105 as a 
light-yellow foam (275 mg, 82% yield). Rf = 0.43 (silica, EtOAc:hexanes, 1:1); Rotamers were 
shown in ( ). 1H NMR (400 MHz, Chloroform-d) δ 7.42 – 7.25 (m, 5H), 6.79 (m, 1H), 6.02 (m, 
1H), 5.29 – 4.99 (m, 2H), 4.58 – 4.19 (m, 3H), 3.68 (s+ s’, 3H), 3.16 (m, 1H), 2.64 – 2.50 (m, 1H), 
2.19 – 2.04 (m, 1H), 0.78 (m, 9H), -0.12 (m, 6H). 13C NMR (101 MHz, Chloroform-d) δ (196.73, 
196.71), (173.07, 173.05), (146.50, 146.07), (128.64, 128.43), (128.11, 128.04), (127.91, 127.87), 
(127.41, 127.14), (72.33, 71.09), (67.65, 67.25), (60.75, 60.69), (60.41, 60.08), (52.47, 52.28), 
(37.62, 36.61), (34.89, 33.94), (29.73, 29.71),  (25.53, 25.51), (17.79, 17.78), (-5.43, -5.49).  
New compound; Procedure was taken from reference 40. 
Notebook Entries: 
Procedure– cwh4-182      1H     – cwh4-156-B   13C – cwh4-156-B    
NO
CO2Me
Cbz
OBz
H
NO
CO2Me
Cbz
H
H
Pd(dba)3CHCl3, Tribenzylphosphene
Et3N, HCO2H
THF
82%OTBS
OTBS
131 
 
 
132 
1-benzyl 2-methyl (2S,3aR,6R,7R,7aS)-7-((tert-butyldimethylsilyl)oxy)-6-hydroxy-
2,3,3a,6,7,7a-hexahydro-1H-indole-1,2-dicarboxylate (106) 
 
   105             106 
 
To a stirred solution of compound 105 (55 mg, 0.12 mmol, 1 eq) in THF:MeOH 1:1 (1.4 mL, 
0.0875M) was added CeCl3 •7H2O (45 mg, 0.12 mmol, 1 eq) and stirred for 5 mins. Then NaBH4 
(4.5 mg, 0.12 mmol, 1 eq) was added portion wise, and then was stirred at room temperature. After 
5 mins, the reaction was quenched with saturated aqueous NaHCO3 and organic layer was 
extracted with EtOAc (× 3). The combined organic layers were washed with brine, dried with 
anhydrous Na2SO4, and concentrated in vacuo. The crude residue was purified by flash column 
chromatography (silica gel, EtOAc:hexanes, 1:1) to give compound 106 as a white foam (54.5 mg, 
99% yield). Rf = 0.39 (silica, EtOAc:hexanes, 1:1); Rotamers were shown in ( ). 1H NMR (400 
MHz, Chloroform-d) δ 7.38 – 7.29 (m, 5H), 5.71 – 5.45 (m, 2H), 5.28 – 4.95 (m, 2H), 4.50 – 4.08 
(m, 4H), 3.64 (s+ s’, 3H), 2.31 (m, 1H), 1.97 (m, 2H), 0.85 (m, 9H), 0.12 – -0.17 (m, 6H). 13C 
NMR (101 MHz, Chloroform-d) δ (173.29, 173.22), (154.64, 154.11), (136.24, 136.16), (129.27, 
128.85), (128.64, 128.63), (128.40, 128.36), (126.52, 126.24), (69.74, 68.82), (68.70, 68.65), 
(67.47, 67.14), (60.54, 60.27), (59.59, 58.95), (52.31, 52.12), (36.81, 35.81), (35.01, 34.03), 
(25.96, 25.93), (18.03, 18.01), (-4.67, -4.87). New compound; Procedure was taken from reference 
41. 
Notebook Entries: 
Procedure    – cwh4-161 
1H                – cwh4-184 
13C               – cwh4-184 
 
NO
CO2Me
Cbz
H
H
OTBS
NHO
CO2Me
Cbz
H
H
OTBS
CeCl3. 7H2O, NaBH4
THF/MeOH
99%
133 
 
 
134 
1-benzyl 2-methyl (2S,3aR,6S,7R,7aS)-7-((tert-butyldimethylsilyl)oxy)-6-((2-
nitrophenyl)selanyl)-2,3,3a,6,7,7a-hexahydro-1H-indole-1,2-dicarboxylate (107) 
 
      106      107             108  
     
To a stirred solution of compound 106 (100 mg, 0.22 mmol, 1 eq) in THF (2.2 mL, 0.1 M) was 
added o-NO2-C6H4SeCN (98 mg, 0.44 mmol, 2 eq). Then Bu3P (0.12 mL, 0.48 mmol, 2.2 eq) was 
added drop wise and the reaction mixture was refluxed. After 16 h, the reaction was quenched with 
saturated aqueous NaHCO3 and organic layer was extracted with EtOAc (× 3). The combined 
organic layers were washed with brine, dried with anhydrous Na2SO4, and concentrated in vacuo. 
The crude residue was purified by flash column chromatography (silica gel, EtOAc:hexanes, 1:3) 
to give compound 107 as a white foam (40 mg, 29% yield). Rf = 0.77 (silica, EtOAc:hexanes, 1:3); 
Rotamers were shown in ( ). 1H NMR (400 MHz, Chloroform-d) δ 8.54 – 7.50 (m, 7H), 7.36 – 
7.21 (m, 2H), 6.24 – 5.86 (m, 2H), 5.44 – 5.10 (m, 2H), 4.95 – 4.16 (m, 4H), 3.85 (s+ s’, 3H), 3.17 
(m, 1H), 2.54 (m, 1H), 2.25 (m, 1H), 1.17 – 0.97 (m, 9H), 0.30 – -0.06 (m, 6H). 13C NMR (101 
MHz, Chloroform-d) δ (173.40, 173.27), (154.33, 153.80), (147.62, 147.61), (136.36, 135.94), 
(134.78, 133.38), (131.71, 131.62), (130.41, 130.07), (129.68, 128.41), (128.02, 127.99), (127.97, 
127.65), (126.50, 126.42), (126.36, 126.03), (121.54, 121.22), (68.43, 67.30), (67.20, 66.92), 
(59.60, 59.43), (57.27, 56.62), (52.35, 52.15), (42.24, 41.74), (36.30, 35.53), (35.34, 34.52), 
(25.68, 25.66), (17.75, 17.70), (-4.80, -5.17). 
 
NHO
CO2Me
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H
OTBS
NSe
CO2Me
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H
H
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N
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H
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OTBSO2N
+
4                   :              9
135 
Compound 108 was obtained as a white foam (90 mg, 67% yield). Rf = 0.75 (silica, 
EtOAc:hexanes, 1:3); [Rotamers were shown in ( )]. 1H NMR (400 MHz, Chloroform-d) δ 8.28 – 
8.16 (m, 2H), 7.49 – 7.43 (m, 4H), 7.35 – 7.29 (m, 3H), 6.08 – 5.88 (m, 2H), 5.28 – 4.87 (m, 2H), 
4.67 – 4.06 (m, 4H), 3.60 (s+ s’, 3H), 3.00 – 2.76 (m, 1H), 2.48 (m, 1H), 2.23 – 2.03 (m, 1H), 0.84 
(m, 9H), -0.01 (m, 6H). 13C NMR (101 MHz, Chloroform-d) δ (173.29, 173.28), (153.94, 153.93), 
(147.92, 147.90), (135.30, 135.29), (133.70, 133.63), (130.67, 130.28), (129.32, 129.10), (128.67, 
128.58), (128.40, 128.38), (128.24, 128.10), (127.98, 127.90), (126.82, 126.75), (126.07, 125.50), 
(67.43, 67.01), (62.90, 62.20), (59.51, 59.24), (58.03, 56.92), (52.31, 52.08), (39.71, 38.83), 
(38.02, 37.70), (35.99, 34.67), (25.75, 25.73), (17.76, 17.75), (-4.68, -5.16). New compounds; 
Procedure was taken from reference 52. 
Notebook Entries: 
Procedure    – cwh4-185 
1H                – x; cwh4-185-A, y; cwh4-185-A  
 13C              – x; cwh4-185-B, y; cwh4-185-B 
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138 
1-benzyl 2-methyl (2S,3aS,7S,7aS)-7-((tert-butyldimethylsilyl)oxy)-4-hydroxy-2,3,3a,4,7,7a-
hexahydro-1H-indole-1,2-dicarboxylate (109) 
 
                             108                109 
 
To a stirred solution of compound 108 (41 mg, 0.0635 mmol, 1 eq) in DCM (3.0 mL, 0.025 M) 
was added 77% mCPBA (17 mg, 0.0762 mmol, 1.2 eq) in DCM (0.76 mL, 0.10 M) at -78 C, and 
then reaction mixture was stirred at 4 C. After for 5 h, the reaction was quenched with saturated 
aqueous NaHCO3 and organic layer was extracted with DCM (× 3). The combined organic layers 
were washed with brine, dried with anhydrous Na2SO4, and concentrated in vacuo. The crude 
residue was purified by flash column chromatography (silica gel, EtOAc:hexanes, 1:1) to give 
compound 109 as a white foam (20 mg, 70% yield). Rf = 0.45 (silica, EtOAc:hexanes, 1:1); 
Rotamers were shown in ( ). 1H NMR (400 MHz, Chloroform-d) δ 7.37 – 7.24 (m, 5H), 6.06 – 
5.83 (m, 2H), 5.26 – 4.93 (m, 2H), 4.70 – 4.00 (m, 4H), 3.66 (s+ s’, 3H), 2.62 – 2.15 (m, 3H), 0.80 
(m, 9H), 0.02 – -0.17 (m, 6H). 13C NMR (101 MHz, Chloroform-d) δ (173.51, 173.41), (154.68, 
154.20), (136.45, 136.32), (134.22, 133.69), (129.02, 128.82), (128.54, 128.39), (128.28, 128.16), 
(127.96, 127.91), (69.44, 69.02), (67.29, 66.95), (63.46, 62.58), (59.46, 59.30), (58.56, 57.65), 
(52.29, 52.12), (43.55, 42.68), (35.87, 34.66), (29.97, 29.72), (25.65, 25.64), (17.74, 17.71), (-4.72, 
-5.20). New compound; Procedure was taken from reference 52. 
 
Notebook Entries: 
Procedure    – cwh4-192 
1H                – cwh4-192-B 
13C               – cwh4-192-B 
NSe
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141 
1-benzyl 2-methyl (2S,3aS,4S,7S,7aS)-7-((tert-butyldimethylsilyl)oxy)-4-hydroxy-
2,3,3a,4,7,7a-hexahydro-1H-indole-1,2-dicarboxylate (101) 
 
                               107    101 
 
To a stirred solution of compound 107 (78 mg, 0.1209 mmol, 1 eq) in DCM (5.0 mL, 0.025 M) 
was added 77% mCPBA (32 mg, 0.1451 mmol, 1.2 eq) in DCM (1.5 mL, 0.10 M) at -78 C, and 
then reaction mixture was stirred at 4 C. After for 5 h, the reaction was quenched with saturated 
aqueous NaHCO3 and organic layer was extracted with DCM (× 3). The combined organic layers 
were washed with brine, dried with anhydrous Na2SO4, and concentrated in vacuo. The crude 
residue was purified by flash column chromatography (silica gel, EtOAc:hexanes, 1:1) to give 
compound 101 as a white foam (41 mg, 74% yield). Rf = 0.46 (silica, EtOAc:hexanes, 1:1); 
Rotamers were shown in ( ). 1H NMR (400 MHz, Chloroform-d) δ 7.53 – 7.26 (m, 5H), 5.98 – 
5.84 (m, 2H), 5.33 – 4.92 (m, 2H), 4.45 – 3.91 (m, 4H), 3.65 (s+ s’, 3H), 3.07 – 2.79 (m, 1H), 2.32 
(m, 1H), 2.01 (m, 1H), 0.79 (m, 9H), 0.08 – -0.23 (m, 6H). 13C NMR (101 MHz, Chloroform-d) δ 
(173.61, 173.57), (154.54, 153.82), (136.48, 136.43), (131.19, 130.76), (128.52, 128.39), (128.25, 
128.08), (128.02, 127.98), (125.11, 124.94), (69.31, 68.36), (67.91, 67.73), (67.13, 67.00), (60.04, 
59.74), (56.62, 55.99), (52.28, 52.09), (36.64, 35.66), (35.35, 34.35), (25.65, 25.62), (17.64, 
17.63), (-5.18, -5.44). New compound; Procedure was taken from reference 52. 
 
Notebook Entries: 
Procedure    – cwh4-193 
1H                – cwh4-193-B 
13C               – cwh4-193-B 
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144 
1-benzyl 2-methyl (2S,3aS,7S,7aS)-7-((tert-butyldimethylsilyl)oxy)-4-oxo-2,3,3a,4,7,7a-
hexahydro-1H-indole-1,2-dicarboxylate (103) 
 
          109                         103 
 
To a stirred solution of compound 109 (20 mg, 0.044 mmol, 1 eq) in DCM (0.45 mL, 0.10 M) was 
added DMP (37 mg, 0.088 mmol, 2 eq) and K2CO3 (18 mg, 0.132 mmol, 3 eq), and then was 
stirred at room temperature. After for 4 h, the reaction was diluted with H2O and organic layer was 
extracted with DCM (× 3). The combined organic layers were washed with brine, dried with 
anhydrous Na2SO4, and concentrated in vacuo. The crude residue was purified by flash column 
chromatography (silica gel, EtOAc:hexanes, 1:1) to give compound 103 as a white foam (18 mg, 
90% yield). Rf = 0.53 (silica, EtOAc:hexanes, 1:1); Rotamers were shown in ( ). 1H NMR (400 
MHz, Chloroform-d) δ 7.40 – 7.27 (m, 5H), 7.01 – 6.89 (m, 1H), 6.11 (dd, J = 10.0, 8.0 Hz, 1H), 
5.30 – 4.97 (m, 2H), 4.78 – 4.33 (m, 3H), 3.67 (s+ s’, 3H), 3.26 – 3.10 (m, 1H), 2.56 (m, 1H), 2.33 
– 2.24 (m, 1H), 0.80 (m, 9H), -0.09 (s, 6H). 13C NMR (101 MHz, Chloroform-d) δ (198.10, 
198.09), (172.81, 72.80), (153.79, 53.78), (146.88, 146.65), (136.11, 136.10), (130.81, 130.73), 
128.65), (128.56, 128.44), (128.12, 127.97), (67.65, 67.26), (62.85, 61.94), (59.64, 59.55), (59.36, 
58.98), (52.46, 52.28), (45.80, 44.87), (33.71, 32.80), (29.97, 29.72), 25.55, (17.66, 17.65), (-4.62, 
-5.28). New compound; Procedure was taken from reference 39. 
Notebook Entries: 
Procedure    – cwh4-254 
1H                – cwh4-192-A 
13C               – cwh4-192-A 
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146 
1-benzyl 2-methyl (2S,7R,7aS)-7-((tert-butyldimethylsilyl)oxy)-6-oxo-2,3,5,6,7,7a-
hexahydro-1H-indole-1,2-dicarboxylate (110) 
 
                       104       110 
 
To a stirred solution of compound 104 (260 mg, 0.476 mmol, 1 eq) in MeOH (2 mL, 0.223 M) 
was added activated Zn (250 mg, 3.812 mmol, 8 eq) and glacial acetic acid (0.06 mL, 0.952 mmol, 
2 eq), and was refluxed. After 0.5 h reaction mixture was filtered through celite pad and the organic 
layer was concentrated in vacuo. Then the crude residue was purified by flash column 
chromatography (silica gel, EtOAc:hexanes, 1:3) to give compound 110 as a white foam (161 mg, 
74% yield). Rf = 0.39 (silica, EtOAc:hexanes, 1:3); Rotamers were shown in ( ). 1H NMR (400 
MHz, Chloroform-d) δ 7.58 – 7.32 (m, 5H), 5.72 (m, 1H), 5.32 – 4.74 (m, 3H), 4.59 – 4.25 (m, 
2H), 3.81 – 3.40 (s+ s’, 3H), 3.17 – 2.57 (m, 4H), 0.87 – 0.74 (m, 9H), 0.08 – -0.14 (m, 6H). 13C 
NMR (101 MHz, Chloroform-d) δ (207.58, 207.57), (172.64, 172.63), (154.12, 153.93), (135.84, 
133.32, 128.64), (128.45, 128.41), (128.35, 128.22), (116.80, 116.70), (73.39, 72.00), (67.66, 
67.36), (62.87, 62.29), (60.85, 60.38), (52.07, 52.06), (36.73, 35.10), (25.49, 25.48), (17.89, 
17.88), (-5.15, -5.44). New compound; Procedure was taken from reference 39. 
 
Notebook Entries: 
Procedure    – cwh4-179 
1H                – cwh4-179 
13C               – cwh4-179 
NO
CO2Me
Cbz
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H
OTBS
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CbzHOTBS
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148 
1-benzyl 2-methyl (2S,7R,7aS)-7-((tert-butyldimethylsilyl)oxy)-6-
(((trifluoromethyl)sulfonyl)oxy)-2,3,7,7a-tetrahydro-1H-indole-1,2-dicarboxylate (111) 
 
                            110     111 
 
To a stirred solution of compound 110 (48 mg, 0.104 mmol, 1 eq) in THF (1 mL, 0.10 M) was 
cooled to – 78 C. Then PhNTf2 (41 mg, 0.115 mmol, 1.1 eq) was added followed by KHMDS 
(0.25 mL, 0.125 mmol, 1.2 eq), and then was stirred at – 78 C. After 0.5 h, the reaction was 
quenched with H2O and the organic layer was extracted with EtOAc (× 3). The combined organic 
layers were washed with brine, dried with anhydrous Na2SO4, and concentrated in vacuo. The 
crude residue was purified by flash column chromatography (silica gel, EtOAc:hexanes, 1:3) to 
give compound 111 as a white foam (38 mg, 62% yield). Rf = 0.54 (silica, EtOAc:hexanes, 1:3); 
Rotamers were shown in ( ). 1H NMR (400 MHz, Chloroform-d) δ 7.42 – 7.33 (m, 5H), 6.12 (m, 
1H), 5.84 (m, 1H), 5.25 – 4.54 (m, 5H), 3.78 – 3.45 (m, 3H), 3.05 – 2.76 (m, 2H), 0.85 – 0.75 (m, 
9H), 0.13 – -0.17 (m, 6H). (172.57, 172.56), (154.16, 154.14), (150.74, 150.73), (140.12, 138.62), 
(135.74, 133.43), (129.66, 128.66), (128.48, 128.43), (127.50, 123.62), (118.07, 117.32), (112.84, 
112.83), (68.08, 67.48), (67.33, 66.33), (65.06, 64.41), (62.05, 61.42), (52.55, 52.21), (33.63, 
33.28), (25.52, 25.44), (18.03, 18.02), (-5.10, -5.49). New compound; Procedure was taken from 
reference 39. 
 
Notebook Entries: 
Procedure    – cwh4-252 
1H                – cwh4-252 
13C               – cwh4-252 
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150 
1-benzyl 2-methyl (2S,7S,7aS)-7-((tert-butyldimethylsilyl)oxy)-2,3,7,7a-tetrahydro-1H-
indole-1,2-dicarboxylate (103) 
 
    111               103 
 
To a stirred solution of compound   111 (25 mg, 0.042 mmol, 1 eq) in DMF (0.5 mL, 0.10 M) was 
added Pd(OAc)2 (2.0 mg, 0.01 mmol, 0.2 eq) and PPh3 (4.4 mg, 0.017 mmol, 0.4 eq). Then n-
Bu3N (0.05 mL, 0.210 mmol, 5 eq) and HCO2H (0.005 mL, 0.126 mmol, 3 eq) were added, and 
then was stirred at 65 C. After 0.5 h, the reaction was quenched with 1M HCl and organic layer 
was extracted with EtOAc (× 3). The combined organic layers were washed with brine, dried with 
anhydrous Na2SO4, and concentrated in vacuo. The crude residue was purified by flash column 
chromatography (silica gel, EtOAc:hexanes, 1:3) to give compound 103 as a white foam (23 mg, 
61 % yield). Rf = 0.41 (silica, EtOAc:hexanes, 1:3); Rotamers were shown in ( ). 1H NMR (400 
MHz, Chloroform-d) δ 7.41 – 7.30 (m, 5H), 6.18 – 5.76 (m, 3H), 5.24 – 4.95 (m, 2H), 4.73 – 4.40 
(s+ s’, 3H), 3.76 – 3.41 (m, 3H), 3.00 – 2.73 (m, 2H), 0.89 – 0.73 (m, 9H), 0.09 – -0.14 (m, 6H). 
13C NMR (101 MHz, Chloroform-d) δ (173.10, 172.85), (136.93, 136.91), (128.53, 128.41), 
(128.32, 128.17), (128.14, 128.08), (126.68, 126.34), (125.72, 125.43), (116.01, 115.89), (67.45, 
67.14), (63.46, 62.84), (62.53, 61.68), (61.43, 61.09), (52.36, 51.98), (34.37, 33.94), (29.72, 
29.69), (25.66, 25.63), (17.91, 17.90), (-3.94, -5.06). New compound; Procedure was taken from 
reference 39. 
Notebook Entries: 
Procedure    – cwh4-253 
1H                – cwh4-253 
13C               – cwh4-253 
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152 
1-benzyl 2-methyl (2S,3aR,7aR)-6-oxo-2,3,3a,6,7,7a-hexahydro-1H-indole-1,2-dicarboxylate 
(16) 
 
                        15              16 
 
To a stirred solution of compound 15 (900 mg, 2.17 mmol, 1 eq) in THF (10 mL, 0.22 M) was 
added Pd(dba)3CHCl3 (45 mg, 0.043 mmol, 0.02 eq) and tribenzylphosphene (52 mg, 0.172 mmol, 
0.08 eq). After stirring for 1-minute, Et3N (1.0 mL, 7.53 mmol, 3.47 eq) was added immediately 
followed by the addition of 95% HCO2H (0.3 mL, 7.53 mmol, 3.47 eq), and was refluxed. After 
12 h, the reaction was quenched with saturated aqueous NaHCO3 and the organic layer was 
extracted with EtOAc (× 3). The combined organic layers were washed with brine, dried with 
anhydrous Na2SO4, and concentrated in vacuo. The crude residue was purified by flash column 
chromatography (silica gel, EtOAc: hexanes, 1:1) to give compound 16 as a light-yellow foam 
(643 mg, 90% yield). Rf = 0.44 (silica, EtOAc:hexanes, 1:1); Rotamers were shown in ( ). 1H NMR 
(400 MHz, Chloroform-d) δ 7.39 – 7.27 (m, 5H), 6.78 (m, 1H), 6.05 (m, 1H), 5.23 – 4.93 (m, 2H), 
4.65 – 4.44 (m, 2H), 3.76 + 3.54 (s+ s’, 3H), 3.21 – 2.94 (m, 2H), 2.51 – 2.27 (m, 3H). 13C NMR 
(101 MHz, Chloroform-d) δ (196.96, 196.85), (172.76, 172.60), (146.47, 146.21), (136.30, 
136.21), (130.21, 130.01), (128.84,128.77), (128.68, 128.52), (128.37, 128.23), (67.86, 67.46), 
(59.88, 59.64), (56.79, 56.78), (56.50, 56.16), (52.83, 52.58), (41.09, 40.18), (37.43, 36.68), 
(34.16, 33.09). Known compound; all the spectral data matches the data reported in reference 40. 
Notebook Entries: 
Procedure    – cwh2-365 
1H                – cwh2-211-B 
13C               – cwh2-211-B 
 
NO
CO2Me
Cbz
OBz
H
NO
CO2Me
Cbz
H
H
Pd(dba)3CHCl3, Tribenzylphosphene
Et3N, HCO2H
THF
90%
153 
 
 
154 
1-benzyl 2-methyl (2S,3aR,6S,7aR)-6-hydroxy-2,3,3a,6,7,7a-hexahydro-1H-indole-1,2-
dicarboxylate (95) 
 
   16                95 
 
To a stirred solution of compound 16 (50 mg, 0.52 mmol, 1 eq) in THF:MeOH 1:1 (2.0 mL, 
0.0875M) was added CeCl3 •7H2O (57 mg, 0.152 mmol, 1 eq), and was stirred. After 5 mins, 
NaBH4 (6 mg, 0.152 mmol, 1 eq) was added portion wise, and then was stirred at room 
temperature. After 5 mins, the reaction was quenched with saturated aqueous NaHCO3 and organic 
layer was extracted with EtOAc (× 3). The combined organic layers were washed with brine, dried 
with anhydrous Na2SO4, and concentrated in vacuo. The crude residue was purified by flash 
column chromatography (silica gel, EtOAc:hexanes, 1:1) to give compound 95 as a white foam 
(50 mg, 99% yield). Rf = 0.41 (silica, EtOAc:hexanes, 1:1); Rotamers were shown in ( ). 1H NMR 
(400 MHz, Chloroform-d) δ 7.32 (m, 5H), 5.85 – 5.55 (m, 2H), 5.23 – 5.02 (m, 2H), 4.47 – 4.34 
(m, 1H), 4.22 (m, 1H), 3.74 – 3.54 (s+ s’, 3H), 2.82 (m, 1H), 2.54 – 2.43 (m, 1H), 2.16 – 2.03 (m, 
2H), 1.33 (m, 2H). 13C NMR (101 MHz, Chloroform-d) δ (173.16, 173.02), (155.05, 154.25), 
(136.60, 136.59), (133.08, 133.07), (128.73, 128.69), (128.62, 128.60), (128.26, 128.22), (128.16, 
128.09), (128.01, 126.77), (126.55, 126.54), (67.45, 67.37), (59.78, 59.75), (55.98, 55.44), (52.53, 
52.37), (37.05, 36.14), (34.99, 34.82). Known compound; all the spectral data matches the data 
reported in reference 40. 
Notebook Entries: 
Procedure    – cwh3-194 
1H                – cwh3-194-pure 
13C               – cwh3-194-pure 
 
NO
CO2Me
Cbz
H
H
NHO
CO2Me
Cbz
H
H
CeCl3. 7H2O, NaBH4
THF/MeOH
99%
155 
 
 
156 
1-benzyl 2-methyl (2S,3aR,6R,7aR)-6-((2-nitrophenyl)selanyl)-2,3,3a,6,7,7a-hexahydro-1H-
indole-1,2-dicarboxylate (96) 
 
         95            96 
To a stirred solution of compound 95 (60 mg, 0.181 mmol, 1 eq) in THF (1.8 mL, 0.1 M) was 
added o-NO2-C6H4SeCN (82 mg, 0.362 mmol, 2 eq) and Bu3P (0.10 mL, 0.398 mmol, 2.2 eq) drop 
wise, and then was refluxed. After 16 h, the reaction was quenched with saturated aqueous 
NaHCO3 and organic layer was extracted with EtOAc (× 3). The combined organic layers were 
washed with brine, dried with anhydrous Na2SO4, and concentrated in vacuo. The crude residue 
was purified by flash column chromatography (silica gel, EtOAc:hexanes, 1:1) to give compound 
96 as a white foam (66 mg, 71% yield). Rf = 0.57 (silica, EtOAc:hexanes, 1:1); Rotamers were 
shown in ( ). 1H NMR (600 MHz, Chloroform-d) δ 8.35 – 8.20 (m, 1H), 7.60 – 7.45 (m, 2H), 7.32 
(m, 4H), 7.07 (m, 2H), 6.08 – 5.75 (m, 2H), 5.12 – 4.92 (m, 2H), 4.58 (m, 1H), 4.41 (m, 1H), 4.23 
– 4.12 (m, 1H), 3.73 + 3.51 (s+ s’, 3H), 2.90 – 2.46 (m, 2H), 2.23 – 2.19 (m, 1H), 2.02 – 1.96 (m, 
1H), 1.90 – 1.85 (m, 1H). 13C NMR (151 MHz, Chloroform-d) δ (172.95, 172.70), (154.06, 
153.96), (146.99, 146.98), (136.38, 136.07), (133.85, 133.70), (130.04, 129.84), (129.36, 129.20), 
(128.48, 128.44), (128.41, 128.19), (128.04, 127.87), (127.43, 126.61), (126.26, 125.98), (125.77, 
125.51), (67.02, 66.95), (66.88, 66.83), (58.87, 58.68), (54.22, 53.58), (52.36, 52.23), (36.65, 
36.29), (35.80, 35.20), (34.24, 33.52), (30.05, (29.73). New compound; Procedure was taken from 
reference 52. 
Notebook Entries: 
Procedure    – cwh3-410 
1H                – cwh3-410-B        13C              – cwh3-410-B 
NHO
CO2Me
Cbz
H
H
NSe
CO2Me
Cbz
H
H
O2N
o-NO2-C6H4SeCN, Bu3P
THF
71%
157 
 
 
158 
1-benzyl 2-methyl (2S,3aS,7aR)-4-hydroxy-2,3,3a,4,7,7a-hexahydro-1H-indole-1,2-
dicarboxylate (97) 
 
                                96       97 
 
To a stirred solution of compound 96 (40 mg, 0.078 mmol, 1 eq) in DCM (3.0 mL, 0.025 M) was 
added mCPBA (21 mg, 0.093 mmol, 1.2 eq) in DCM (0.9 mL, 0.10 M) at 0 C, and then was 
stirred at 4 C. After 16 h, the reaction was quenched with saturated aqueous NaHCO3 and organic 
layer was extracted with DCM (× 3). The combined organic layers were washed with brine, dried 
with anhydrous Na2SO4, and concentrated in vacuo. The crude residue was purified by flash 
column chromatography (silica gel, EtOAc:hexanes, 1:1) to give compound 97 as a white foam 
(29 mg, 74% yield). Rf = 0.45 (silica, EtOAc:hexanes, 1:1); Rotamers were shown in ( ). 1H NMR 
(600 MHz, Chloroform-d) δ 7.41 – 7.23 (m, 5H), 5.90 – 5.73 (m, 2H), 5.26 – 4.98 (m, 2H), 4.37 – 
4.04 (m, 3H), 3.65 (s+ s’, 3H), 2.85 – 2.58 (m, 2H), 2.12 – 1.62 (m, 4H). 13C NMR (151 MHz, 
Chloroform-d) δ (172.94, 172.69), (154.76, 154.22), (136.47, 136.40), (128.52, 128.49), (128.42, 
128.05), (127.67, 127.64), (127.05, 126.96), (126.78, 126.10), (67.13, 66.98), (66.25, 65.83), 
(57.86, 57.81), (52.36, 52.21), (51.78, 51.52), (51.09, 50.94), (44.71, 44.25), (43.31, 42.71), 
(32.82, 31.86), (28.26, 27.57). New compound; Procedure was taken from reference 52. 
 
Notebook Entries: 
Procedure    – cwh3-420 
1H                – cwh3-420-B 
13C               – cwh3-420-B 
 
NSe
CO2Me
Cbz
H
H
O2N N
CO2Me
Cbz
H
H
OH
mCPBA
DCM
74%
159 
 
 
160 
4-benzyl 5-methyl (3aR,5S,6aS)-2-oxooctahydro-4H-oxireno[2,3-e]indole-4,5-dicarboxylate 
(67) 
 
                       16         67 
 
To a stirred solution of compound 16 (383 mg, 1.16 mmol, 1 eq) in DCM (11 mL, 0.10 M) was 
bubbled with argon for 5 minutes. Then H2O2 (20 mL, 6.05 mmol, 5.2 eq) was added followed by 
4M NaOH (0.030 mL, 0.116 mmol, 0.1 eq) at 0 C, and then was stirred at 0 C. After 0.5 h, the 
reaction was quenched with 3 drops of glacial acetic acid and organic layer was extracted with 
DCM (× 3). The combined organic layers were washed with brine, dried with anhydrous Na2SO4, 
and concentrated in vacuo. The crude residue was purified by flash column chromatography (silica 
gel, EtOAc:hexanes, 1:1) to give compound 67 as a white foam ( 268 mg, 67% yield). Rf = 0.29 
(silica, EtOAc:hexanes, 1:1); Rotamers were shown in ( ). 1H NMR (400 MHz, Chloroform-d) δ 
7.34 – 7.30 (m, 5H), 5.26 – 4.82 (m, 2H), 4.45 (td, J = 19.0, 17.4, 7.1 Hz, 1H), 4.25 – 4.05 (m, 
1H), 3.72 – 3.30 (m, 4H), 2.75 – 1.47 (m, 3H). New compound; Procedure was taken from 
reference 39. 
 
Notebook Entries: 
Procedure    – cwh2-353 
1H                – cwh2-353-crude 
 
NO
CO2Me
Cbz
H
H
NO
CO2Me
Cbz
H
H
H2O2, 4M NaOH
DCM
67%
O
161 
 
 
 
 
 
 
 
 
 
 
 
162 
1-benzyl 2-methyl (2S,3aS,7aR)-4-hydroxy-2,3,3a,4,7,7a-hexahydro-1H-indole-1,2-
dicarboxylate (65) 
 
      67          65 
 
To a stirred solution of compound 67 (213 mg, 0.62 mmol, 1 eq) in DCM (6.2 mL, 0.10 M) was 
added N2H4.H2O (0.06 mL, 1.23 mmol, 2 eq) followed by 1 drop of glacial acetic acid at 0 C, and 
then was stirred at room temperature. After 16 h, the reaction was quenched with saturated aqueous 
NaHCO3 and organic layer was extracted with DCM (× 3). The combined organic layers were 
washed with brine, dried with anhydrous Na2SO4, and concentrated in vacuo. The crude residue 
was purified by flash column chromatography (silica gel, EtOAc:hexanes, 1:1) to give compound 
65 as a white foam (41 mg, 20% yield). Rf = 0.45 (silica, EtOAc:hexanes, 1:1); Rotamers were 
shown in ( ). 1H NMR (600 MHz, Chloroform-d) δ 7.41 – 7.23 (m, 5H), 5.90 – 5.73 (m, 2H), 5.26 
– 4.98 (m, 2H), 4.37 – 4.04 (m, 3H), 3.65 (s+ s’, 3H), 2.85 – 2.58 (m, 2H), 2.12 – 1.62 (m, 4H). 13C 
NMR (151 MHz, Chloroform-d) δ (172.94, 172.69), (154.76, 154.22), (136.47, 136.40), (128.52, 
128.49), (128.42, 128.05), (127.67, 127.64), (127.05, 126.96), (126.78, 126.10), (67.13, 66.98), 
(66.25, 65.83), (57.86, 57.81), (52.36, 52.21), (51.78, 51.52), (51.09, 50.94), (44.71, 44.25), 
(43.31, 42.71), (32.82, 31.86), (28.26, 27.57). New compound; Procedure was taken from 
reference 39. 
 
Notebook Entries: 
Procedure    – cwh2-367 
1H                – cwh3-420-B 
13C               – cwh3-420-B 
NO
CO2Me
Cbz
H
H
O
N
CO2Me
Cbz
H
H
OH
N2H4 . H2O, CH3CO2H
DCM
20%
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164 
1-benzyl 2-methyl (2S,3aS,7aR)-4-oxo-2,3,3a,4,7,7a-hexahydro-1H-indole-1,2-dicarboxylate 
(70) 
 
                            65        70 
 
To a stirred solution of compound 65 (11 mg, 0.036 mmol, 1 eq) in DCM (0.4 mL, 0.10 M) was 
added DMP (15 mg, 0.108 mmol, 2 eq) and K2CO3 (48 mg, 0.180 mmol, 3 eq), and was stirred at 
room temperature. After 4 h, the reaction was diluted with H2O and organic layer was extracted 
with DCM (× 3). The combined organic layers were washed with brine, dried with anhydrous 
Na2SO4, and concentrated in vacuo. The crude residue was purified by flash column 
chromatography (silica gel, EtOAc:hexanes, 1:1) to give compound 70 as a white foam (8.3 mg, 
83% yield). Rf = 0.52 (silica, EtOAc:hexanes, 1:1); Rotamers were shown in ( ). 1H NMR (400 
MHz, Chloroform-d) δ 7.48 – 7.27 (m, 5H), 6.95 – 6.81 (m, 1H), 6.16 – 6.06 (m, 1H), 5.34 – 5.01 
(m, 2H), 4.59 (dd, J = 14.8, 7.6 Hz, 1H), 4.53 – 4.38 (m, 1H), 3.83 + 3.45 (s+ s’, 3H), 3.23 – 3.05 
(m, 1H), 2.94 (m, 1H), 2.38 – 2.20 (m, 3H). New compound; Procedure was taken from reference 
39. 
 
Notebook Entries: 
Procedure    – cwh2-332` 
1H                – cwh2-332 
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166 
1-benzyl 2-methyl (2S,3aR,6R,7S,7aS)-7-((tert-butyldimethylsilyl)oxy)-6-
((methylsulfonyl)oxy)-2,3,3a,6,7,7a-hexahydro-1H-indole-1,2-dicarboxylate (84) 
 
  83                84 
 
To a stirred solution of compound 83 (89 mg, 0.193 mmol, 1 eq) in DCM (0.7 mL, 0.267 M) was 
added Et3N (0.04 mL, 0.290 mmol, 1.5 eq) and MsCl (0.02 mL, 0.232 mmol, 1.2 eq) at -78 C, 
and then was stirred at -78 C. After 1 h, the reaction was quenched with saturated aqueous 
NaHCO3 and organic layer was extracted with DCM (× 3). The combined organic layers were 
washed with brine, dried with anhydrous Na2SO4, and concentrated in vacuo. The crude residue 
was purified by flash column chromatography (silica gel, EtOAc:hexanes, 1:3) to give compound 
84 as a white foam (93.6 mg, 90% yield). Rf = 0.46 (silica, EtOAc:hexanes, 1:3); Rotamers were 
shown in ( ). 1H NMR (400 MHz, Chloroform-d) δ 7.46 – 7.27 (m, 5H), 5.77 – 5.54 (m, 2H), 5.32 
– 4.99 (m, 4H), 4.64 (m, 1H), 4.47 – 4.40 (m, 1H), 4.23 – 4.13 (m, 1H), 3.56 (s+ s’, 3H), 3.02 (s+ 
s’, 3H), 2.40 – 2.28 (m, 1H), 1.98 (m, 1H), 0.86 – 0.79 (m, 9H), 0.08 – -0.23 (m, 6H). 13C NMR 
(101 MHz, Chloroform-d) δ (173.35, 173.34), (154.18, 154.17), (136.36, 136.35), (129.04, 
128.87), (128.81, 128.63), (128.58, 128.34), (124.52, 123.86), (77.88, 77.65), (68.47, 67.73), 
(67.47, 67.29), (60.73, 60.45), (59.56, 58.90), (52.58, 52.41), (38.83, 38.73), (37.17, 36.12), 
(34.89, 33.92), (26.03, 26.00), (18.28, 18.27), (-4.36, -5.05). New compound; Procedure was taken 
from reference 50. 
Notebook Entries: 
Procedure    – cwh3-168 
1H                – cwh3-168-A 
13C               – cwh3-271-c13 
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Cbz
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168 
1-benzyl 2-methyl (2S,3aR,6R,7S,7aR)-3a-(benzoyloxy)-7-((tert-butyldimethylsilyl)oxy)-6-
hydroxy-2,3,3a,6,7,7a-hexahydro-1H-indole-1,2-dicarboxylate (30) 
 
  29                          30 
 
To a stirred solution of compound 29 (37 mg, 0.064 mmol, 1 eq) in THF:MeOH 1:1 (1.0 mL, 
0.0875M) was added CeCl3 •7H2O (24 mg, 0.064 mmol, 1 eq), and was stirred for 5 mins. Then 
NaBH4 (2.4 mg, 0.064 mmol, 1 eq) was added portion wise, and then was stirred at room 
temperature. After 5 mins, the reaction was quenched with saturated aqueous NaHCO3 and organic 
layer was extracted with EtOAc (× 3). The combined organic layers were washed with brine, dried 
with anhydrous Na2SO4, and concentrated in vacuo. The crude residue was purified by flash 
column chromatography (silica gel, EtOAc:hexanes, 1:3) to give compound 30 as a white foam 
(36.6 mg, 99% yield). Rf = 0.39 (silica, EtOAc:hexanes, 1:3); Rotamers were shown in ( ). 1H 
NMR (400 MHz, Chloroform-d) δ 7.92 – 7.22 (m, 10H), 5.92 – 5.69 (m, 2H), 5.25 – 4.50 (m, 6H), 
3.37 (s+ s’, 3H), 2.80 – 2.55 (m, 2H), 0.83 (s+ s’, 9H), 0.16 – -0.17 (m, 6H). 13C NMR (101 MHz, 
Chloroform-d) δ (172.22, 171.55), (165.30, 165.29), (154.31, 154.30), (136.27, 136.26), (134.17, 
134.16), (133.62, 133.34), (130.48, 130.47), (129.83, 129.79), (129.03, 128.87), (128.64, 128.50), 
(128.48, 128.34), (124.65, 124.27), (86.12, 85.10), (72.81, 71.56), (69.42, 69.24), (67.83, 67.48), 
(64.93, 64.10), (59.60, 59.41), (52.47, 52.32), (40.70, 39.97), (26.17, 26.14), (18.38, 18.37), (-4.23, 
-4.47). Known compound; all the spectral data matches the data reported in reference 41. 
Notebook Entries: 
Procedure    – cwh3-147 
1H                – cwh3-147-pure 
13C               – cwh3-147-pure 
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169 
 
 
170 
1-benzyl 2-methyl (2S,3aR,6R,7S,7aR)-6-acetoxy-3a-(benzoyloxy)-7-((tert-
butyldimethylsilyl)oxy)-2,3,3a,6,7,7a-hexahydro-1H-indole-1,2-dicarboxylate (31) 
 
  30        31 
 
To a stirred solution of compound 30 (37 mg, 0.064 mmol, 1 eq) in DCM (0.6 mL, 0.10 M) was 
added acetic anhydride (0.02 mL, 0.195 mmol, 3.05 eq), DMAP (0.8 mg, 0.064 mmol, 0.10 eq), 
and Et3N (0.03 mL, 0.198 mmol, 3.10 eq), and then was stirred at room temperature. After 4 h, the 
reaction was quenched with saturated aqueous NaHCO3 and the organic layer was extracted with 
DCM (× 3). The combined organic layers were washed with brine, dried with anhydrous Na2SO4, 
and concentrated in vacuo. The crude residue was purified by flash column chromatography (silica 
gel, EtOAc:hexanes 1:3) to give compound 31 as a light-yellow foam (37.6 mg, 94% yield). Rf = 
0.30 (silica, EtOAc:hexanes, 1:3); Rotamers were shown in ( ). 1H NMR (600 MHz, Chloroform-
d) δ 7.96 – 7.25 (m, 10H), 5.95 (m, 1H), 5.80 – 5.61 (m, 2H), 5.36 – 4.51 (m, 6H), 3.59 + 3.24 (s+ 
s’, 3H), 2.89 – 2.64 (m, 2H), 2.12 (s+ s’, 3H), 0.96 – 0.76 (m, 9H), 0.09 – -0.25 (m, 6H). 13C NMR 
(151 MHz, Chloroform-d) δ (172.06, 171.44), (170.03, 169.95), (165.29, 164.98), (153.96, 
153.95), (136.08, 136.04), (133.19, 133.15), (130.18, 130.15), (129.64, 129.59), (128.77, 128.64), 
(128.42, 128.30), (128.28, 128.12), (125.19, 124.89), (86.05, 85.00), (71.97, 71.69), (70.57, 
69.37), (67.49, 67.25), (64.82, 63.90), (59.36, 59.16), (52.29, 52.15), (40.34, 39.68), (29.74, 
29.73), (25.82, 25.78), (21.30, 21.23), (18.18, 18.15), (-4.60, -4.74). Known compound; all the 
spectral data matches the data reported in reference 41. 
Notebook Entries: 
Procedure    – cwh3-148 
1H                – cwh3-148                 13C               – cwh3-148 
NHO
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H
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Ac2O, DMAP, Et3N
DCM
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172 
1-benzyl 2-methyl (2S,3aR,6S,7aR)-3a-acetoxy-6-hydroxy-2,3,3a,6,7,7a-hexahydro-1H-
indole-1,2-dicarboxylate (57) 
 
      56          57 
 
To a stirred solution of compound 56 (70 mg, 0.18 mmol, 1 eq) in THF:MeOH 1:1 (2.0 mL, 
0.0875M) was added CeCl3 •7H2O (67 mg, 0.18 mmol, 1 eq), and was stirred for 5 mins. Then 
NaBH4 (6.7 mg, 0.13 mmol, 1 eq) was added portion wise, and then was stirred at room 
temperature. After 5 mins, the reaction was quenched with saturated aqueous NaHCO3 and organic 
layer was extracted with EtOAc (× 3). The combined organic layers were washed with brine, dried 
with anhydrous Na2SO4, and concentrated in vacuo. The crude residue was purified by flash 
column chromatography (silica gel, EtOAc:hexanes, 1:1) to give compound 57 as a white foam 
(69.4 mg, 99% yield). Rf = 0.37 (silica, EtOAc:hexanes, 1:1); Rotamers were shown in ( ). 1H 
NMR (400 MHz, Chloroform-d) δ 7.45 – 7.24 (m, 5H), 6.01 – 5.88 (m, 1H), 5.79 (m, 1H), 5.26 – 
5.04 (m, 2H), 4.60 – 4.43 (m, 2H), 3.66 (s+ s’, 3H), 2.82 – 2.63 (m, 2H), 2.45 – 2.36 (m, 1H), 1.92 
(s+ s’, 3H), 1.48 – 1.38 (m, 1H). 13C NMR (101 MHz, Chloroform-d) δ 171.84, 171.24, 170.35, 
170.09, 154.77, 154.27, 136.68, 136.46, 136.21, 128.80, 128.66, 128.40, 128.33, 128.31, 128.25, 
128.18, 125.42, 125.10, 85.47, 84.38, 77.45, 67.75, 67.43, 66.15, 65.95, 60.99, 60.25, 58.66, 58.52, 
52.50, 52.38, 43.63, 39.74, 39.04, 38.91, 38.02, 22.11, 22.03. Known compound; all the spectral 
data matches the data reported in reference 38. 
Notebook Entries: 
Procedure    – cwh3-363 
1H                – cwh3-363-pure 
13C               – cwh3-363-c13 
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174 
1-benzyl 2-methyl (2S,3aR,6R,7aR)-3a-acetoxy-6-bromo-2,3,3a,6,7,7a-hexahydro-1H-
indole-1,2-dicarboxylate (58) 
 
         57          58 
 
To a stirred solution of compound 57 (63 mg, 0.162 mmol, 1 eq) in DCM (1.6 mL, 0.10 M) was 
added CBr4 (59 mg, 0.178 mmol, 1.1 eq) and PPh3 (47 mg, 0.178 mmol, 1.1), and then was stirred 
at room temperature. After 16 h, the reaction was quenched with saturated aqueous NaHCO3 and 
organic layer was extracted with DCM (× 3). The combined organic layers were washed with 
brine, dried with anhydrous Na2SO4, and concentrated in vacuo. The crude residue was purified 
by flash column chromatography (silica gel, EtOAc:hexanes, 1:1) to give compound 58 as a white 
foam (57 mg, 78% yield). Rf = 0.45 (silica, EtOAc:hexanes, 1:1); Rotamers were shown in ( ). 1H 
NMR (400 MHz, Chloroform-d) δ 7.54 – 7.25 (m, 5H), 6.11 (m, 1H), 5.80 (m, 1H), 5.28 – 5.02 
(m, 2H), 4.82 – 4.69 (m, 1H), 4.56 – 4.47 (m, 1H), 3.66 (s+ s’, 3H), 3.15 – 2.85 (m, 2H), 2.74 (m, 
1H), 2.48 (m, 1H), 2.06 – 1.88 (m, 4H). 13C NMR (101 MHz, Chloroform-d) δ (171.73, 171.72), 
(170.02, 170.01), (152.87, 152.86), (136.33, 136. 32), (134.49, 134.03), (128.83, 128.67), (128.48, 
128.40), (128.34, 128.28), (126.67, 126.50), (84.07, 83.06), (67.85, 67.49), (61.26, 60.44), (58.43, 
58.26), (52.54, 52.41), (42.29, 42. 28), (39.85, 39.84), (38.95, 38.82), (22.02, 21.95). New 
compound; Procedure was taken from reference 44. 
 
Notebook Entries: 
Procedure    – cwh3-364 
1H                – cwh3-365-A-pure 
13C               – cwh3-365-A-pure 
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H
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DCM
78%
175 
 
 
 
176 
(5aS,10aS)-octahydro-5H,10H-dipyrrolo[1,2-a:1',2'-d]pyrazine-5,10-dione (126) 
 
                  L-Proline      126 
 
To a stirred solution of L-Proline (2.5 g, 21.7 mmol, 1 eq) in DMF (2.0 mL, 10.85 M) was 
microwaved at 220 C and 200 W for 25 minutes. The reaction was quenched with saturated 
aqueous NaHCO3 and organic layer was extracted with EtOAc (× 3). The combined organic layers 
were washed with brine, dried with anhydrous Na2SO4, and concentrated in vacuo to give 
compound 126 as a white foam (3.4 g, 80% yield). Rf = 0.55 (silica, EtOAc: MeOH, 9:1); 1H 
NMR (400 MHz, Chloroform-d) δ 4.17 (t, J = 8.1 Hz, 2H), 3.61 – 3.49 (m, 4H), 2.32 (m, 2H), 2.23 
– 2.13 (m, 2H), 2.06 – 1.90 (m, 4H). 13C NMR (101 MHz, Chloroform-d) δ 166.58, 60.75, 45.42, 
27.90, 23.56. Known compound; all the spectral data matches the data reported in reference 53. 
 
Notebook Entries: 
Procedure    – cwh1-172 
1H                – cwh1-172 
13C               – cwh1-148-c13 
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178 
(5aR,10aR)-11-(1l4,2l4-trisulfan-1,2-dienylidene)tetrahydro-1H,5H,6H,10H-11l4-5a,10a-
epithiodipyrrolo[1,2-a:1',2'-d]pyrazine-5,10-dione (127) 
 
      126       127 
 
To a stirred solution of S8 (263 mg, 8.21 mmol, 8 eq) in THF (5 mL, 1.6 M) was added NaHMDS 
(5 mL, 3.078 mmol, 3 eq) dropwise and stirred for 1 minutes.  Then compound 126 (200 mg, 1.026 
mmol, 1 eq) dissolved in THF (5 mL, 0.2 M) was added to the reaction mixture drop wise, and 
then NaHMDS (3.5 mL, 2.052 mmol, 2 eq) was added. The reaction mixture was stirred at room 
temperature for 1 h. The reaction was quenched with saturated aqueous NH4Cl and organic layer 
was extracted with EtOAc (× 3). The combined organic layers were washed with brine, dried with 
anhydrous Na2SO4, and concentrated in vacuo. The crude residue was purified by flash column 
chromatography (silica gel, EtOAc: MeOH: DCM, 8:1:1) to give compound 127 as a white foam 
(203 mg, 62% yield). Rf = 0.54 (silica, EtOAc: MeOH: DCM, 8:1:1); 1H NMR (400 MHz, 
Chloroform-d) δ 3.73 (m, 2H), 3.50 (m, 2H), 2.31 – 2.19 (m, 6H), 2.03 (m, 2H). Known compound; 
all the spectral data matches the data reported in reference 54. 
 
Notebook Entries: 
Procedure    – cwh3-405 
1H                – cwh3-257 
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180 
(5aR,10aR)-tetrahydro-1H,5H,6H,10H-5a,10a-epidithiodipyrrolo[1,2-a:1',2'-d]pyrazine-
5,10-dione (128) 
 
   127         128 
 
To a stirred solution of compound 127 (328 mg, 1.026 mmol, 1 eq) in THF: EtOH 1:1 (10 mL, 
0.10 M) was bubbled with argon for 5 minutes. Then the reaction mixture was cooled to 0 C and 
NaBH4 (951 mg, 25.65 mmol, 25 eq) was added portion wise. The reaction mixture was allowed 
to reach room temperature and stirred for 1 h. The reaction was quenched with saturated aqueous 
NH4Cl and organic layer was extracted with EtOAc (× 3). The combined organic layers were 
washed with brine, dried with anhydrous Na2SO4, and diluted with EtOAc (0.002M). The organic 
layer was bubbled with O2 (g) for 15 h and concentrated in vacuo. The crude residue was purified 
by flash column chromatography (silica gel, EtOAc) to give compound 128 as a white foam (113 
mg, 43% yield). Rf = 0.60 (silica, EtOAc); 1H NMR (600 MHz, Chloroform-d) δ 3.88 (m, 2H), 
3.57 (m, 2H), 3.05 – 2.94 (m, 2H), 2.43 – 2.30 (m, 4H), 2.27 – 2.19 (m, 2H). 13C NMR (101 MHz, 
Chloroform-d) δ 163.40, 45.93, 44.36, 38.02, 32.24, 29.74, 23.68, 19.32. Known compound; all 
the spectral data matches the data reported in reference 39. 
 
Notebook Entries: 
Procedure    – cwh3-406 
1H                – cwh3-406 
13C               – cwh4-048 
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182 
(5aR,10aR)-5a,10a-bis(methylthio)octahydro-5H,10H-dipyrrolo[1,2-a:1',2'-d]pyrazine-
5,10-dione (131) 
 
         127       131 
 
To a stirred solution of compound 127 (165 mg, 0.515 mmol, 1 eq) in THF: EtOH 1:1 (5 mL, 0.10 
M) was bubbled with argon for 5 minutes. Then the reaction mixture was cooled to 0 C and 
NaBH4 (477 mg, 12.87 mmol, 25 eq) was added portion wise. The reaction mixture was allowed 
to reach room temperature and stirred for 1 h. Then the reaction was added MeI (1.6 mL, 25.75 
mmol, 50 eq), and then was stirred at room temperature. After 12h, the reaction was quenched 
with saturated aqueous NH4Cl and organic layer was extracted with EtOAc (× 3). The combined 
organic layers were washed with brine, dried with anhydrous Na2SO4, and concentrated in vacuo. 
The crude residue was purified by flash column chromatography (silica gel, EtOAc) to give 
compound 131 as a white foam (94 mg, 64% yield). Rf = 0.53 (silica, EtOAc); 1H NMR (400 
MHz, Chloroform-d) δ 3.74 – 3.65 (m, 2H), 3.57 (ddd, J = 11.8, 9.7, 2.1 Hz, 2H), 2.46 (dd, J = 
12.8, 6.6 Hz, 2H), 2.31 – 2.26 (m, 2H), 2.21 (s, 6H), 2.07 – 1.98 (m, 4H). 13C NMR (101 MHz, 
Chloroform-d) δ 165.03, 71.53, 45.59, 34.28, 20.13, 14.84. Known compound; all the spectral data 
matches the data reported in reference 54. 
 
Notebook Entries: 
Procedure    – cwh3-380 
1H                – cwh3-380-1 
13C               – cwh3-380-c13 
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184 
(5aS,10aS)-octahydro-5H,10H-dipyrrolo[1,2-a:1',2'-d]pyrazine-5,10-dione-5a,10a-d2 (129) 
 
     126        129 
 
To a stirred solution of compound 126 (100 mg, 0.51 mmol, 1 eq) in THF (17 mL, 0.03 M) was 
added NaHMDS (3 mL, 3.06 mmol, 6 eq) drop wise at -78 C, and was stirred at room temperature. 
After 1h D2O (3 mL, 0.17 M) was added, and then was stirred at room temperature. After 2 h, the 
reaction was quenched with saturated aqueous NH4Cl and organic layer was extracted with DCM 
(× 3). The combined organic layers were washed with brine, dried with anhydrous Na2SO4, and 
concentrated in vacuo. The crude residue was purified by flash column chromatography (silica gel, 
EtOAc: MeOH: DCM, 8:1:1) to give compound 129 as a white foam (68.7 mg, 68% yield). Rf = 
0.44 (silica, EtOAc: MeOH: DCM, 8:1:1); 1H NMR (400 MHz, Chloroform-d) δ 3.67 – 3.42 (m, 
4H), 2.35 – 1.91 (m, 8H). 13C NMR (101 MHz, Chloroform-d) δ 166.61, 45.43, 27.80, 23.57. 
Known compound; all the spectral data matches the data reported in reference 54. 
 
Notebook Entries: 
Procedure    – cwh3-281 
1H                – cwh3-281 
13C               – cwh3-281-c13 
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186 
(5aS,10aS)-5a,10a-dimethyloctahydro-5H,10H-dipyrrolo[1,2-a:1',2'-d]pyrazine-5,10-dione 
(130) 
 
   126        130 
 
To a stirred solution of compound 126 (100 mg, 0.51 mmol, 1 eq) in THF (17 mL, 0.03 M) was 
added NaHMDS (3 mL, 3.06 mmol, 6 eq) dropwise at -78 C. The reaction was stirred for 1 h and 
MeI (1.6 mL, 25.5 mmol, 50 eq) was added. After 12 h, the reaction was quenched with saturated 
aqueous NH4Cl and organic layer was extracted with DCM (× 3). The combined organic layers 
were washed with brine, dried with anhydrous Na2SO4, and concentrated in vacuo. The crude 
residue was purified by flash column chromatography (silica gel, EtOAc: MeOH: DCM, 8:1:1) to 
give compound 130 as a white foam (78 mg, 69% yield). Rf = 0.56 (silica, EtOAc: MeOH: DCM, 
8:1:1); 1H NMR (400 MHz, Chloroform-d) δ 3.83 – 3.68 (m, 2H), 3.51 – 3.38 (m, 2H), 2.09 – 
1.93 (m, 8H), 1.47 (s, 6H). Known compound; all the spectral data matches the data reported in 
reference 54. 
 
Notebook Entries: 
Procedure    – cwh3-282 
1H                – cwh3-282 
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188 
1-benzyl 2-methyl (2S,3aS,4S,7S,7aS)-4,7-bis((tert-butyldimethylsilyl)oxy)-2,3,3a,4,7,7a-
hexahydro-1H-indole-1,2-dicarboxylate (132) 
 
                       101       132 
 
To a stirred solution of compound 101 (30 mg, 0.065 mmol, 1 eq) in DCM (0.65 mL, 0.10 M) was 
added Et3N (0.02 mL, 0.130 mmol, 2 eq) and TBSOTf (0.02 mL, 0.078 mmol, 1.2 eq), and then 
was stirred at room temperature. After 2 h, the reaction was quenched with saturated aqueous 
NaHCO3 and organic layer was extracted with DCM (× 3). The combined organic layers were 
washed with brine, dried with anhydrous Na2SO4, and concentrated in vacuo. The crude residue 
was purified by flash column chromatography (silica gel, EtOAc:hexanes, 1:1) to give compound 
132 as a white foam (34 mg, 92% yield). Rf = 0.78 (silica, EtOAc:hexanes, 1:1); Rotamers were 
shown in ( ). 1H NMR (400 MHz, Chloroform-d) δ 7.43 – 7.26 (m, 5H), 6.00 – 5.66 (m, 2H), 5.31 
– 4.97 (m, 2H), 4.52 – 3.91 (m, 4H), 3.66 (s+ s’, 3H), 3.01 – 2.78 (m, 1H), 2.40 – 2.19 (m, 1H), 
1.98 (m, 1H), 0.93 – 0.76 (m, 18H), 0.20 – -0.17 (m, 12H). 13C NMR (101 MHz, Chloroform-d) δ 
(173.74, 173.61), (154.61, 153.71), (136.69, 136.56), (129.56, 129.31), (128.62, 128.51), (127.88, 
127.81), (125.90, 125.56), (70.99, 70.37), (69.85, 68.74), (67.37, 67.21), (66.85, 66.76), (59.66, 
59.61), (56.80, 56.16), (53.42, 52.21), (36.61, 36.40), (35.61, 35.40), (35.14, 34.36), (25.85, 
25.63), (17.92, 17.62), (-4.33, -5.35). New compound; Procedure was taken from reference 39. 
Notebook Entries: 
Procedure    – cwh4-207 
1H                – cwh4-207 
13C               – cwh4-207 
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190 
1-benzyl 2-methyl (2S,3aS,4S,7S,7aS)-4-acetoxy-7-((tert-butyldimethylsilyl)oxy)-
2,3,3a,4,7,7a-hexahydro-1H-indole-1,2-dicarboxylate (134) 
 
                       101       134 
To a stirred solution of compound 101 (48 mg, 0.104 mmol, 1 eq) in DCM (1 mL, 0.10 M) was 
added acetic anhydride (0.02 mL, 0.208 mmol, 2 eq), DMAP (2.3 mg, 0.021 mmol, 0.2 eq), and 
Et3N (0.04 mL, 0.312 mmol, 3.0 eq), and then was stirred at room temperature. After 15 h, the 
reaction was quenched with saturated aqueous NaHCO3 and the organic layer was extracted with 
DCM (× 3). The combined organic layers were washed with brine, dried with anhydrous Na2SO4, 
and concentrated in vacuo. The crude residue was purified by flash column chromatography (silica 
gel, EtOAc:hexanes 1:1) to give compound 134 as a light-yellow foam (47 mg, 92% yield). Rf = 
0.72 (silica, EtOAc:hexanes, 1:1); Rotamers were shown in ( ).  1H NMR (400 MHz, Chloroform-
d) δ 7.44 – 7.25 (m, 5H), 6.15 – 5.71 (m, 2H), 5.34 – 4.97 (m, 3H), 4.68 – 4.00 (m, 3H), 3.66 (s+ 
s’, 3H), 2.92 (m, 1H), 2.52 – 2.17 (m, 2H), 2.10 – 1.92 (m, 3H), 0.91 – 0.73 (m, 9H), 0.13 – -0.16 
(m, 6H). 13C NMR (101 MHz, Chloroform-d) δ (173.48, 173.40), (170.48, 169.91), (154.46, 
153.84), (136.42, 136.18), (133.28, 132.81), (130.33, 130.21), (129.42, 128.91), (128.12, 128.01), 
(127.95, 127.91), (121.71, 121.28), (70.64, 70.19), (67.33, 67.01), (66.98, 66.73), (63.09, 62.24), 
(59.86, 59.11), (58.95, 57.06), (56.97, 56.41), (52.30, 52.08), (40.60, 39.80), (36.56, 35.21), 
(34.31, 34.20), (25.65, 25.63), (21.22, 20.90), (17.72, 17.59), (-4.71, -5.47). New compound; 
Procedure was taken from reference 38. 
Notebook Entries:  
Procedure    – cwh4-208      1H    – cwh4-208     13C       – cwh4-208 
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192 
(2S,3aS,4S,7S,7aS)-1-((benzyloxy)carbonyl)-4,7-bis((tert-butyldimethylsilyl)oxy)-
2,3,3a,4,7,7a-hexahydro-1H-indole-2-carboxylic acid (133) 
 
                        132         133 
 
To a stirred solution of compound 132 (75 mg, 0.130 mmol, 1 eq) in THF:MeOH 1:1 (1.3 mL, 0.1 
M) was added 2M KOH (1.3 mL, 0.10 M), and then was stirred at 45 C. After 1 h, the reaction 
was acidified to pH 2 with 1M HCl and organic layer was extracted with EtOAc (× 3). The 
combined organic layers were dried with anhydrous Na2SO4 and concentrated in vacuo to give 
compound 133 as a white foam (71 mg, 98% yield). Rf = 0.11 (silica, EtOAc:hexanes, 
1:1);  Rotamers were shown in ( ). 1H NMR (400 MHz, Chloroform-d) δ 7.48 – 7.29 (m, 5H), 5.97 
– 5.67 (m, 2H), 5.34 – 5.10 (m, 2H), 4.45 – 3.86 (m, 4H), 2.88 (t, J = 10.1 Hz, 1H), 2.38 – 2.08 
(m, 2H), 0.96 – 0.79 (m, 18H), 0.15 – -0.21 (m, 12H). Crude was directly used in next reaction 
without further purification. New compound; Procedure was taken from reference 39. 
 
Notebook Entries: 
Procedure    – cwh4-232 
1H                – cwh4-209 
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194 
Methyl.(2S,3aS,4S,7S,7aS)-4-acetoxy-7-((tert-butyldimethylsilyl)oxy)-2,3,3a,4,7,7a-
hexahydro-1H-indole-2-carboxylate  (135) 
 
                         134       135 
 
To a stirred solution of compound 134 (35 mg, 0.069 mmol, 1 eq) in DCM (0.70 mL, 0.10 M) was 
added Pd(OAc)2 (18 mg, 0.083 mmol, 1.2 eq) and Et3N (0.02 mL, 0.166 mmol, 2.4 eq), and was 
stirred for 5 mins at 45 C. Then Et3SiH (0.10 mL, 0.690 mmol, 10 eq) was added drop wise, and 
then was stirred at 45 C. After 20 h, the reaction was filtered through celite pad and concentrated 
in vacuo to give compound 135 as an oily residue (13 mg, 52% yield). Rf = 0.31 (silica, 
EtOAc:hexanes, 1:3); Rotamers were shown in ( ). 1H NMR (400 MHz, Chloroform-d) δ 5.55 – 
5.47 (m, 2H), 3.90 – 3.77 (m, 2H), 3.71 (s, 3H), 3.61 (dd, J = 5.8, 3.4 Hz, 1H), 2.84 (td, J = 5.9, 
3.1 Hz, 1H), 2.16 – 1.98 (m, 6H), 0.90 (s, 9H), 0.09 (d, J = 15.4 Hz, 6H). New compound; 
Procedure was taken from reference 39. 
 
Notebook Entries: 
Procedure    – cwh4-215 
1H                – cwh4-216 
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196 
Benzyl (2S,3aS,4R,7R,7aS)-2-((2S,3aS,4R,7R,7aS)-4,7-bis((tert-butyldimethylsilyl)oxy)-2-
(methoxycarbonyl)-2,3,3a,4,7,7a-hexahydro-1H-indole-1-carbonyl)-4,7-bis((tert-
butyldimethylsilyl)oxy)-2,3,3a,4,7,7a-hexahydro-1H-indole-1-carboxylate (136) 
 
     133                                        135      136  
 
To a stirred solution of carboxylic acid 133 (24 mg, 0.043 mmol, 1 eq) and amine 135 (16 mg, 
0.043 mmol, 1 eq) in DCM (0.40 mL, 0.10 M) was cooled to 0 ºC. Then Et3N (0.02 mL, 0.130 
mmol, 3.0 eq) was added and stirred. After 5 mins, BOPCl (13 mg, 0.052 mmol, 1.2 eq) was added 
portion wise, and then was stirred at room temperature. After 20 h, the reaction was concentrated 
in vacuo and the crude residue was purified by flash column chromatography (silica gel, 
EtOAc:hexanes, 3:1) to give compound 136 as a white foam (9 mg, 23% yield). Rf = 0.61 (silica, 
EtOAc:hexanes, 3:1); Rotamers were shown in ( ). 1H NMR (400 MHz, Chloroform-d) δ 7.48 – 
7.31 (m, 5H), 6.09 – 5.66 (m, 4H), 5.23 – 5.04 (m, 2H), 4.63 – 4.09 (m, 6H), 3.90 – 3.72 (s+ s’, 
3H), 3.06 (s, 2H), 2.53 – 1.97 (m, 9H), 0.97 – 0.77 (m, 27H), 0.33 – -0.26 (m, 16H).  
New compound; Procedure was taken from reference 39. 
 
Notebook Entries: 
Procedure    – cwh4-217 
1H                – cwh4-217-C 
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198 
 (1S,4S,4aS,6aS,7aS,8S,11S,11aS,13aS,14aS)-4,8,11-tris((tert-butyldimethylsilyl)oxy)-6,13-
dioxo-4,4a,6a,7,7a,8,11,11a,13,13a,14,14a-dodecahydro-1H,6H-pyrazino[1,2-a:4,5-
a']diindol-1-yl acetate (137) 
 
                         136       137 
 
To a stirred solution of compound 136 (9 mg, 0.0098 mmol, 1 eq) in DCM (1.0 mL, 0.01 M) was 
added Pd(OAc)2 (0.44 mg, 0.002 mmol, 0.2 eq) and Et3N (0.5 L, 0.004 mmol, 0.4 eq), and was 
stirred for 5 mins at 45 C. Then Et3SiH (0.01 mL, 0.069 mmol, 7 eq) was added drop wise, and 
then was stirred at 45 C. After 2 h, the reaction was filtered through celite pad and concentrated 
in vacuo to give compound 137 as an oily residue. Rf = 0.63 (silica, EtOAc:hexanes, 1:3); 1H NMR 
(400 MHz, Chloroform-d) δ 6.22 – 5.84 (m, 4H), 5.45 – 5.08 (m, 3H), 4.80-4.32 (m, 4H), 3.81 (m, 
1H), 3.75 (m, 1H), 2.31 – 2.10 (m, 4H), 2.08-1.90 (m, 4H), 0.90 (m, 27H), 0.02 (m, 18H). New 
compound; Procedure was taken from reference 39. 
 
Notebook Entries: 
Procedure    – cwh4-226 
1H                – cwh4-226-B 
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ADDENDUM 
